var title_f8_22_8544="Predicted body weight and tidal volume for men";
var content_f8_22_8544=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F87507&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F87507&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Predicted body weight and tidal volume for men",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <colgroup span=\"9\" width=\"11%\">",
"     </colgroup>",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\" colspan=\"3\">",
"        Height",
"       </td>",
"       <td class=\"subtitle1\">",
"        PBW",
"       </td>",
"       <td class=\"subtitle1\" colspan=\"5\">",
"        Tidal volume",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2\">",
"        Feet/inches",
"       </td>",
"       <td class=\"subtitle2\">",
"        Inches",
"       </td>",
"       <td class=\"subtitle2\">",
"        Centimeters",
"       </td>",
"       <td class=\"subtitle2\">",
"        Kg",
"       </td>",
"       <td class=\"subtitle2\">",
"        4 mL/kg",
"       </td>",
"       <td class=\"subtitle2\">",
"        5 mL/kg",
"       </td>",
"       <td class=\"subtitle2\">",
"        6 mL/kg",
"       </td>",
"       <td class=\"subtitle2\">",
"        7 mL/kg",
"       </td>",
"       <td class=\"subtitle2\">",
"        8 mL/kg",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"centered\">",
"        4' 0\"",
"       </td>",
"       <td class=\"centered\">",
"        48",
"       </td>",
"       <td class=\"centered\">",
"        122",
"       </td>",
"       <td class=\"centered\">",
"        22.4",
"       </td>",
"       <td class=\"centered\">",
"        90",
"       </td>",
"       <td class=\"centered\">",
"        112",
"       </td>",
"       <td class=\"centered\">",
"        134",
"       </td>",
"       <td class=\"centered\">",
"        157",
"       </td>",
"       <td class=\"centered\">",
"        179",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"centered\">",
"        4' 1\"",
"       </td>",
"       <td class=\"centered\">",
"        49",
"       </td>",
"       <td class=\"centered\">",
"        124",
"       </td>",
"       <td class=\"centered\">",
"        24.7",
"       </td>",
"       <td class=\"centered\">",
"        99",
"       </td>",
"       <td class=\"centered\">",
"        124",
"       </td>",
"       <td class=\"centered\">",
"        148",
"       </td>",
"       <td class=\"centered\">",
"        173",
"       </td>",
"       <td class=\"centered\">",
"        198",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"centered\">",
"        4' 2\"",
"       </td>",
"       <td class=\"centered\">",
"        50",
"       </td>",
"       <td class=\"centered\">",
"        127",
"       </td>",
"       <td class=\"centered\">",
"        27",
"       </td>",
"       <td class=\"centered\">",
"        108",
"       </td>",
"       <td class=\"centered\">",
"        135",
"       </td>",
"       <td class=\"centered\">",
"        162",
"       </td>",
"       <td class=\"centered\">",
"        189",
"       </td>",
"       <td class=\"centered\">",
"        216",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"centered\">",
"        4' 3\"",
"       </td>",
"       <td class=\"centered\">",
"        51",
"       </td>",
"       <td class=\"centered\">",
"        130",
"       </td>",
"       <td class=\"centered\">",
"        29.3",
"       </td>",
"       <td class=\"centered\">",
"        117",
"       </td>",
"       <td class=\"centered\">",
"        147",
"       </td>",
"       <td class=\"centered\">",
"        176",
"       </td>",
"       <td class=\"centered\">",
"        205",
"       </td>",
"       <td class=\"centered\">",
"        234",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"centered\">",
"        4' 4\"",
"       </td>",
"       <td class=\"centered\">",
"        52",
"       </td>",
"       <td class=\"centered\">",
"        132",
"       </td>",
"       <td class=\"centered\">",
"        31.6",
"       </td>",
"       <td class=\"centered\">",
"        126",
"       </td>",
"       <td class=\"centered\">",
"        158",
"       </td>",
"       <td class=\"centered\">",
"        190",
"       </td>",
"       <td class=\"centered\">",
"        221",
"       </td>",
"       <td class=\"centered\">",
"        253",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"centered\">",
"        4' 5\"",
"       </td>",
"       <td class=\"centered\">",
"        53",
"       </td>",
"       <td class=\"centered\">",
"        135",
"       </td>",
"       <td class=\"centered\">",
"        33.9",
"       </td>",
"       <td class=\"centered\">",
"        136",
"       </td>",
"       <td class=\"centered\">",
"        170",
"       </td>",
"       <td class=\"centered\">",
"        203",
"       </td>",
"       <td class=\"centered\">",
"        237",
"       </td>",
"       <td class=\"centered\">",
"        271",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"centered\">",
"        4' 6\"",
"       </td>",
"       <td class=\"centered\">",
"        54",
"       </td>",
"       <td class=\"centered\">",
"        137",
"       </td>",
"       <td class=\"centered\">",
"        36.2",
"       </td>",
"       <td class=\"centered\">",
"        145",
"       </td>",
"       <td class=\"centered\">",
"        181",
"       </td>",
"       <td class=\"centered\">",
"        217",
"       </td>",
"       <td class=\"centered\">",
"        253",
"       </td>",
"       <td class=\"centered\">",
"        290",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"centered\">",
"        4' 7\"",
"       </td>",
"       <td class=\"centered\">",
"        55",
"       </td>",
"       <td class=\"centered\">",
"        140",
"       </td>",
"       <td class=\"centered\">",
"        38.5",
"       </td>",
"       <td class=\"centered\">",
"        154",
"       </td>",
"       <td class=\"centered\">",
"        193",
"       </td>",
"       <td class=\"centered\">",
"        231",
"       </td>",
"       <td class=\"centered\">",
"        270",
"       </td>",
"       <td class=\"centered\">",
"        308",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"centered\">",
"        4' 8\"",
"       </td>",
"       <td class=\"centered\">",
"        56",
"       </td>",
"       <td class=\"centered\">",
"        142",
"       </td>",
"       <td class=\"centered\">",
"        40.8",
"       </td>",
"       <td class=\"centered\">",
"        163",
"       </td>",
"       <td class=\"centered\">",
"        204",
"       </td>",
"       <td class=\"centered\">",
"        245",
"       </td>",
"       <td class=\"centered\">",
"        286",
"       </td>",
"       <td class=\"centered\">",
"        326",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"centered\">",
"        4' 9\"",
"       </td>",
"       <td class=\"centered\">",
"        57",
"       </td>",
"       <td class=\"centered\">",
"        145",
"       </td>",
"       <td class=\"centered\">",
"        43.1",
"       </td>",
"       <td class=\"centered\">",
"        172",
"       </td>",
"       <td class=\"centered\">",
"        216",
"       </td>",
"       <td class=\"centered\">",
"        259",
"       </td>",
"       <td class=\"centered\">",
"        302",
"       </td>",
"       <td class=\"centered\">",
"        345",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"centered\">",
"        4' 10\"",
"       </td>",
"       <td class=\"centered\">",
"        58",
"       </td>",
"       <td class=\"centered\">",
"        147",
"       </td>",
"       <td class=\"centered\">",
"        45.4",
"       </td>",
"       <td class=\"centered\">",
"        182",
"       </td>",
"       <td class=\"centered\">",
"        227",
"       </td>",
"       <td class=\"centered\">",
"        272",
"       </td>",
"       <td class=\"centered\">",
"        318",
"       </td>",
"       <td class=\"centered\">",
"        363",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"centered\">",
"        4' 11\"",
"       </td>",
"       <td class=\"centered\">",
"        59",
"       </td>",
"       <td class=\"centered\">",
"        150",
"       </td>",
"       <td class=\"centered\">",
"        47.7",
"       </td>",
"       <td class=\"centered\">",
"        191",
"       </td>",
"       <td class=\"centered\">",
"        239",
"       </td>",
"       <td class=\"centered\">",
"        286",
"       </td>",
"       <td class=\"centered\">",
"        334",
"       </td>",
"       <td class=\"centered\">",
"        382",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"centered\">",
"        5' 0\"",
"       </td>",
"       <td class=\"centered\">",
"        60",
"       </td>",
"       <td class=\"centered\">",
"        152",
"       </td>",
"       <td class=\"centered\">",
"        50",
"       </td>",
"       <td class=\"centered\">",
"        200",
"       </td>",
"       <td class=\"centered\">",
"        250",
"       </td>",
"       <td class=\"centered\">",
"        300",
"       </td>",
"       <td class=\"centered\">",
"        350",
"       </td>",
"       <td class=\"centered\">",
"        400",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"centered\">",
"        5' 1\"",
"       </td>",
"       <td class=\"centered\">",
"        61",
"       </td>",
"       <td class=\"centered\">",
"        155",
"       </td>",
"       <td class=\"centered\">",
"        52.3",
"       </td>",
"       <td class=\"centered\">",
"        209",
"       </td>",
"       <td class=\"centered\">",
"        262",
"       </td>",
"       <td class=\"centered\">",
"        314",
"       </td>",
"       <td class=\"centered\">",
"        366",
"       </td>",
"       <td class=\"centered\">",
"        418",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"centered\">",
"        5' 2\"",
"       </td>",
"       <td class=\"centered\">",
"        62",
"       </td>",
"       <td class=\"centered\">",
"        157",
"       </td>",
"       <td class=\"centered\">",
"        54.6",
"       </td>",
"       <td class=\"centered\">",
"        218",
"       </td>",
"       <td class=\"centered\">",
"        273",
"       </td>",
"       <td class=\"centered\">",
"        328",
"       </td>",
"       <td class=\"centered\">",
"        382",
"       </td>",
"       <td class=\"centered\">",
"        437",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"centered\">",
"        5' 3\"",
"       </td>",
"       <td class=\"centered\">",
"        63",
"       </td>",
"       <td class=\"centered\">",
"        160",
"       </td>",
"       <td class=\"centered\">",
"        56.9",
"       </td>",
"       <td class=\"centered\">",
"        228",
"       </td>",
"       <td class=\"centered\">",
"        285",
"       </td>",
"       <td class=\"centered\">",
"        341",
"       </td>",
"       <td class=\"centered\">",
"        398",
"       </td>",
"       <td class=\"centered\">",
"        455",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"centered\">",
"        5' 4\"",
"       </td>",
"       <td class=\"centered\">",
"        64",
"       </td>",
"       <td class=\"centered\">",
"        163",
"       </td>",
"       <td class=\"centered\">",
"        59.2",
"       </td>",
"       <td class=\"centered\">",
"        237",
"       </td>",
"       <td class=\"centered\">",
"        296",
"       </td>",
"       <td class=\"centered\">",
"        355",
"       </td>",
"       <td class=\"centered\">",
"        414",
"       </td>",
"       <td class=\"centered\">",
"        474",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"centered\">",
"        5' 5\"",
"       </td>",
"       <td class=\"centered\">",
"        65",
"       </td>",
"       <td class=\"centered\">",
"        165",
"       </td>",
"       <td class=\"centered\">",
"        61.5",
"       </td>",
"       <td class=\"centered\">",
"        246",
"       </td>",
"       <td class=\"centered\">",
"        308",
"       </td>",
"       <td class=\"centered\">",
"        369",
"       </td>",
"       <td class=\"centered\">",
"        431",
"       </td>",
"       <td class=\"centered\">",
"        492",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"centered\">",
"        5' 6\"",
"       </td>",
"       <td class=\"centered\">",
"        66",
"       </td>",
"       <td class=\"centered\">",
"        168",
"       </td>",
"       <td class=\"centered\">",
"        63.8",
"       </td>",
"       <td class=\"centered\">",
"        255",
"       </td>",
"       <td class=\"centered\">",
"        319",
"       </td>",
"       <td class=\"centered\">",
"        383",
"       </td>",
"       <td class=\"centered\">",
"        447",
"       </td>",
"       <td class=\"centered\">",
"        510",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"centered\">",
"        5' 7\"",
"       </td>",
"       <td class=\"centered\">",
"        67",
"       </td>",
"       <td class=\"centered\">",
"        170",
"       </td>",
"       <td class=\"centered\">",
"        66.1",
"       </td>",
"       <td class=\"centered\">",
"        264",
"       </td>",
"       <td class=\"centered\">",
"        331",
"       </td>",
"       <td class=\"centered\">",
"        397",
"       </td>",
"       <td class=\"centered\">",
"        463",
"       </td>",
"       <td class=\"centered\">",
"        529",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"centered\">",
"        5' 8\"",
"       </td>",
"       <td class=\"centered\">",
"        68",
"       </td>",
"       <td class=\"centered\">",
"        173",
"       </td>",
"       <td class=\"centered\">",
"        68.4",
"       </td>",
"       <td class=\"centered\">",
"        274",
"       </td>",
"       <td class=\"centered\">",
"        342",
"       </td>",
"       <td class=\"centered\">",
"        410",
"       </td>",
"       <td class=\"centered\">",
"        479",
"       </td>",
"       <td class=\"centered\">",
"        547",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"centered\">",
"        5' 9\"",
"       </td>",
"       <td class=\"centered\">",
"        69",
"       </td>",
"       <td class=\"centered\">",
"        175",
"       </td>",
"       <td class=\"centered\">",
"        70.7",
"       </td>",
"       <td class=\"centered\">",
"        283",
"       </td>",
"       <td class=\"centered\">",
"        354",
"       </td>",
"       <td class=\"centered\">",
"        424",
"       </td>",
"       <td class=\"centered\">",
"        495",
"       </td>",
"       <td class=\"centered\">",
"        566",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"centered\">",
"        5' 10\"",
"       </td>",
"       <td class=\"centered\">",
"        70",
"       </td>",
"       <td class=\"centered\">",
"        178",
"       </td>",
"       <td class=\"centered\">",
"        73",
"       </td>",
"       <td class=\"centered\">",
"        292",
"       </td>",
"       <td class=\"centered\">",
"        365",
"       </td>",
"       <td class=\"centered\">",
"        438",
"       </td>",
"       <td class=\"centered\">",
"        511",
"       </td>",
"       <td class=\"centered\">",
"        584",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"centered\">",
"        5' 11\"",
"       </td>",
"       <td class=\"centered\">",
"        71",
"       </td>",
"       <td class=\"centered\">",
"        180",
"       </td>",
"       <td class=\"centered\">",
"        75.3",
"       </td>",
"       <td class=\"centered\">",
"        301",
"       </td>",
"       <td class=\"centered\">",
"        377",
"       </td>",
"       <td class=\"centered\">",
"        452",
"       </td>",
"       <td class=\"centered\">",
"        527",
"       </td>",
"       <td class=\"centered\">",
"        602",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"centered\">",
"        6' 0\"",
"       </td>",
"       <td class=\"centered\">",
"        72",
"       </td>",
"       <td class=\"centered\">",
"        183",
"       </td>",
"       <td class=\"centered\">",
"        77.6",
"       </td>",
"       <td class=\"centered\">",
"        310",
"       </td>",
"       <td class=\"centered\">",
"        388",
"       </td>",
"       <td class=\"centered\">",
"        466",
"       </td>",
"       <td class=\"centered\">",
"        543",
"       </td>",
"       <td class=\"centered\">",
"        621",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"centered\">",
"        6' 1\"",
"       </td>",
"       <td class=\"centered\">",
"        73",
"       </td>",
"       <td class=\"centered\">",
"        185",
"       </td>",
"       <td class=\"centered\">",
"        79.9",
"       </td>",
"       <td class=\"centered\">",
"        320",
"       </td>",
"       <td class=\"centered\">",
"        400",
"       </td>",
"       <td class=\"centered\">",
"        479",
"       </td>",
"       <td class=\"centered\">",
"        559",
"       </td>",
"       <td class=\"centered\">",
"        639",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"centered\">",
"        6' 2\"",
"       </td>",
"       <td class=\"centered\">",
"        74",
"       </td>",
"       <td class=\"centered\">",
"        188",
"       </td>",
"       <td class=\"centered\">",
"        82.2",
"       </td>",
"       <td class=\"centered\">",
"        329",
"       </td>",
"       <td class=\"centered\">",
"        411",
"       </td>",
"       <td class=\"centered\">",
"        493",
"       </td>",
"       <td class=\"centered\">",
"        575",
"       </td>",
"       <td class=\"centered\">",
"        658",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"centered\">",
"        6' 3\"",
"       </td>",
"       <td class=\"centered\">",
"        75",
"       </td>",
"       <td class=\"centered\">",
"        190",
"       </td>",
"       <td class=\"centered\">",
"        84.5",
"       </td>",
"       <td class=\"centered\">",
"        338",
"       </td>",
"       <td class=\"centered\">",
"        423",
"       </td>",
"       <td class=\"centered\">",
"        507",
"       </td>",
"       <td class=\"centered\">",
"        592",
"       </td>",
"       <td class=\"centered\">",
"        676",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"centered\">",
"        6' 4\"",
"       </td>",
"       <td class=\"centered\">",
"        76",
"       </td>",
"       <td class=\"centered\">",
"        193",
"       </td>",
"       <td class=\"centered\">",
"        86.8",
"       </td>",
"       <td class=\"centered\">",
"        347",
"       </td>",
"       <td class=\"centered\">",
"        434",
"       </td>",
"       <td class=\"centered\">",
"        521",
"       </td>",
"       <td class=\"centered\">",
"        608",
"       </td>",
"       <td class=\"centered\">",
"        694",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"centered\">",
"        6' 5\"",
"       </td>",
"       <td class=\"centered\">",
"        77",
"       </td>",
"       <td class=\"centered\">",
"        196",
"       </td>",
"       <td class=\"centered\">",
"        89.1",
"       </td>",
"       <td class=\"centered\">",
"        356",
"       </td>",
"       <td class=\"centered\">",
"        446",
"       </td>",
"       <td class=\"centered\">",
"        535",
"       </td>",
"       <td class=\"centered\">",
"        624",
"       </td>",
"       <td class=\"centered\">",
"        713",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"centered\">",
"        6' 6\"",
"       </td>",
"       <td class=\"centered\">",
"        78",
"       </td>",
"       <td class=\"centered\">",
"        198",
"       </td>",
"       <td class=\"centered\">",
"        91.4",
"       </td>",
"       <td class=\"centered\">",
"        366",
"       </td>",
"       <td class=\"centered\">",
"        457",
"       </td>",
"       <td class=\"centered\">",
"        548",
"       </td>",
"       <td class=\"centered\">",
"        640",
"       </td>",
"       <td class=\"centered\">",
"        731",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"centered\">",
"        6' 7\"",
"       </td>",
"       <td class=\"centered\">",
"        79",
"       </td>",
"       <td class=\"centered\">",
"        201",
"       </td>",
"       <td class=\"centered\">",
"        93.7",
"       </td>",
"       <td class=\"centered\">",
"        375",
"       </td>",
"       <td class=\"centered\">",
"        469",
"       </td>",
"       <td class=\"centered\">",
"        562",
"       </td>",
"       <td class=\"centered\">",
"        656",
"       </td>",
"       <td class=\"centered\">",
"        750",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"centered\">",
"        6' 8\"",
"       </td>",
"       <td class=\"centered\">",
"        80",
"       </td>",
"       <td class=\"centered\">",
"        203",
"       </td>",
"       <td class=\"centered\">",
"        96",
"       </td>",
"       <td class=\"centered\">",
"        384",
"       </td>",
"       <td class=\"centered\">",
"        480",
"       </td>",
"       <td class=\"centered\">",
"        576",
"       </td>",
"       <td class=\"centered\">",
"        672",
"       </td>",
"       <td class=\"centered\">",
"        768",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"centered\">",
"        6' 9\"",
"       </td>",
"       <td class=\"centered\">",
"        81",
"       </td>",
"       <td class=\"centered\">",
"        206",
"       </td>",
"       <td class=\"centered\">",
"        98.3",
"       </td>",
"       <td class=\"centered\">",
"        393",
"       </td>",
"       <td class=\"centered\">",
"        492",
"       </td>",
"       <td class=\"centered\">",
"        590",
"       </td>",
"       <td class=\"centered\">",
"        688",
"       </td>",
"       <td class=\"centered\">",
"        786",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"centered\">",
"        6' 10\"",
"       </td>",
"       <td class=\"centered\">",
"        82",
"       </td>",
"       <td class=\"centered\">",
"        208",
"       </td>",
"       <td class=\"centered\">",
"        100.6",
"       </td>",
"       <td class=\"centered\">",
"        402",
"       </td>",
"       <td class=\"centered\">",
"        503",
"       </td>",
"       <td class=\"centered\">",
"        604",
"       </td>",
"       <td class=\"centered\">",
"        704",
"       </td>",
"       <td class=\"centered\">",
"        805",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"centered\">",
"        6' 11\"",
"       </td>",
"       <td class=\"centered\">",
"        83",
"       </td>",
"       <td class=\"centered\">",
"        211",
"       </td>",
"       <td class=\"centered\">",
"        102.9",
"       </td>",
"       <td class=\"centered\">",
"        412",
"       </td>",
"       <td class=\"centered\">",
"        515",
"       </td>",
"       <td class=\"centered\">",
"        617",
"       </td>",
"       <td class=\"centered\">",
"        720",
"       </td>",
"       <td class=\"centered\">",
"        823",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"centered\">",
"        7' 0\"",
"       </td>",
"       <td class=\"centered\">",
"        84",
"       </td>",
"       <td class=\"centered\">",
"        213",
"       </td>",
"       <td class=\"centered\">",
"        105.2",
"       </td>",
"       <td class=\"centered\">",
"        421",
"       </td>",
"       <td class=\"centered\">",
"        526",
"       </td>",
"       <td class=\"centered\">",
"        631",
"       </td>",
"       <td class=\"centered\">",
"        736",
"       </td>",
"       <td class=\"centered\">",
"        842",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     PBW: predicted body weight.",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: the NHLBI ARDS Network.",
"     <a href=\"file://www.ardsnet.org/node/77460\" target=\"_blank\">",
"      file://www.ardsnet.org/node/77460",
"     </a>",
"     (Accessed on November 20, 2012). Copyright &copy; 2012.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f8_22_8544=[""].join("\n");
var outline_f8_22_8544=null;
var title_f8_22_8545="Antegrade AV conduction through an accessory pathway";
var content_f8_22_8545=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F75296&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F75296&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 474px\">",
"   <div class=\"ttl\">",
"    Antegrade atrioventricular conduction through an accessory pathway",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 454px; height: 300px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAEsAcYDASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwD6pooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiq97fWlhGr311BbIxwGmkCAn6mgCxRWZH4g0aWRUj1fT3djgKtyhJPtzWnQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFRXbyx2sz28YlmVGZIy20MwHAz2ye9S1HcQx3NvLBOgeGVSjqejKRgigDxLwN8TtXbWJYvHd0dIuo7S4u7jSrrR3ttqRAsWgnLkSAKOc9RyK0vgT8TtQ8b3mr2GvjTkvooob+1WzbINtKuQrcn50OA3TBaum/4VP4MNtcwPpMssdxAbZvNvriRkiJBKIzSExqSBkIRkcdOK2rXwd4ftPEFvrdnpcFrqUFu1qktvmIeUxyVKKQrcgHkEigDjvFfxZ/4R/W9ctB4dvLuw0O4tIdQvkuI1WMXCoUZUJ3McuBgfnU//C1bVfEJtZNKuU0b+130EamZV/4/EUsV8r72z5SN3qOldJqfgbw7qn9t/btO83+2nt5L/wDfyL5zQbfKPDDbt2L93Gcc5rnfC+heH7zxnqVzqeiQ2fiyyuDcuizSGGUOCqXccZOwllG0tt3BgwJ4BIBy0fxhvJ9c0jVZ9Pm07wlPpeoaiFZklmuo4du18DlD1+XPO4ZNdn8NfiIPGt1eW76Pc6dJBDHcI7v5kcqPnjcAAGGOV9+Cas6Z8L/B2mXZuLPRgreVNbiOS4mkiWKb/WII2coFbn5QMcn1rT8L+DdD8LvI2iW08G9BFtku5plRAchUWR2CD2XAoA6GiignAyelABRXNweOfDFxrsWj2+t2cuoyu0aRRvuDOoyyBh8u4A/dzn2rpKACiiq2p39ppen3F9qNxHbWduhklmlbaqKOpJoAmmljgieWaRI4kBZnc4CgdST2Fcc3jO41cyf8IfpyahaRgl9VvJjbWQx1KPtZpccnKrt4+8K4fW9YXX3GpeId/wBgMo+w6TNGXRAf9V5kC4M9y/3hESVjBGQCCT1D+EdQ8Z29vN4zZrSwjZXt9EgKlFA6G4IyJHPHyjKL23H5qVyFO97dDAuvEFxqsc0s2s63rNpEcP8A8I1FHYWQOfu/a5ZAXI7lJQPYHgV9Ojs1lM+neDPD8MrAj7brN9Jd3BHbkRSFs/8AXQV6BD4F0qGdJklvjIn3C8+/Z9Mg4/Crc1zqeh27yXu3UdPi5adTtnjTuWXG18DJJBBwOlF2ZudRayVl9/8AkefnT4dTR0u9Z8C26k7Ps40EMhPdXaSUb+ewCmmp4c1LRIRcafp1zDbjkXPhPU22gev2GfMWB6KXPoK9J1LQ7a+YXdkY7W/yHW6iQHf7OP41Oeh/DB5rMsLK1uL2a1ntTpOsIvmGSxcxpMvTzFxwwzgEMDjj2JLsOepF2lYwtD8X60YJ5IRbeJra1IFzHbQtZalbj/ppaycMcZPBTOPlU12Ph/xNo3iBX/sjUYLmRBmWANtmh9pIzhkPI4YA1zuv6TBcX1n/AMJEGhu1Pl2evWLeRNESeEcjpn0OUY9VHAqhrngrX9S8tLy80fVJIObXUp4JLS/t/pLAw56cqFB7g0zWMlI9Cvby2sLWS6vriG2tohuklmcIiD1LHgCvMvEfxVlkurXTvA+i3OsX17u+zzyJ5cTqoyXRWKtIo6b8pHkgeZzTLT4QLqF4L3xn4g1DWLgHKRozRpEOwRmLSKRz8yMmckkdMeg6F4c0fQRIdI022tZJf9bKiZklPq7n5mPuSaCjxm7bxDpXiKx1HxtcSNcwPFqCsLwhIbZZ0im/dIBEoUSo7ffYKOXavfAcjI6VznjXwuniS0gMdy1nqFqWa3uAnmKAw2vHJGeJI3HDIevYggEeYaH461P4XyjQPiRYXEOiRbV0/WbfM8CR9BGzfeIXjGRvxgENjeQD3Kis3Qde0nxDZC70LUrPULbvJbTLIAfQ4PB9jWlQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABXI/EKziWC01i11Cz03XdPLPZz3UojjlU4MkEhPWNwBn+6QrDlRXXV5/8ZrB5NC0/V7eaC3uNKvY5DPPAJ44opD5UjPGSAyqH3nkEbMg5FAEugfFXwprGlQXkeoiNnUeZFsaQxPjlCygqceoJBGCODWgfiB4eb5bae9vJT0itNPuJ3P4Ihx9TxXEa9deMfBur3PimfRNMubFbfGqnT70ot0ijCSiKRcpKnTAZ9ynbyQuEHxevNQuY4tN07SbW3cBhe3l9I6EH+6scRz9SwFJtIznVhT+NpHa/8JF4g1E7dE8KXMKHgXOsXCW0f1CJvkP0Krn1HWue8Tafp+mWCXPju7uPE2r3b7LbSI2KQTyHpFFahtrLxy0m4gZJYDNPsZfEfiozQTeNNEsrJz5e3Q7Yi6IPXEkrttPXBCZ9MEV0nhHwH4c8KO02kacn26Qfvb64YzXMueu6Vstz6Zx7Uy4yUldO55rqfgS90qzfx74kmhk1jR2ju7TTbJdtnptpG4aaKNeNzGPfl8DnGBgc+4qwZQykFSMgjoRVDWrjTFs5bbV7m1it7hGidJ5VQOrAgjk9xmuI8F+MbfS5NM8Ka7cQyXqqtpZahbSieG+CrhSSvMchAyVYAZztLUDPR68s8YahBr2vz79s+j6ESkcbZMVzqP3ssBwyW6LuI6bm9Urp/HWsXEf2Pw/odwkevauxjicfM1rCBmW5I9FHC54Lsg7mswaRZ2Xh7XI9Pj2afpdhPYWi53c7C00hPdmYgEnklWz1NJkTbtZbsb8MdAEltB4m1SH/AE66hBsopBlrS3YZH/bWTO+RuuSF6KK9BrK8J/8AIq6N/wBeUP8A6AK1aZSSSsgpGUOpVgCpGCDyCKWigZjeGMwWk+nMTusJmgXP/PPho/8AxxlH1BqDxoJodNi1GzjR7yxmWSMMdu5SdrLn0IP8vQVrW9msN9d3IYlrjZkHoNoxVLxZ/wAi/df8A/8AQxS6GEo2pNdv6RPYXNvrWl75IP3cm6Oa3mUEqwJDIw6cEEVmWM40TXE0iV5DZXSl7JpCW2MPvQ7j7fMvtkdhVyC2msvEMzQxlrK+TzJMdI5lwM/8CXH4p71V8S2FvqWp6Va3ab4n87ocFSFBDA9iDyDQKXNbm+0tDoaKxNHvZoLj+ytUaRrxM+TOUO25jHRsgY3AHDD1GRwa434h+NdYh8Qx+GPCNnJLqToDLcqisY2YFhGgfCBto3F2JCqQdrkhaZtGSkrnc+INf0vw9aLcaxexWyO2yNWOXlb+6iDLO3soJryfXPEeu/EppdG8N6UqaN5qi6a5YgOFYEpNIpxGpx80Sb5CPlbys5rW8P8AwkSa6bUvGuoTarfyriSFZWKEf3HlOHkX/ZGyM/8APMV6hZWtvY2sVrZQRW1tEoWOKFAiIo7ADgCgo5T4f+AdN8HpJPDibVbhBHcXKp5SFBjbGkQO1EUABRyRzkkkk9jRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABUN9aQX9lcWl5Es1tcRtFLGwyHRhgqfYgkVNRQB86eKtVuZ/CPhTTpriSbyLVizOcs+12jQse5xH19zXB2ttDpMNy3niOz3GUK5AWHP3sHsM5PtmtXVdSibT7O5mkVLWK0WQSEjHlsTID+Tg11fw98CW99p7eL/AIhpHa6BDH9otdOu8BNg5E9wD19VQ8DgnJxjGzlJnz8qE8XiZpbX1+RzXw7TWfE2rQXfhbRbu5treUOuoXD/AGW1yp6iQgs2D1CqT9Otdn4g1JtdvZdM1XWNU12937W0zRlktbdMH+JImMxGe8siIeoxXYy6lqHiRbJHlm8LeF7n5IG4ivLxQOAD0tkI6f8ALQ9vLNdHpHhp9FsFstFvIrGzXJWOG0TjPcnqzerHJJ5Oa0StsepSoRoLkpX8+/4nmGh/CydGNxaeGNG04kcNqLpLOfqEV9v4yvn8Kil+C8VxqLXEWneGI76PnNtJNCyn1wgGD74r1b+ztNlfZqOrz30mcFJbsIpPpsTap/EGrknhvRXiWMaZaxhfutFGI2X3DLgg+4NM0Ub7L8TzTStN1LwQJ31DSZbOynwLnVNICX0oUAcyExJLtAzyEcL+td9fLZL8PLw6S6yWD6bLJDIGLeYrRlg2T1znOe+aka7u9BH/ABM5Gu9MBwLzH7yEf9NQOo/2x+I71ieGAvhzVn8J3aq+j3oln0aXGUMZy0lqfdMkr6x8fwGhFw5b+fmdN4T/AORV0b/ryh/9AFatch8NDJZaRd+H7hy82g3LWKMx5aDAeA+/7p0Un1Vq6+mahRRRQAVBfWsV7avbzgmN8ZwcdDn+lT0UCavowqhLYtLrNvevJmOCF0SP/bYjLfkMfiav0UA0nuNKKWVioLL0JHIrxo3x0/x1qF0gtpNTtdWuJri2u7pLV2hkt44oXQvwybY8ZGRkHvmvZ6p32l6ffur31jaXLqMK00KuQPQZFAzjP+E+u/8AoFab/wCDy3rE1D4oXqaja2do/hl764uYraLTYNRN3cuXcKSxRQkeASxBJ4UnPavRf+Ec0P8A6A2m/wDgKn+Feb+OLWCT4v8Aw/0i1iigitmlvY4okCqCFYs5A9BGEH/XX8gD12imyyJDG0krrHGoyzMcAD3Ncz8Q/FQ8KeFJNUtrYahdySRW9larJt+0zSuFRA3PXOc+gNAHUUV5Vp/xa+1aN4G1d9MWLT9evG029YyndYXPKqhBHILqwycYGDzmum8G+Mv+Eh0XW9aktRb6TZ3lxDazK283MMPDSgY4BYOAP9mgDr6K860z4w+F74TPJ/aVjbx6cdVSe8s3iSa3UgM0ZP3sEge+eM1KPix4eXTr24uYdUtrq1kt4/7PmtCLmVp/9SI0BO7fg454wc4oA9AoryfRvjFZ/YNVuNfsri2nj1yfSrKyhi/0iVY40kJcFtoYBzuOQOBXoXhTxBp/irw9Za1o0rS2N2paNmUqwIYqwIPQhgQfcUAa1FFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAVgePtSk0jwVrd9bgtcxWkggUdWlI2xj8WKj8a364f4qXhWx0uwjQSPNeLeSIenlWo+0tn2LRxp/wMds0AcDpXgXStW8aeVMif8Ix4UhhhupZJMx3l3HEnyEHgRxKFLD+8QD90iu10yym8fahb63rCMnhiBxNpWnsCPtRB+W6mB6jvGh6DDHnAXjfCtuh8AeBvC16+yPWIl1jWZZQR5kcjiQxMfWWWREI/uK49K9yACgAAADgAUExjGN1EbNFHPE0c0aSRtwyuMg/UGso+GdGK7f7Ph8v/AJ5jIT6bc4x7YrYooCUIy3RRGj6YIvKGnWYjxjYIFxj6Yqo3hvT0ybET6e/Y2crRAf8AAB8p/EGtmilYTpwfQ5+S9vNIBXWyl1pxGDepHtKf9dUHGP8AaHHqB1rlfG+l3Wm6Zbto48+O2uUvtLTP+quE58gN/clQyRj0L46EY9JZQ6lWAKkYIPIIrl301bGddHkHm6JqIeOKNj81s4UvtU/3cKSO6kccYwMynFxaa/r/AID/AK8smPVrePxRoPiXT38zRPE1rHZSPjBSYBpLdiO2Q0sZ752A9K7+vENMuJ4Ph94k0q4DnUPC+qLqgVQcvCtyLklR1xlJ4wOeFx3Fe2xSJLGkkTB43AZWU5BB6EUzeL5kmh1FFFAwooooAKK57V/Gfh/Sbo2lzqUUt+OPsVqrXNyT/wBcowz/AKVSHiDxFqZxofheS3iPS51m4W2U+6xpvkP0YJ+FAHXVn61relaHbfaNZ1GzsIT0e5mWMH2GTyfYVgHw3rupgHX/ABTcoh5Nto0Is4z7FyXl/FXX6Vo6L4Q8P6JcG6sNLt1vCMNeS5muGHvK5Ln8TQBnf8Jq1/geG9B1jVgek7QfZLce/mTbSw90V68t+KSeJbLx14N8R6xc2eiRyXA01ZdOP2h7cynZgySoEOVkkblMAxDrXS61rc3iOeO983U5dIu5XtNE0rTLo2suqMoy9xJKrKywjBwcgbfmO4uq0y4+ED6xYvHq9zp1mJUK/Z7S3knEWVwT5s0hLOMnD7V7HGaAOzh8AaG8qTaxHc67cKdwk1edrlQfVY2/dof91RUnjDwPpHi+TR11tZpbLTJmnSyRgsMrlCilxjPygkrgjk856VtaJpw0rTYbT7XeXpjGDPeS+ZLIfVjwPyAHtV6gDzk/B/w2PCmu+HIZNQh0nVbsXvlRyqDaSgqcwHblfuDru/Wuq0bwvp+j+DYPDNiJU06G0NmpyN5UqQWJxjcckk4xk9K3KKAPP/8AhU/h57PT7S5e+uLaz0Z9DWOSRcPAxUlmIUHf8owRge1Qn4R6LJZ3S3Wpa1c6jNNbTrqcs6G5ga3/ANT5ZCBRtyeqnOTnJr0aigDzRvg3oL2LxS6hrEt6dTl1ZdQkkiadJ5EVJMfu9hVggypU13HhrR4tA0W202C4nuI4d372fbvYsxYk7FVerHgACtOigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACvJvidqX2Wfx1qXX+x/DHkQN12zXLSlhjqP9VAT9RXrNeKfEkG4+HHxdvcZ8yfyEP+xFBApH/ffmH8aAOi0WyivtY06yk+WKbwrFH8v8OXAyPcV2mh6i9wJLO+2pqdrhZkHRx2kX/Zbr7HI7VyWgk2/irwe38F54bliP+9G1syj8pH/Kuu1rSvt3lXFtL9m1G3yYLgDOPVWH8SHuPx60jOaafNE1KKyLHWM3CWWqxfYr9uEUtmOb3jf+L6HDD071r0yoyUtUFFFFBQVg+NLmKx0iO/mcJ9kuIpVzzn5gpUAdyrMPxp2ueJrDSYpBl7y6TrbWoEkg92A+6Pc14h8SvHuqXmp28SSWkEFoUulSAiYK+MjcxyGIB7DGSRzWVWqqauzTDYaePqPD0Gua19dl6nUu7z/EqW2jktRb+INKv4LWdXz5jAxugOOOAZj64J/H0D4e36aj4K0eZUMckcC280THJimj/dyIfdXVh+FeHQ+NL/xf4Quru18PXd1q/ht11G21C3VLWNCuWJdXIJ3CNlIRSGDHgda7fw3aeJbjxhrFhLrNtotnqcMWtRx6XGLhiX/dyBJZlwOUjY/u+TKTxVwlzK6Jnh54aTpTd2u33nrFzPDbQPNcyxwwoMtJIwVVHqSelcs/j/Rp3MehLe6/KO2kwGeP6GbiIH6uKdbeANAE63GpW0us3ancJ9Wma7Kn1VXJVP8AgCrXVIqoqqihVUYAAwAKok5H7R411Uf6PZaV4fhP8d3Ib2f/AL9xlUB/7aN9PU/4QeK+bf4k1nV9aPeGW4+z2/08qEIrD2fdXX0UAUdH0jTdFtBa6PYWlhbDpFbQrGv5KBV6iigArk/ic/meGo9MWRkk1e8t9O+VirGOSQedgjnPkiU8en411leey6zpV/8AF2K3vNRtQdLt/s1lC0qgyXswZpQo7ukKIPYTEfxUAXPBNnHfa/rGuGOOOC2kbRdNiRcLBbwNsk2joC0qsDjtGg7V21cj8MWWLw/d6eSDNp+p3ttL6k+e7qx92R0b/gVddQAUUU2WRIY2kldY41GWZjgAe5oAdRXN/EHxPB4S8Dav4gco62lsZIgT8skh4jX6Fio/GvIU+MeuD4R69qksmkf8JNo2pR2Nw0AMtsyPIoWRQG5BVmA56qaAPoKiuB+EXinV/FFjrL6stvPBZ3zW1nqNvbvbx3sYAO8RuSRgkjIJB7dDXfUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAeefHPx7dfDzwZFqun2kN1dz3kdpGsxOxcq7kkDk8IRjI5IPbFdf4U1hPEHhjSdYjjES39pFc+WG3bN6Biue5GcfhXnfx2hj1PU/h9osyCRLnX47h0P8AEkSMWH0w1W/2apHk+CfhtpGLEC4XJOeBcSgD8gBUqV5OP9df8gPTaKKKoAooooAKKKKACiiigAooooAKKKKACiiigAooooAK89stKGueG/iFoTqPMub28tmVuxlgRlP/AHzIh/GvQq5DTSdP+J+s2p/1eq2EN/H7yRMYZf8Ax029AGDpd39o0X4UawRt80RwS9tolspOPr5iRivTa8mtbdx8Mte02yBfUPC2pzSW6Y5JgmF1CoH+1EyJ75NepWF3Bf2NteWciy21xGs0UinIZGAII+oIoAL20t763a3vII54W6pIoYVmJo1xbYXT9XvIYh0im2zqo9iw3f8Aj1bVFFiXBN3ZkGw1Uj/kNEe4tUpg8Pwzc6jeX98e4lnKIf8AgCbVP4g1tUUrE+yj11IbS1t7OFYbSCKCIdEiQKB+ArmPFnw/0LxPcC4voZYbrG0zWzBGYZzyCCD1POM11tFKUVJWaOijVnQkp0nZ+R5bY6DbfDrxDZxQSTT6Drf+h3P2naxSbny8kAcHLDH1z2r5zsfGGp/C34+NDqmo3t9olhK+mKLmV3EdiWAGwE8bdqnA4JQ19X/FgWH/AAguotqdwLYIFe3cAljOD+7VAOWZmwoABJzxXy98dvD8918NvCnjtpFm1K6upjfyRx7VR5WLqgBHRCjJnnJ5zyKmEeRuK2OnE1XiIRrS1ls/0f3XXyPs6N0ljWSNldGAZWU5BB6EGnV4r4a8ZXfhH4c+GNc1HUbK/wDCM1vbxmRo3S6s1MZG0kFhLtZQvRT16063+LPiXxbqElj8P/BlyqJy+pa9utoE9PkXJbPoDn2pyqQguaTsjise0VS1PVdO0qMSapf2llGejXEyxg/ixFeayeE/HetxH/hIvH0tgrdbbQbRYAv0lbLn9K8b+Jvwg03QtZiuLm61PVYbpcrcX1yZJN4+8GYAZ65H19qMDVp46usPRkuZ99NjDGYhYSk61ROy7H0FqPxb8Aafn7R4t0hsf88ZxN/6Bmubvf2ivhvbNiPWbi594bKXH/jyivnuPwpoUa7V02DH+1lj+ZNO/wCEW0T/AKBlt/3zX0K4fr/zL8f8jw3xLh/5H+H+Z7Trf7RnhC8057Tw/qU1vqlyyQQ3N3assVuXYKZX9kBLY74x3rjvHqQ61YXmjeDLyGKLwtbprelzwhvtOpSqf9JkM4YHcA2flGWZgc8Vwk3hPQ5Yyh06FQe6ZUj8QafocsngfxJo99pPmy29s7StbM28sgGJEGezxlxjpuCntUVMlq0YSlLXtbv6WNKWfUq9SMY3Xe/a3e/Q7Xw948/4V74mfVIHkvPC+tWkN9HBNcZl8ps4Ku5+eWJhJEQzZZQmTwte4aX8RrXxHYpc+DdH1XW43+XzhELWBG7hpJiucdDsDkHjFfM+pWOgaBc6rpFqkLX9pqEOoaLNFCXe8026XPl7gOBGGD5bAyDjrW34Z1/VfCGqtqWgSKfMObqxkOIbse/91/Rxz2ORxWFHASxdD2tL4o6Nd/P1OivmMcFiFSrfDLVPt5PyPon7H4z1Qk3ep6boMB/5Z6fEbucf9tZQEH08o/WnReANDeRJtYjudduEO4SavO1yoPqsbfu1P+6orW8Ka7aeJvDmn6zp5b7NeRCQK33kPRkb/aVgVPuDWtXlnrmTr/h3SvEFlbWesWa3NpbTx3McO9lTfGcpkKQGAP8ACcqe4rF1D4aeENQl1CS40aMHUBCLlYZpIkk8pt0Z2owAIPcAE9812FFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQB5V48zefHH4e2xGUs7a/u2H+9GEB/AipP2ayY/hRZWLfesLq6tj9RO7f+zVDd/6X+0kmQdll4Zznj773P8ALbUnwFH2ePxzYdrbxNebP9xthX8etcUZ3xUo+S/X/Mq3unqdFFFdpIUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFch8RLC8S1g8R6NKqatokcs0cTgbLmEgGWBvTcEXDDoyqeRkV19cT4qMvirWW8J2u9dMjVZdanGRmM8raqfWQcv6Jx1cUAYXh7VRZ/G7ULZd/2HxRo9vq1uWGMSxDy2X6mPYT/uit/wADqdB1jVPCcgItrc/btLOOPssjHMQ/65yblx2Ro6xb2zW8/aD0ZrN4Qmk6DK08anBQSSBY1AHrhj9B7jPQeP7e6s47TxPpcZlvtFEjyW6jJubVtvnRD/awiuvq0ajoTQB11FYGueMdA0Pw9FrepanBFp00aywSZyZwwyuxRyxIIPFeVXXxR8Z+MEZfhr4WlSyJ2jUtR2qD7qCQvH1b6VM5xgrydkG57oeBzWTc+JdCtY2kuta0yGNfvNJdRqB9STXmNl8NNW1+x8z4jeKdU1G4lB32VpN5Nqme21QNx98Aex61paX8G/A2nxlRoiXLHq9zK8h/InA/AV51TNqEXZXZagzdf4q+BkYqfE+nZBxw5I/MCm/8LX8C/wDQzaf/AN9H/CnaX4C8J6Wxex8O6XG/9826uw+hYEitT+wtI/6BVh/4Dp/hWDzqHSDH7M43wDdwePdRm8XX1zDdpZXc1rp1lGd0VlsYqZD/AHpXXDbuysAvUk8l4jsLO/8Agd4w0C/vbaGDTrq5gspbiRYwzRMJU5JAyWJH0Ndcl/Z+FdV8cXkUEMMUK2rpFGoUPIYsAYHqcDPp9K8E+Knw+u7zw/eST27r4m00HUnUc/abRwu8D/ajYE/i/XArnjWnXrXlKyurfn/kehRov6pUl6fhu/lf8TA+GfxZs9C8NaXpPiWKe707RriS6tbO3QFriRs7BIzEBY0LO2PmJYrxheftPS7sX+m2l4EKC4hSUKTnbuUHGfxr8xK/Sb4fv5ngPw24bdu0y2O7Oc/ul5qs3oRhyzj1ucFN3N6uc+IOif274Wu7dF3XEY86H13r2H1GR+NdHRXl4bETw1WNanvFpr5BWpRrU5U57NWPkmium+I2j/2L4svIUXbBMfPh442tzgfQ5H4VzNfvGGxEMTRjWhtJJ/eflFejKhUlSlunYKzb/wD5DOmf9tf/AEGtKs2//wCQzpn/AG1/9Bq63wr1X5odD4n6P8mYfiGyt9BuNO1ewgSGG3l8q5WNcZjfjJ9cH+Yrq1ljZyiujMAGKg8gHoa5X4kRai+hs9hJ/ow/4+YgoJZfXPoO9cv8KLgjX7qN2J8y3JyeckMv9Ca8v60sNjPq6jZSt6bdPwPWWEeKwX1mUruF/N2vfX8e+lj6h/Z+182Gu3/hq4f/AEa9DX9lk/dlGBMg+o2uB6hzXvVfHKXlzpd5Z6rp4JvtPmW6hXON5X7yfRlLIfZq+u9I1C31fSbLUrF99reQpcQt6o6hgfyIrws5wvsMRzLaWv8AmfRZHi/rGGUZbx0+XT+vIt0UUV5J7IUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAeT+Hv9K+P3jiYYP2OwsbbIHTepfGal+FX+j/Ez4n2P9y9tLn/AL+wk9fwqL4dfv8A4n/E68PV761t8k8/u4cflzxUvw4/5LT8VP8AuFf+kzV5VGV8fUXl/kW/hR6nRRRXqkBRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQBHcTxW1vLPcSJFDEpeSR2wqKBkkk9ABXL/DZWuNGu9alV1k1u8lvxvUhvJOEgyDyP3McRwemaZ8Tk+16FZaY+PI1LUrW1nz0MRlDSL9GVGX/gVT/EbXDoPgXXtRt8me3s5TCB3kKkIB9WKisqlaFK3O7XGk2cX8EI5Nf13xj47uMmPVr9rSw54+ywHyww/wB4ryPVPc56fxxqur3N/D4Z8LyJaahdW7Tz6nKodbOEHbuVMjfIScAcAckngA3PBGir4a8HaNokWAtlaxwtj+JgPmb8Wyfxqh/zVD/uD/8AtevIrZtzXjRXzZap9zJ8MfCbwvokFoLm1k1i6t4xGlxqbmcqB0CofkUDsAOK71EWNFSNQqKMBVGAB6ClorxKlWdR3m7mqVgoooqACiioL+6jsbG5u5v9VBG0r/RRk/yo3A8kmf8A4ST4lXNnAM6fJqKvIT/y0FrGFY/7vmF0+qGur+I6f2ZPpPiWNdxsJhDcrjIa3k+Vs/Qnj61z3wRs3kaW9uADLb2NtbZHTzHXzp//ACIxP416R4h0xNZ0O+06RtouImjDEZ2nsfwODXVVko1FHotD0faKjOnCWyWv/b2r/B2+R8PftC/D0eBPGjPYoBoep7riyK9E5G+P/gJIx/ssvfNfY3wmkWX4W+EGQ5A0i0X8RCoP6g15X8SNCHj3wJo+n6ni21XStTGlyyk5CyOhjjb3VpTBn/gWOxr1P4T2lzYfDbw7ZX0Elvd2tmlvNFIMFXT5WH5g11Yuv7XDwUn7yZ59Sk6NSUH0OsoooryxHnvxm0I6hoKalAmZ7EkvjqYz1/I4P0zXhdfWkiJLG0cihkYFWUjIIPUGvnT4geF5fDWssiKzWE5L28nt3Un1H8sGv0jgzNoyg8BUeq1j6dV8t/8Ahj4ziXL2prFwWj0f6P8AQ5aszWMR3OmSg4cXIQD+8GVgR/X8K06yvEKlILa8jYCe2mUoCMhtx2Fce4b88V9xX0g32/Q+Yw+tRLvp9+hqkBgQwBB4IPeuAg0I+H/HdlPbKf7Ouy6Lj/lmxUnb+fT/AOtXf0jorgB1DAEEZHQjoajEYaNblk94tNf15mmGxUqHNFbSTTX9dha90/Z61f7V4OuNIlYmbSLloVB6mF/3kZ+g3Mg/6514XXa/BPVP7M+JMVuzYh1e1e2PvLHmSP8A8d87868/PKHtMNzreOv6Hp8P4j2WK5HtJW+e6PpGiiivjD7oKKKKACiiigAooooAKKKKACiiigAooooAKKKKAPJfgv8Av7vx/e9pvE94ikDgqm0Aj9am+Hh8v42/E5HBBlTTJE91EDA/rUH7P/73wTe3vOb3Vry4JPU5lI59D8vapvDX+j/tC+JoxwLrRbac4PB2vs5HrXh4WV8fU+f5o0l8KPVaKKK9wzCiiigAooooAKKKKACiiigAooooAKKKKACiiigDkviL/qvD3/YZtv8A2as74jhbq20LS3Py6jq9tGy4+8sRNwy/QiAg+xqx8VLg2tl4dlC5H9vWMZ4zjfJs/wDZqoeMXQfEHwAkhPzXV4UHONwtJP6Fq8HM1+/i/J/hdmsNjta5Y8fFBc8btGO33xOM/lkfmK1/E1zNZeG9VurZ9k8FpLLG2AdrKhIODx1FctZ3M0+v+A9Rnffc3mlXEUzYA3F0glJwBjrH+pryKcd36/lc3dN8ntOl7Hd0UUVkQFFFFABXL/FCRk+H2vRxkrJc2rWiEdQ0v7tf1cV1Fch8T5VTQ9Pjk/1Uuq2Rk/3Y51lI/ERkfjWlL416ha+iIvhLGreFXvlXb9vu5rnHp85XH/jtdpXJfCeJofh9pCv1KyN+BkYj9DXW0qvxs6sa/wDaJ27v8zy/VdNlv9Y+IOmWmEvbi3tryxB6edGu5W/7+hK9B8P6pDrehadqlt/qby3juEHcBlBwfcZxXE6/rVtoXxatZrtJDDc6WluXQD5C05wze3AH41seAP8AQJde0EjA02/d4Bn/AJYT/vkx7Au6D/rnWs03C/p/k/0KxkHeFRrSUV+Ct+h1tFFFc5xhWfr2j2euabLZahFvifkEfeRuzKexFaFFXTqSpSU4OzWzJnCM4uMldM+fPFnw91bQ3eW3ja+sRyJYlyyj/aXqPqMivOdciuG+yTQRGdbeXzXgDbS+FOME9wSDivsmvPfi9o2kSeGppXs7WPUbuaGyguWGwJJNIsYdyCMhdxbBPOMdSK+6y/jKUoqjjIX/AL0d/mtv62Pl8Rw2oz9phpW8nt9+/wDW54LZXUV7aRXNuSYpVDKSMHBqau/g+G0Z1y+0HTr0wtp9vC0RuFBEyleT8uNuDgYwaiu/hb4jgOIktbgesU2P/QgK+sw/EeXVoq9ZJ+en5nhYvIsdh52dN23VtdHtscLVnR7k2Xibw9eA48nVbXcfRWlVG/8AHXauoi+G3ih3Ctpyxj+81xHj9GNa158O30Pwxfalq00Ut3H5flRRZKoTIoySepwfTj3qMxzvARoSgqqk5KySaer9CsuyzF/WIT9m0k022rbep7/RRRXyZ94FFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFQ3k32a0nnIBEUbPgnHQZqasTxxP9l8FeILglQItPuJMscDiNjzQBwX7OiLH8G/DwVg5InZjjuZ5Dz+eKdaAD9phsADPhHn3/ANMrP/ZolLfDK3hYn91KcewZFb+ZNaNr/wAnMH/sUf8A28rxKdJ0cynB+f46hTqqrSU0eq0UUV7YBRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQBwvxvXHw01S6CljYPb3/AyQIZ45SfyQ1z3xUna18WfDXUUINsNZ+zNIDxmaFkXn3ya9P1nT4dW0i+066Gbe8gkt5B6q6lT+hryLWI59Y+AMFwyh9V0e2juDjki5snHmAe5aF1/GvJzKNp05+q+8uHU9R1G2W90+5tZPuTxNE30YEH+deZeH7x0074f3s44trybS5wesZaORUP8A30ka/wDA69St5kuLeOaFg0Uih1YdwRkGvJNWX7H4Y+IMAyH0m+GsxY6psZbhcf8AfqvDo6+7/Wun6noQ97Dzj2s/0/VHr1FAORkdKK5zlCiiigArz74zMZNF0+ziOJZZ5ps/3VitZpC35qq/VhXoNeffFI5u7BRkt/Z2pvgDoBb4z+bAfjWtD41/XQ0o/wASPqvzOo8FKF8HaGFGB9hgP5xitmsfwZ/yJ+hf9eEH/ota2KifxMdf+LL1Z5frVlB4o8ZeKrZmQyWmlpaxLkZL7vNDDvw2AfrjvVjwjqTT+JvD+ou+863orQTsP4prWQEE/UTTc+30rC8IkP8AECx1SAtt1TUdSAcn/WQqisn5Nn8q3PAWlR2ni6Sxiu1vYfDunmzEyrtHn3MxlkXGTgqkcOef4q65JKLXl/wPzselmKjTpxp31Vrfc1L8Uj0miub13U7u18Z+F7GCXZa3v2rz02g79kYK8kZGD6YrY03U7TUvtX2Kbzfss7203yldsi43LyOcZHI4rkcWkmebKjKMVPo1f8WtfuLlFFcl41vrjSdZ8Oak00qaVHPJBeKrkKfMUKjOOhCkE89KUY8zsFGk6s+Rb6/lt89jpNTvI9O027vZw7RW0LzOEALFVBJxnvxWferpviPwjKb+M/2VqFnvkWTgrG6Z5xnBAOcjoRVf4h3kdj4J1mSXo9s8IA7s42D9WqKW2ksvho9rONs0GkGJx6MsOD/KritE/Mp00qHtOt7fgcl8Ori8u/E2hXWpySS3dx4Xjmd5AA7bpgVL4AG7aRn3zXqdedeFf+R40f8A7FaH/wBGivRaqvrIvE/Y/wAKCuY+I+ZPDSWw63eoWNrj2e6iVvyUsfwrp65nxUPtniHwlpq4Ik1A3ko9I4InYH/v4YR+NXg489eC8zklsdtRRRX2JzhRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABXHfGO4+y/CrxZISBnTZ4+mfvIV/rXY15x+0VcfZvgx4mkywzFFHx/tTIv9aAMD9nJPL8DFOfldBz7RJV+f/R/2jtJl5H2rw7NBkfxbZ9+Pb1qH4Bp5fha7jwBsuAP/HFqbxR/o/x3+HkvI+1WuowZHfbEHwfb+tebjFy51Uj/AF8KOXLZc2ChL+t2er0UUV6R1BRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAV5j4NaO28Z+PfC9wgMIu11KFW6PFdJlwB6easuf8Aer06vP8AxxajSPHPhrxTHhYpCdEvz6xzHMLH6TBV/wC2prjx9L2tCSW61+4qLsw+Fcs8XhZdGv3L3+hzNpkxJyWWPHlP/wACiMbf8CrL8cWCWviRJpG2ad4gtn0i9bsrspEbn+X0FSarO3hr4taddN8umeJrf7DKc8JeQhniJ93QunvsFdP4w0ca94cvbDpK6boW6bZF5U57cgfhXzLfLNT6S/r8Gd2FqKE7T+F6P0f+W/yIfAWovqfhLTpbhQl5ChtbpP7k8RMcg/77Vse2K368x+HWtMmt+XcjZFrqGdcjHl30KhLiMjtvRUlA9pK9OrOtHlkZzg6cnCW60CiiisyArzD4oXX2fWL6dgG8jw/NDGPT7RcRIx/8cWvT68j+KLfab3xUwPy2el2EA5HzSSXTuwx6hUQ/8CrfDr3/AOvQ6MHFSxFNP+Zfmen6JZnT9FsLInJtreOEn12qB/SqXjTUf7K8KareA7XjgYIfR2+Vf1IrarjPiZ/pdvoujjn+0NQiR19Y1+Zv6VnD3pq48Ova1483e7/NnB6zNc2OseAvB2kxfZdVa1M0upAkvZxy7hIET7u9tr4ZgQNvAz09e8P6LYeH9Ki0/S4fKt48nklmdics7MeWYnJJPJJrzXxTbv8A8Jjq2sQQSTvpV9p0k7Rculusbs6gf8Dzj/azXpJ13TF0Uas17CNOZN4mJ4I9PXPbHXPFbVm3GKX9Pf8AUuspVoxq7tt/fe9vxv8AecJ8R9eXT/HHh8W6PNe2kFw6RRjcWklTZGuP94Z+ldd4F0d9D8NWttcj/THzNctnJaVjk5PcjgZ9q5X4eaFPqmt3fjDWY2E1y5NnE45SPoG/75wB7ZPcV6TUVWklBdDfG1I04Rw0PsrV+ert8m2FU9Z0231jS7mwvVLQXCFGx1HoR7g4I+lXK5/xDrN1Za9oGl2UULPqMsm95ScLHGoZsAfxEHj6e9ZRTb0OGjGUprk3Wv3a/ocPqR1dtT0PwdrC+eovI5o7xelxbRgkqw7MMc/T8T3fjy6Wx8D+IbpxlYdPuJMeuI2OPxrI+Ijf2df+Gtd3FVsr7yZmIyqQyja7H0wAPzqb4hSfbrPTdAgy8us3KRtt5C2yESTsfbYuz6yL1rde84vp/V/wOnFz9pTpzSte/wB99fwsUPD1s1v8Q4oGOWsfD8Nq59W8wH+ld7XF+CX/ALV8S+JNdiH+hzSR2ls/98RDDMPYnGK7Ss6r97Uzxa5ZqHZJfhqFc5p4F78Urpzyul6RHGvs1zKxYfXFtH+Yro6574fkXl/4q1VTujudUaCJu2yCNISB/wBtElr0MohzV+bsjiqPQ7GiiivpjEKKKKACvnzxv4u8QWHiz4o3Ft4ql06PwzHYTadYukLQTtLBueNwyb23EYG1gQW+lfQdYtz4U8O3Os/2vc6DpM2q7lb7bJZxtPlQADvI3ZAAA56CgDyyX4va+/io6da+HYRDZ/YhfxTOyzL58aO7AnCqE34AYHdtPIrE8P8AjXxeviPw5Z2+p20lpf6/rFtOL9s70h3FE3bSVCj7u0jJwDxXueo+G9D1PUIL/UtG028voMeVcXFqkkkeDkbWIJHPpTZvDGgTQpDNoelyQpcG7RGtIyqzE5MoGOHJ53daAPNfDvxXv9T+J1joItrG40bULq9tre8gDoym3Vm53H5uFwcKBk8FgKs/Ev4oaj4P8QXuj2+kRX15JZRXmmIGYG4wz+ere6ohYY9RmvQLfwt4fttXOq22haVDqhdpDeR2cazb2BDNvA3ZIJBOecmrl1pen3d/bXt1Y2k97ah1gnkhVpIg4wwRiMqCODjqOtAHkNx8X72+0hb7QYNPIvdVnstLWdZHa7hhjy8owVUfNnksAAM81Ul+OGoQeG9A1WbRIM67pryWEaSMTJfrOsXkf7pDBgevX0zXrknhXw9Lpdtpkmg6S+m2r+ZBaNZxmKFsk7kTGFOSTkDuakTw5oaW1hbJo2mrb6fJ5tnELVAts+c7oxjCHJJyMGgDzC4+KmvDx7PotvolrLZ2F7b2N8d7LIPMClplJIAUFvlUglgOo6V7JXG+PLTTrCS08RTeE7HWZrSVTcXH2ZJLu3hAP7yLKlmKnB2gg4zjJwK6nTL+01TT7e+064jubO4QSRTRNuV1PQg0AWa8m/agl2/Ce6h/5+by2i5P/TQN+P3a9Zrxn9qdyPBGgxDGJtdto2PoNkp4/IVdNc00vMirLlg5dkXPgVj/AIR7UB3+1f8Asi0/xp/yW74V/wDcV/8ASZarfAj/AJBOqf8AXdf/AEGrHjg7PjT8LJG4QNqaFu2Wt1AH415mZ+7ntT1/9tOXJ3fL6fp+p6xRRRXoHaFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABWP4x0VfEXhbVNJL+U13A0ccveOTGUce6sFb8K2KKAPKruC7+IXwqTgWniOAh1zgfZtRtn5HsPMQj/db3rr/Cmsx+IfDmn6rGhi+0xBniPWKQcOh91YMp9xWLrKf8If4y/tXdt0HXpY4LwY+W2vMBI5fZZAFjb/aEZ/iJqPTnHhrx7c6Y2V03xAXvbM9o7tR+/j/4GoEg9xLXyuLw7pSdPpuvTr/Xkbxd9Tn9Y0aX/hKdY0exkS2urny9c0mVx8sd3GcMDjs3zBh/dJFd94V1uLxBosN9HG0EuWiuLeT79vMp2vG3urAj34PQ1Q8aaDPqkVtfaVL5GtaexktZOgbPVG9mxj/62a5XQ9ejt9fi1lImtbTVZl0/V7VuPsl+PlilPs/ERPc+V6GsP4sPNf1+P5+p2117WCrx6WUvXZP5r8T0+iiiuY5AryXxl+813XLTr9r1LTIMeuUY/wBK9arybxP/AMjxJ/2HdK/9FPW+H3fp+qOnB/x4s9Zrjda/0n4n+HoTyLS0uLnH+98mf0rsq4LXbwaV8WNFnnA8q/smsQwPIbfuH6lR+NRSWr9GVg03OVt+WX5f5Gn4L/fa14yuiOJNWEa9fux2sCY/76D/AJ+1PTwF4YTUDejSIDOXL4LMUz/uE7fwxSeA/wDmYv8AsMXH/stdRTnJxlozCnVqU0+STV+zAcdKyvFkskHhXWZoJHjljspnR0OGVghIII6GtWud+Id5HY+CdZkl6PbPAo9WcbB+rVEFeSRWHi5VYpd1+Zd8JyyT+FdGmnkeSWSyhd3c5ZmKAkknqawteb7R8TfC8EYy9pBdXEnsjrsH6it/w7C2neGdMgu8RvbWcSSZOApVAD/Kuc+H6Nq2oar4onUj7dIYLQHqtuhwPzIyfcVa0cpf1qdMLRlVq9FdL1ldfld/I6LxVbw3XhnVYbllSF7WQM7DIT5T82Pbr+FeM6Z4gu9W061uLCBkmisI/DttM2QGnkkHmlPYJFFub+8QP4TXrHjrXLbRdDkEsCXt7d5t7LTyu43czA7Y9vp3Y9AoJPSuN+Hmio+qafbwMs2meHYpIvPVdq3F7Id0zqB2yzH24rWj7tNyf9f1sGEmuR8y0i+b8NF83b7j0fRNNg0fSLTT7UYht4wgOOp7k+5OT+NXaKK5W76s4pScm5PdmN4y1Z9D8M399boJLtEEdtEf+Wk7kJEn/AnZR+NanhXR08P+HNN0qNzL9kgWNpW6yvj5nPuzZY+5rl9Skj1v4iaRogdWh0qL+2LtM9XyY7dT/wACMj/WNPWu9r6XKaPJS53vL8jnqO7sFFFFeqQFFFFABRRRQAUUUUAFFFFABRRRQAV8zfHvX/FHwt1YS+BrS7stAvpEu7qUxrJarcb8lY/+ee/A3g4DHpjLE/TNR3MEN1byQXMUc0EilXjkUMrA9QQeCKAMTwF4osvGfhLTde004hu4gzR5yYnHDIfcMCPwzXm37VH/ACJ3hr/sYbb/ANFzV6H4Q8F6T4Pm1AeHkks7G9kEz2KtmCOXGC8YPK7hgEA4+UYA7+b/ALU8udA8K2gxmTWo5unOEjf/AOKrWgr1YrzRjiHalN+T/Iu/Agj+ytVGRkTIcf8AAan+KX7jxt8NbznKaybfI6/vYyOnpxVP4Df8ems/9dIv5NVz41f634fHv/wl2njP/fdeVnHu57P1X/pKOfJXfL6fz/NnrNFFFegdwUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFAFHXdKs9d0a80vU4hNZXcTQyoe6kY49D3B7GvCQuv6to+teB76fPjbwrJFqOj3znBvYkP7qQ+5XMb9vn5zzX0JXDfE/wAJ3mtW1trHhmZbTxZpW6SxnPCzKfvW8nqj479Dg8c1zYmh7aOm62/rzGnYu+CfEVv4r8L2GsWyNELhP3kL/ehkB2vG3urAj8K5Px9pVtp+qS312jHQtZj+w6qqceWTwkwPYg9+xHqa5nwN4wtrHVf7YWFrLR9bu/susWUnB0fVh8pLDskuACT/ABBScbiK9m1Gyg1Gxns7yMSW86FHU9wa+XqRdCptp/X5f8E7sNWVOXvap6P0/rVeZg+BNXub2yuNM1d1bWtKcW90w6TKRmOdf9mRcN7HcP4a6avH7dNT0DXo4oo3utX0eIqkY+9qemk58tfWWM/Mv0ZejE16rpGpWesaZbahps63FncoJIpF6EH9QexB5ByDUVoWfMtn/X9f8AVak6U+V69n3XRluvJvE/8AyPEn/Yd0r/0U9es15N4n/wCR4k/7Dulf+inp4fd+n6o0wf8AHj8/yZ6zXmfxm0+5vbnw4bEhbsTyJCc4y5Cso9OSmK9Mrjfihm30vS9TH3dO1KC4c/7Gdp/9CFRRdpqxpl03DERa31/FWG/DK8NxFr8dx5cV+mqSvcW6uGMTMF4OO2QcHvitrxLpF7qQt5dM1a5027t9xQoA0b5xw6H7w4/CvOrZW0DW9U8VW5b7ONZntdRQchoWKhXx6qSP0969eVldQyEMpGQQcgirq+7LmRm06XLWhs/z6rX+rM4l/EWv6AY28Vadavp24JJf2LkiPPAZkPOM9T/+qo77/isfFx04Sr/Yuk+RdS7CD9plcboxn+5j/PQjuJoo54nimRZI3BVkYZDA9QRXm/hsWHgXxH4lspyFsvs6X6TZJKxglRGfcFsL3NEGmm0tTroTjUUpwjaolpbbVpX9Uv60Nz4iXk0traeH9Pfbf6u/k7h/yzhHMjn8OPxPpW3Pc6V4W0FGvLmCw020jWMSTOFUADAGT1J/MmsDwRZXWo31x4p1eMx3N4nl2kDf8sLfqPxbqf8A6+Kw7zVbS91u58T38L3trYXB03QbRct51wuVlmUdMl8xhuwjYj73LUL+70X5/wBfqzCtF+7hqerW/r/wNvvZmXF5qGv+IXu7W1kttW1WL7PpwuE2yWGnD787L1R5WJOODtVBwRivU9C0q20TSbbT7JdsEC7QT1Y92PuTzWP4O0O6s5rzV9aZH1nUCDKE5WFB92JT6Dv9O+M109TWnf3VsiK84xiqNN3S3fd/5LZff1Co7ieK2t5Z7iRY4YlLu7HAVQMkn8Kkrz/4yyXmoaFaeE9HfZqfiOf7EGHWK3A3TykegQbfq4qaNJ1aigupyt2VxvwHWbWLDXvGt7GyTeI74yW6uMMlnFmOBT+AY++7PevUqq6Tp9tpOl2enWEYitLSFIIUH8KKAAPyFWq+0jFQiorZHMFFFFUAUUUUAFFFFABRRRQAUUUUAFFR3M8Vrby3FzKkMESGSSR2CqigZJJPQAd687tPjf8ADu7vYrSHxJF50riNd9tOiZJxy7IFA9ycUAekUUDnpRQAV4D+1BNu1zwLZg53S3c7DPTaiYJH4nH4179Xzd+0TP53xT8PWuc/ZtLkuMZ6b5Cv/stdWBjzYmmvNfmceYS5MLUf91/kdZ8Bv+PTWf8ArpF/JqufGv8A1nw+/wCxu0//ANqVQ+Aj5h1tMfdaFs/Xf/hV/wCNf+s+H3/Y3af/AO1K8XO9M9nfvH/0lEZJ/wAi+n8/zZ6zRRRXoHeFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAeKfGfwRd2moTeMfC1rHcSSw/Z9d0t1LRajbYxuZRyWUdwN2ORkjDZvwH+IIv7+bwpqF49x5cfn6VPcMDM8A6wyMOGkQEfMPvLhhkYJ99rwH4qfDK10fV4/FWhyyaXDBJ55urZcnTZdxPmFP47dix3p/BksvylxXDjcLGtBu2v9f16FRlY9O8XeHzrMVvcWU/2XVrJvMtLgD7rd1b1U9/8g+e2PiG78O69dXAsZofMYy6voqrkhv4ru0/vA9XjHJ5YZIO7vPAfic+JNPnW7tjZ6vYuIL636or4BDRt0aNgQysOoNXfFHh621+zVJWaC7hO+2uo+JIXHQg+nqP/AKxr5uMvZvkqLQ9CnVhOKpVduj6r/NeX3Gjpt9a6nYW99p9xHc2lwgkimjbcrqehBry3xIyyeN5ihDBfEGlxnHZlhLEfgHQ/8CFVo7OPwvezQ+I5dV0aGdzJ9s0md1tJ3OSWMQBEbnqdoGTzjvWv4K0i21LW7fUNNguE0CwMjwTXUryS3ty+A87F8seBjJ9BjHQXGMad5J6G9HDzoT9rP4VfXo9NEv6uup6ZWT4s0w6z4b1HT0x5k8LKmem8crn8QK1qK5U7O6OGE3CSlHdHkHhe9dbWaDUoEbRvEdwLSaXefMsr7yFiZXQj7shiBVgeGcAjkGt7QPFCeFrK30Pxak9pPajyY7zy2eCZB90hgPTA/Dn0FHxfowh1y+03zfs1j4kTMM3a21CMho5B9WCt7ke1dR4V8Qx6/Fc6ZrFolprlmAt9p8mGHPSRM/fibqG/A4IIrqm1KPNbT+v+G+7ud1ScKbaavCfvLWzX/DaonvPGnhy1s2uZNasXRQDtimEjnPoi5P6cd64fQfD9/wCMvE0viLW4GttHlZHhtXPMyoP3e4f3e59c8cGu7ufDHhtYTJPo+lxJGRIZPs6Jt2nOSQBxxz7deKx7j4h2B0+W90rTNV1KzX/V3UUAit5fdZZSq7P9vpxwTUQ2fs18xQxMKEWsOnzS0u+3lbr5/cX/AB9qdzZ6RFYaTJs1jVZRY2bD/lkzAl5cekaB3/4CB3rn/C9jaal4jsY9Jjx4c8NQ/ZbVs5Es2ACwP8WB39ee9c9otnr/AI/1s6pqEv2XTxG9uJIQQkUTEF4oSRuZm2qGlIGcYAUZDev6dY22m2UNpYwrDbxLtRFHAH+e9OdqUeXr/X9feTy/VU+b42rW7J738326dSxRRRXMcRHczxWttLcXMiRQRIZJJHOFRQMkk9gBXG/C+CbxDqF9461CN0/tBPs2kwyDBgsVOQ2OzSt859tg7VW8bQy+Ndei8FWbummIEutenjOCIScx2wI6NIQSfRAf7wr0yGKOCGOKFFjiRQqIowFA4AA9K+hynC8sfbS3e3oZVJdB9FFFeyZhRRRQAUUUUAFFFZfia91LT9EubrQ9K/tjUY9vlWX2lbfzcsAf3jcLhSW564x3oA1KK8wHiv4nS/Mnw2tLcdNsuuwsT75UYo/t34rS/Mng7QoF/uS6pub81GKAPT6Dx1rzAah8XpPmXRPCEKnokl3MzD6kcVU1Hw/8TvFsK6X4m1Dw3pOg3Df6YdHM5u3i7xBnG0BuhI7eoyCARa5ql78VtUuvDfhi4e28IW7GHV9Yj63R/itoD3BHDN0wfTAb0a78M6Td+FD4bms0bR/sy2iwHkLGqgLgnJyMDB65ANW9E0mx0PSrbTdJto7WxtkCRRRjAUf1Pck8k8mr1AHlvwk1e90bVL34d+I5hJqOjxK+n3RBX7bZdFbr95eFP5c4Jr1KuL+I3gpvEqWepaPeHTPFGmEvp9+vQE9Y5B/FG3QjB/HkHnYPiR4o0Zvsni74e69JdKMfaNBiF7DMf7wGQUB9CSaAPVq+Zvj7/wAlrs/+xeT/ANKZK9K/4W7/ANU9+In/AIJf/s68Y8d6pqHib4k3muX2i6vo9ollFZ2MOp2Zt5XjyWckHIPzluhPBFehlcXLFwS7nm5vJRwVRvt+p6X8A/8AmO/9sP8A2pWj8bfvfD//ALG7T/8A2pWT8Bv+PvWf9yL+bVv/ABl0jWtU07w1P4c0z+1LzS9dttSa2+0JBvSIOSNzkAZJUdzznBxXgcQ2jnc23/L/AOkoeQ65fD5/mz1GivMP+Ez+JP8A0Sn/AMuO2/8AiaP+Ez+JP/RKf/Ljtv8A4mu89E9PorzD/hM/iT/0Sn/y47b/AOJo/wCEz+JP/RKf/Ljtv/iaAPT685+K/ibUoLrSvCXhKfyvE2syDEyqH+x2wP7ydgeOgIGevOOQKo3Pin4p3sX2ax+HVppdxKQi3t3rcM8UGTyzRoAzADPT8j0rZ+Hfge70LUtT17xLqSav4m1Last0sXlpDEoGIox2XIyemeOOMkA5+X4Pz6VG+peEvFmuWvijG6S9vLjz471uwmQjBXsMdB2NdT8MfGTeLdKuo9QtRYa/pkxtdSss/wCqlH8Q/wBhsEg/UZOM12VeR+OY7nwD8Q4/Hdpbz3WiajCtlrcUEJd4do/d3AA7DAU56D3YYAPXKK4G9+MPw/s9Pt72XxRYNDP91Yd0sg/3o0Bdf+BAV31ABRRRQAUUUUAFFFFABRRRQAUUUUAFIyhlKsAVIwQehFLRQB4l408I6z4H1AeJfBAaeyt1IksApJjizuMQUcvDkkgAboiSV3KSld34E8X6X400NNS0mUHB2TwFgXgfGSrY49wRwRggkGuyryvxL8P7rQvFD+Mvh7Gkeoyf8hPSCwSDUkzkkHokvJIboT1xls+ZjcvjXXNDSX5lxnbc9EorI8MeI9N8Tad9s0qfeEYxzQuNktvIPvRyIeUcdwf5c1r18zKLi7Pc2CiiikBn69o9nrumSWOoR74n5BHDIw6Mp7EV5/qVlcw+Ta+LfDEviJbMlbXVLRQ05Q9iAQwPY84Pv1PqFFXCo4m9Ovyx5Jrmj2f6Hkv9irOQ9n8NVmQfMn9o3qkBuxMTk9OtdLY+DJdQaG58X3hv5EwY7GL5LWH0AQfex0yfxzXa0VUq0mX9a5F+6io+avf723b5WGxosaKkaqiKMKqjAA9BTqKKyOUK4nxr4vntdUtvDHhWOK98WXy5SNuY7KLvcT46KOw6scAdazviH48ns5X0Pwmn2vXJHFuzoAwgkYZCKDw8pHOPuoPmcgDDb3wr8BQ+C9NuJruX7b4h1F/P1G/c7mlf+6GIztHb1OTgZwPWy/L/AGr9pU2/MiUraI3vCHh6Dw1pAtI5pbq6lcz3d5N/rLqYgbpG+uAABwAABwBW3RRX0aVtEYhRRRTAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACoJ7S2uHVp7eGVl6F0DEfnU9FNNrYTSejI44Y4smONEJ67VAqSiik9dxpWCiiigAooooAKKKKACiiigDJ0/w1oWnajJf6foumWt9JnfcwWsaSNnrlgMnNa1FFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQBw/irwIt3q58Q+FrsaL4mAAedFzDeqOiXEf8Y7bhhh2PGKPDvilrq9Gj+IrM6P4hUE/ZZH3R3IHWS3k6SL3I+8v8QFdxWb4g0PTfEOntZaxaR3NuWDqGyGRh0dGGCrDswII9a4sXgaeJV3o+5UZNDqK821C38f8AgefdpaN418PdfJnlWPUbYegfpMPqNx6e9aHhv4p+F9aufsM94+j6uuA+nasn2WdT6Ybhj/uk189XwFahq1dd0aqSZ3NFAORkdKK4ygoorD8R+K9H8PBE1K8AupP9VZwqZriY+iRICzfgMetOMXN2irsDcrynxf47vNd1yfwj8PlkvNSj+W/vIDhbYdCqyEFVbgguc7cEKHf5ReudP8Y/EMGKY3Xg3ww/DICP7Tu17g4yIFP4t+BxXfeEvC+j+EdGi0vw/YxWdonJC8s7d2djyzH1Ne5g8rfx1vu/zM5T7GJ8O/ANl4St1nlKXesMhR7naQsak7jHECSVUk5JJLOfmYk9O1oor3EklZGQUUUUwCiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKxvE3hbQvFFqLfxDpNnqMS/d8+IMU/3W6r+BFbNFAHltx8FtHt0A8Ma74n8OBfuxWGqSGH6FHLZHsCKhHwt8SAf8lP8AEn/fuL/CvWKKzlRpyd3FfcO7OBsvhvi0EOreLfFepZIL7tQNuG9v3IVgD6bvxrp9A8NaL4fEn9jaZa2jyf6yVE/eS+7ufmY+5JrXopxpxh8KsK4UUUVYBRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAf/9k=);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Schematic representation of atrioventricular conduction in the presence of an accessory pathway with antegrade conduction. The normal pacemaker is in the sinoatrial (SA) node at the junction of the superior vena cava and the right atrium (shown in green). The SA node activates the right and left atria. Ventricular activation results from the impulse traversing the AV node, the specialized infranodal conducting system (His bundle and bundle and fascicular branches, shown in red), thereby activating the ventricular myocardium (shown in yellow). In addition, however, the presence of an accessory pathway (AP) which conducts in the antegrade direction causes early activation (preexcitation) of a portion of the left ventricle (shown in blue). The degree of preexcitation depends upon the time required to conduct through the right and left atria, the AP, and the ventricular myocardium as compared to conduction through the normal pathways. The inset of the right shows the ECG timing of these events. The net effect is a QRS complex that is a fusion of ventricular preexcitation (blue) and normal excitation (yellow). The combination of preexcitation and normal excitation leads to a short PR interval, a delta wave, and prolongation of the QRS duration. This ECG pattern is referred to as the Wolff-Parkinson-White pattern.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f8_22_8545=[""].join("\n");
var outline_f8_22_8545=null;
var title_f8_22_8546="Verruca vulgaris - finger";
var content_f8_22_8546=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F58825&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F58825&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Verruca vulgaris",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 324px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    A well-defined keratotic papule is present on the dorsal finger in this patient with verruca vulgaris (common wart).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f8_22_8546=[""].join("\n");
var outline_f8_22_8546=null;
var title_f8_22_8547="Velaglucerase alfa (glucocerebrosidase): Pediatric drug information";
var content_f8_22_8547=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"9\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Velaglucerase alfa (glucocerebrosidase): Pediatric drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_general\" href=\"UTD.htm?36/4/36931?source=see_link\">",
"    see \"Velaglucerase alfa (glucocerebrosidase): Drug information\"",
"   </a>",
"   and",
"   <a class=\"drug drug_patient\" href=\"UTD.htm?20/15/20724?source=see_link\">",
"    see \"Velaglucerase alfa (glucocerebrosidase): Patient drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F9942752\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      VPRIV&trade;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F11575112\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      VPRIV&trade;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list_set htclist drugH1Div drugBrandNames\" id=\"F10206018\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Therapeutic Category",
"    </span>",
"    <ul>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Enzyme, Glucocerebrosidase",
"      </span>",
"     </li>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Gaucher's Disease, Treatment Agent",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block dos drugH1Div\" id=\"F10206046\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Usual",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_general\" href=\"UTD.htm?36/4/36931?source=see_link\">",
"      see \"Velaglucerase alfa (glucocerebrosidase): Drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:0em;display:inline\">",
"     I.V.: Children (4-17 years) and Adults: 60 units/kg every other week; adjust based upon disease activity; dosing range: 15-60 units/kg every other week. When switching from imiglucerase to velaglucerase alfa, initiate velaglucerase alfa treatment at the same dose as stable imiglucerase therapy.",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F9961750\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Injection, powder for reconstitution:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     VPRIV&trade;: 400 units [contains sucrose 200 mg/vial]",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F9961594\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     No",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F10206047\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Parenteral: Reconstitute the 400 unit vial with 4.3 mL of SWI which results in 100 units/mL concentration; further dilute in 100 mL NS; gently mix; do not shake; infuse over 60 minutes through an in-line low protein-binding 0.2 micron filter",
"    </p>",
"   </div>",
"   <div class=\"block sta drugH1Div\" id=\"F10206023\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Stability",
"    </span>",
"    <p style=\"text-indent:0em;margin-left:0em;margin-top:0em;display:inline\">",
"     Store in refrigerator at 2&deg;C to 8&deg;C (36&deg;F to 46&deg;F); do not freeze; protect from light. Reconstituted or diluted solution stable for 24 hours under refrigeration; do not use if opaque particles or solution discoloration seen; infusion should be completed within 24 hours of reconstitution of vial",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F10206019\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Long-term enzyme replacement therapy (ERT) for patients with Type 1 Gaucher's disease (FDA approved in ages &ge;4 years and adults)",
"    </p>",
"   </div>",
"   <div class=\"block arm drugH1Div\" id=\"F9961688\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Cardiovascular: Flushing, hyper-/hypotension, tachycardia",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Central nervous system: dizziness, fatigue, fever, headache",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Dermatologic: Rash, urticaria",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Gastrointestinal: Abdominal pain, nausea",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Hematologic: aPPT prolonged",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Respiratory: Upper respiratory tract infections",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Miscellaneous: Hypersensitivity reactions, infusion-related reactions",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F10206020\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Hypersensitivity to velaglucerase alfa or any component",
"    </p>",
"   </div>",
"   <div class=\"block pre drugH1Div\" id=\"F10521085\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Precautions",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Development of IgG antibodies has been reported; the clinical significance is unknown. Patients with an immune response to other enzyme replacement therapies who are switching to velaglucerase alfa should be monitored for antibody development. Pediatric patients (4-17 years) may experience a higher frequency) of some adverse effects than adults (&gt;10% difference in incidence), including: Fever, rash, prolonged aPTT, and upper respiratory tract infection.",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F10206021\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity reactions have been reported; appropriate medical support should be readily available.  Infusion-related reactions (eg, dizziness, fatigue, fever, headache, hypo-/hypertension, nausea) frequently reported (during clinical trials: ~52% in treatment-na&iuml;ve, 22% previous enzyme replacement therapy); majority of reactions mild and occurred more frequently during the first 6 months of treatment and decreased with frequency over time. Management strategies are based on severity and include reduction in infusion rate, pretreatment with an antihistamine and/or corticosteroid, or interrupting infusion and resuming at slower infusion.",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F13300212\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     None known.",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F10073433\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:0em;display:inline\">",
"     There are no known significant interactions.",
"    </p>",
"   </div>",
"   <div class=\"block prf drugH1Div\" id=\"F9961600\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Risk Factor",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     B (",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?16/42/17068\">",
"      show table",
"     </a>",
"     )",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F9961601\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Teratogenic effects were not observed in animal studies when administered at ~2-4 times the human dose based on body surface area. There are no adequate and well-controlled studies in pregnant women. Use only if clearly indicated.",
"    </p>",
"   </div>",
"   <div class=\"block mop drugH1Div\" id=\"F10206048\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Monitoring Parameters",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     CBC, platelets, liver function tests, MRI or CT scan (spleen and liver volume), skeletal x-rays",
"    </p>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F10206044\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Velaglucerase alfa, produced by gene activation technology in a human fibroblast cell, replaces the missing enzyme associated with Gaucher's disease, glucocerebrosidase; Gaucher's disease is an inherited metabolic disorder caused by the defective activity of beta-glucosidase and the resultant accumulation of glucosylceramide (or glucocerebroside) laden macrophages in the liver, bone, and spleen; this results in one or more of the following conditions: Anemia, thrombocytopenia, bone disease, hepatomegaly, splenomegaly",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F10206045\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacokinetics (Adult data unless noted)",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      Note:",
"     </b>",
"     Values reported below based on combined pediatric patient (4-17 years) and adult data.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Distribution: V",
"     <sub>",
"      dss",
"     </sub>",
"     : 0.08-0.11 L/kg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Half-life: 11-12 minutes",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Elimination: Clearance: 6.7-7.6 mL/minute/kg",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 15623 Version 24.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0602-197.136.42.3-6F5635152F-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f8_22_8547=[""].join("\n");
var outline_f8_22_8547=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9942752\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F11575112\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10206018\">",
"      Therapeutic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10206046\">",
"      Dosing: Usual",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9961750\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9961594\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10206047\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10206023\">",
"      Stability",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10206019\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9961688\">",
"      Adverse Reactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10206020\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10521085\">",
"      Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10206021\">",
"      Warnings",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13300212\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10073433\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9961600\">",
"      Pregnancy Risk Factor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9961601\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10206048\">",
"      Monitoring Parameters",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10206044\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10206045\">",
"      Pharmacokinetics (Adult data unless noted)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_PED/15623\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_PED/15623|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?36/4/36931?source=related_link\">",
"      Velaglucerase alfa (glucocerebrosidase): Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?20/15/20724?source=related_link\">",
"      Velaglucerase alfa (glucocerebrosidase): Patient drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f8_22_8548="Dimercaptosuccinic acid (succimer): Pediatric drug information";
var content_f8_22_8548=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"13\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Dimercaptosuccinic acid (succimer): Pediatric drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_general\" href=\"UTD.htm?12/26/12709?source=see_link\">",
"    see \"Dimercaptosuccinic acid (succimer): Drug information\"",
"   </a>",
"   and",
"   <a class=\"drug drug_patient\" href=\"UTD.htm?10/31/10740?source=see_link\">",
"    see \"Dimercaptosuccinic acid (succimer): Patient drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F223371\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Chemet&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F223372\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Chemet&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list_set htclist drugH1Div drugBrandNames\" id=\"F1062370\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Therapeutic Category",
"    </span>",
"    <ul>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Antidote, Lead Toxicity",
"      </span>",
"     </li>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Chelating Agent, Oral",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block dos drugH1Div\" id=\"F1062364\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Usual",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_general\" href=\"UTD.htm?12/26/12709?source=see_link\">",
"      see \"Dimercaptosuccinic acid (succimer): Drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Children and Adults: Oral: 10 mg/kg/dose (or 350 mg/m",
"     <sup>",
"      2",
"     </sup>",
"     /dose) every 8 hours for 5 days followed by 10 mg/kg/dose (or 350 mg/m",
"     <sup>",
"      2",
"     </sup>",
"     /dose) every 12 hours for 14 days",
"    </p>",
"    <table border=\"1\" frame=\"border\" rules=\"all\">",
"     <caption style=\"text-align:center;\">",
"      Succimer Dosing",
"     </caption>",
"     <col align=\"center\" width=\"100\">",
"     </col>",
"     <col align=\"center\" width=\"100\">",
"     </col>",
"     <col align=\"center\" width=\"100\">",
"     </col>",
"     <thead valign=\"middle\">",
"      <tr>",
"       <th align=\"center\" colspan=\"2\">",
"        <p style=\"text-indent:0em;\">",
"         Weight",
"        </p>",
"       </th>",
"       <th align=\"center\">",
"        <p style=\"text-indent:0em;\">",
"         Dosage",
"         <sup>",
"          1",
"         </sup>",
"        </p>",
"        <p style=\"text-indent:0em;\">",
"         (mg)",
"        </p>",
"       </th>",
"      </tr>",
"     </thead>",
"     <tfoot valign=\"top\">",
"      <tr>",
"       <td align=\"left\" colspan=\"3\">",
"        <p style=\"text-indent:0em;\">",
"         <sup>",
"          1",
"         </sup>",
"         To be administered every 8 hours.",
"        </p>",
"       </td>",
"      </tr>",
"     </tfoot>",
"     <tbody valign=\"top\">",
"      <tr>",
"       <td align=\"center\">",
"        <p style=\"text-indent:0em;\">",
"         18-35 lbs",
"        </p>",
"       </td>",
"       <td align=\"center\">",
"        <p style=\"text-indent:0em;\">",
"         8-15 kg",
"        </p>",
"       </td>",
"       <td align=\"center\">",
"        <p style=\"text-indent:0em;\">",
"         100",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td align=\"center\">",
"        <p style=\"text-indent:0em;\">",
"         36-55 lbs",
"        </p>",
"       </td>",
"       <td align=\"center\">",
"        <p style=\"text-indent:0em;\">",
"         16-23 kg",
"        </p>",
"       </td>",
"       <td align=\"center\">",
"        <p style=\"text-indent:0em;\">",
"         200",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td align=\"center\">",
"        <p style=\"text-indent:0em;\">",
"         56-75 lbs",
"        </p>",
"       </td>",
"       <td align=\"center\">",
"        <p style=\"text-indent:0em;\">",
"         24-34 kg",
"        </p>",
"       </td>",
"       <td align=\"center\">",
"        <p style=\"text-indent:0em;\">",
"         300",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td align=\"center\">",
"        <p style=\"text-indent:0em;\">",
"         76-100 lbs",
"        </p>",
"       </td>",
"       <td align=\"center\">",
"        <p style=\"text-indent:0em;\">",
"         35-44 kg",
"        </p>",
"       </td>",
"       <td align=\"center\">",
"        <p style=\"text-indent:0em;\">",
"         400",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td align=\"center\">",
"        <p style=\"text-indent:0em;\">",
"         &gt;100 lbs",
"        </p>",
"       </td>",
"       <td align=\"center\">",
"        <p style=\"text-indent:0em;\">",
"         &gt;45 kg",
"        </p>",
"       </td>",
"       <td align=\"center\">",
"        <p style=\"text-indent:0em;\">",
"         500",
"        </p>",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Note:",
"     </b>",
"     Concomitant iron therapy has been reported in a small number of children without the formation of a toxic complex with iron (as seen with dimercaprol); courses of therapy may be repeated if indicated by weekly monitoring of blood lead levels; lead levels should be stabilized to &lt;15 mcg/dL; 2 weeks between courses is recommended unless more timely treatment is indicated by lead levels; patients who have received calcium disodium EDTA with or without BAL may be treated with succimer after at least 4 weeks have passed since treatment",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Dosing adjustment in renal/hepatic impairment:",
"     </b>",
"     Administer with caution and monitor closely",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F223356\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Capsule, oral:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Chemet&reg;: 100 mg",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F223342\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     No",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F1062374\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Oral: Ensure adequate patient hydration; for patients who cannot swallow the capsule, sprinkle the medicated beads on a small amount of soft food or administer with a fruit juice to mask the odor",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F1062373\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Treatment of lead poisoning in children with blood levels &gt;45 mcg/dL; not indicated for prophylaxis of lead poisoning in a lead-containing environment",
"    </p>",
"   </div>",
"   <div class=\"block arm drugH1Div\" id=\"F223392\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      Note:",
"     </b>",
"     As reported in pediatric patients unless otherwise noted.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Cardiovascular: Arrhythmia (adults)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Central nervous system: Chills, dizziness, drowsiness, fatigue, fever, headache, sleepiness",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Dermatologic: Rash (including papular rash, herpetic rash and mucocutaneous eruptions); pruritus",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Endocrine &amp; metabolic: Cholesterol increased",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Gastrointestinal: Abdominal cramps, appetite decreased, diarrhea, hemorrhoid symptoms, metallic taste, loose stools, mucosal irritation, nausea, sore throat, vomiting",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Genitourinary:  Proteinuria (adults), urine output decreased (adults), voiding difficulty (adults)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Hepatic: Alkaline phosphatase increased, ALT increased, AST increased",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Neuromuscular &amp; skeletal: Back pain, flank pain, leg pain (adults), neuropathy, paresthesia, rib pain",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Ocular: Cloudy film in eye, watery eyes",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Otic: Otitis media, plugged ears",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Respiratory: Cough, nasal congestion, rhinorrhea",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Miscellaneous: Flu-like syndrome, moniliasis",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Rare but important or life-threatening: Allergic reactions (especially with retreatment), eosinophilia, neutropenia (causal relationship not established)",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F1062377\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to succimer or any component",
"    </p>",
"   </div>",
"   <div class=\"block pre drugH1Div\" id=\"F1062363\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Precautions",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Use with caution in patients with renal or hepatic impairment; adequate hydration should be maintained during therapy",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F1062362\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Elevated blood lead levels and associated symptoms may return rapidly after discontinuation due to redistribution of lead from bone stores to soft tissues and blood; monitor blood lead levels for &ldquo;rebound&rdquo; after therapy; mild to moderate neutropenia has been reported; monitor CBC with differential prior to and during therapy; discontinue treatment if ANC &lt;1200/microliter",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F13300085\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     None known.",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F6223110\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:0em;display:inline\">",
"     There are no known significant interactions.",
"    </p>",
"   </div>",
"   <div class=\"block prf drugH1Div\" id=\"F223352\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Risk Factor",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     C (",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?16/42/17068\">",
"      show table",
"     </a>",
"     )",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F6165840\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Adverse events were observed in animal reproduction studies. Following maternal occupational exposure, lead crosses the placenta in amounts related to maternal plasma levels. Possible outcomes of maternal lead exposure &gt;10 mcg/dL includes spontaneous abortion, postnatal developmental delay, and reduced birth weight. Chelation therapy during pregnancy is for maternal benefit only and should be limited to the treatment of severe, symptomatic lead poisoning.",
"    </p>",
"   </div>",
"   <div class=\"block mop drugH1Div\" id=\"F1062369\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Monitoring Parameters",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Blood lead levels; liver enzymes and CBC with differential (prior to therapy and weekly during therapy)",
"    </p>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F1062361\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Forms stable water-soluble complexes with lead resulting in increased urinary excretion; also chelates other toxic heavy metals such as arsenic and mercury",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F1062376\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacokinetics (Adult data unless noted)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Absorption: Oral: Rapid, variable",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Metabolism: Extensive to mixed succimer-cysteine disulfides",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Half-life, elimination: 2 days",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Time to peak serum concentration: &sim;1-2 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Elimination: &sim;25% in urine with peak urinary excretion occurring between 2-4 hours after dosing; of the total amount of succimer eliminated in urine, 90% is eliminated as mixed succimer-cysteine disulfide conjugates; 10% is excreted unchanged; fecal excretion of succimer probably represents unabsorbed drug",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Dialysis: Succimer is dialyzable but lead chelates are not",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      American Academy of Pediatrics Committee on Environmental Health, \"Lead Exposure in Children: Prevention, Detection, and Management,\"",
"      <i>",
"       Pediatrics",
"      </i>",
"      , 2005, 116(4):1036-46.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?8/22/8548/abstract-text/16199720/pubmed\" id=\"16199720\" target=\"_blank\">",
"        16199720",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Binns HJ, Campbell C, Brown MJ, et al, \"Interpreting and Managing Blood Lead Levels of Less Than 10 micrograms/dL in Children and Reducing Childhood Exposure to Lead: Recommendations of the Centers for Disease Control and Prevention Advisory Committee on Childhood Lead Poisoning Prevention,\"",
"      <i>",
"       Pediatrics",
"      </i>",
"      , 2007, 120(5):e1285-98.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?8/22/8548/abstract-text/17974722/pubmed\" id=\"17974722\" target=\"_blank\">",
"        17974722",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Gracia RC and Snodgrass WR, \"Lead Toxicity and Chelation Therapy,\"",
"      <i>",
"       Am J Health Syst Pharm",
"      </i>",
"      , 2007, 64(1):45-53.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?8/22/8548/abstract-text/17189579/pubmed\" id=\"17189579\" target=\"_blank\">",
"        17189579",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Mann KV and Travers JD, &ldquo;Succimer, An Oral Lead Chelator,&rdquo;",
"      <i>",
"       Clin Pharm",
"      </i>",
"      , 1991, 10(12):914-22.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?8/22/8548/abstract-text/1663439/pubmed\" id=\"1663439\" target=\"_blank\">",
"        1663439",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 12808 Version 27.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0603-200.131.240.2-D8D1174216-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f8_22_8548=[""].join("\n");
var outline_f8_22_8548=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F223371\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F223372\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1062370\">",
"      Therapeutic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1062364\">",
"      Dosing: Usual",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F223356\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F223342\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1062374\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1062373\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F223392\">",
"      Adverse Reactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1062377\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1062363\">",
"      Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1062362\">",
"      Warnings",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13300085\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F6223110\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F223352\">",
"      Pregnancy Risk Factor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F6165840\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1062369\">",
"      Monitoring Parameters",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1062361\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1062376\">",
"      Pharmacokinetics (Adult data unless noted)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_PED/12808\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_PED/12808|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?12/26/12709?source=related_link\">",
"      Dimercaptosuccinic acid (succimer): Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?10/31/10740?source=related_link\">",
"      Dimercaptosuccinic acid (succimer): Patient drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f8_22_8549="Cystic hygroma CXR I";
var content_f8_22_8549=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F76171%7EPULM%2F65973&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F76171%7EPULM%2F65973&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Cystic hygroma in newborn",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 272px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    A chest radiograph shows a large mass involving the chest wall of the left hemithorax.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Paul Stark, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Cystic hygroma in newborn",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 360px; height: 226px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    A CT scan shows several large cystic structures in the left chest wall and anterior mediastinum.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Paul Stark, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f8_22_8549=[""].join("\n");
var outline_f8_22_8549=null;
var title_f8_22_8550="EEG focal slow activity";
var content_f8_22_8550=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=RHEUM%2F68743&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=RHEUM%2F68743&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 603px\">",
"   <div class=\"ttl\">",
"    Focal polymorphic delta activity",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 583px; height: 387px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Focal slow activity is present in the right temporal region in this electroencephalogram. The presence of localized polymorphic delta or theta activity is often associated with a focal brain lesion.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Shahram Khoshbin, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f8_22_8550=[""].join("\n");
var outline_f8_22_8550=null;
var title_f8_22_8551="Causes of metabolic alkalosis";
var content_f8_22_8551=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Causes of metabolic alkalosis",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?8/22/8551/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?8/22/8551/contributors\">",
"     Michael Emmett, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?8/22/8551/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?8/22/8551/contributors\">",
"     Richard H Sterns, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?8/22/8551/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?8/22/8551/contributors\">",
"     John P Forman, MD, MSc",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?8/22/8551/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Dec 3, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Metabolic alkalosis, which produces an elevation of the serum bicarbonate, is a relatively frequent clinical problem that is most commonly due to the loss of hydrogen ions from the gastrointestinal tract or in the urine. These lost hydrogen ions are derived from the dissociation of water into hydrogen and hydroxyl ions. When the hydrogen ion is removed, the remaining hydroxyl ion combines with carbon dioxide to form bicarbonate. Gastrointestinal and renal hydrogen loss is usually accompanied by potassium loss and hypokalemia.",
"   </p>",
"   <p>",
"    The plasma bicarbonate concentration may also be increased by hydrogen movement into the cells, alkali administration, or volume contraction around a relatively constant amount of extracellular bicarbonate (called a contraction alkalosis) (",
"    <a class=\"graphic graphic_table graphicRef57489 \" href=\"UTD.htm?26/4/26699\">",
"     table 1",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?8/22/8551/abstract/1-4\">",
"     1-4",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Patients with preserved renal function will rapidly excrete excess bicarbonate in the urine. Thus, for metabolic alkalosis to persist, there must be a reduction in the ability to excrete the excess bicarbonate in the urine. This is usually due to hypovolemia, reduced effective arterial blood volume (including heart failure and cirrhosis), chloride depletion, hypokalemia, renal impairment, or combinations of these factors [",
"    <a class=\"abstract\" href=\"UTD.htm?8/22/8551/abstract/3,5,6\">",
"     3,5,6",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The causes of metabolic alkalosis will be reviewed here. The pathogenesis, evaluation, and treatment of this disorder are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?10/28/10692?source=see_link\">",
"     \"Pathogenesis of metabolic alkalosis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/35/39479?source=see_link\">",
"     \"Clinical manifestations and evaluation of metabolic alkalosis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/14/14568?source=see_link\">",
"     \"Treatment of metabolic alkalosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     GASTROINTESTINAL HYDROGEN LOSS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Gastrointestinal hydrogen loss can result from the removal of gastric secretions (vomiting or nasogastric suction) or loss of intestinal secretions (some unusual causes of diarrhea).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Removal of gastric secretions",
"    </span>",
"    &nbsp;&mdash;&nbsp;Gastric contents have a high concentration of HCl and lesser amounts of KCl and NaCl. In normal subjects, gastric proton secretion does not lead to metabolic alkalosis since it is not removed from the body but instead is neutralized by bicarbonate that the pancreas secretes in response to the acid that enters the duodenum. The proton and bicarbonate combine to form carbonic acid and water, and the Na and Cl that had been secreted are reabsorbed into the systemic circulation. There is, however, no stimulus to bicarbonate secretion when vomiting or nasogastric tube suction removes gastric acid from the body and prevents it from reaching the duodenum [",
"    <a class=\"abstract\" href=\"UTD.htm?8/22/8551/abstract/7-9\">",
"     7-9",
"    </a>",
"    ]. In some cases, the vomiting is self-induced and denied by the patient, or the patient is unable to provide a history [",
"    <a class=\"abstract\" href=\"UTD.htm?8/22/8551/abstract/10\">",
"     10",
"    </a>",
"    ]. In this setting, measurement of the urine chloride concentration may provide a helpful diagnostic clue. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/35/39479?source=see_link\">",
"     \"Clinical manifestations and evaluation of metabolic alkalosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In comparison, the administration of nonabsorbable antacids does not usually lead to metabolic alkalosis. Although the hydroxide or carbonate component of the antacid buffers gastric protons, the cation component of the antacid (magnesium, aluminum, or calcium) combines with bicarbonate in the gastrointestinal lumen and is excreted in the stool [",
"    <a class=\"abstract\" href=\"UTD.htm?8/22/8551/abstract/11\">",
"     11",
"    </a>",
"    ]. The net effect is that the ingestion of nonabsorbable alkali is matched by a virtually identical excretion of alkali in the stool. An exception occurs if patients with renal failure are treated simultaneously with both a nonabsorbable antacid and a cation-exchange resin administered to bind potassium. Usually, these cation-exchange resins release sodium and bind potassium. However, if given with an antacid, the cation-exchange resin may bind the magnesium, aluminum, or calcium from the antacid instead of potassium. The sodium released from the cation-exchange resin and the carbonate from the antacid are absorbed together while the cation-exchange resin is excreted in the stool combined with the magnesium, aluminum, or calcium [",
"    <a class=\"abstract\" href=\"UTD.htm?8/22/8551/abstract/12\">",
"     12",
"    </a>",
"    ]. The renal failure plays an important role in this pathophysiology because it perpetuates the alkalosis by preventing excretion of the excess bicarbonate.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Loss of intestinal secretions",
"    </span>",
"    &nbsp;&mdash;&nbsp;Intestinal secretions typically have a relatively high bicarbonate concentration. As a result, loss of these secretions (as in diarrhea) typically leads to metabolic acidosis. However, in rare instances, diarrhea can produce metabolic alkalosis [",
"    <a class=\"abstract\" href=\"UTD.htm?8/22/8551/abstract/8\">",
"     8",
"    </a>",
"    ]. This may occur in some patients with a villous adenoma and in some who abuse laxatives. The mechanism responsible for the metabolic alkalosis in such patients is not well understood, but hypokalemia is invariably prominent and probably plays a major pathophysiologic role [",
"    <a class=\"abstract\" href=\"UTD.htm?8/22/8551/abstract/13\">",
"     13",
"    </a>",
"    ]. The concurrent surreptitious use of diuretics may also contribute. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/6/6246?source=see_link\">",
"     \"Factitious diarrhea\"",
"    </a>",
"    and",
"    <a class=\"local\" href=\"#H11\">",
"     'Hypokalemia'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    In addition, patients with congenitally defective intestinal chloride absorption (congenital chloride diarrhea or chloridorrhea) develop diarrhea and metabolic alkalosis. This rare congenital secretory diarrhea is caused by mutations in the downregulated adenoma gene, which directs synthesis of an intestinal anion transporter or a regulator of such a transporter. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?5/5/5210?source=see_link&amp;anchor=H28#H28\">",
"     \"Overview of the causes of chronic diarrhea in children\", section on 'Congenital secretory and osmotic diarrheas'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     RENAL HYDROGEN LOSS",
"    </span>",
"    &nbsp;&mdash;&nbsp;An inappropriate increase in renal acid loss requires enhanced distal hydrogen secretion. This occurs when there is adequate sodium and water delivery to the distal nephron combined with increased mineralocorticoid activity. The mineralocorticoid directly stimulates the secretory H-ATPase pump (",
"    <a class=\"graphic graphic_figure graphicRef51361 \" href=\"UTD.htm?38/43/39613\">",
"     figure 1",
"    </a>",
"    ) and simultaneously stimulates sodium reabsorption through epithelial sodium channels (ENaC) (",
"    <a class=\"graphic graphic_figure graphicRef60693 \" href=\"UTD.htm?12/31/12797\">",
"     figure 2",
"    </a>",
"    ). Sodium reabsorption makes the tubular lumen more electronegative, minimizing the back-diffusion of secreted hydrogen ions from the lumen into the tubular cells [",
"    <a class=\"abstract\" href=\"UTD.htm?8/22/8551/abstract/14,15\">",
"     14,15",
"    </a>",
"    ]. Distal potassium secretion is also enhanced in this setting, resulting in concurrent hypokalemia.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Primary mineralocorticoid excess",
"    </span>",
"    &nbsp;&mdash;&nbsp;Any cause of primary hypersecretion of mineralocorticoids can lead to metabolic alkalosis, which is generally accompanied by hypertension and hypokalemia. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?5/13/5338?source=see_link\">",
"     \"Approach to the patient with hypertension and hypokalemia\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In contrast, patients with secondary hyperaldosteronism due to heart failure or cirrhosis usually do not present with metabolic alkalosis or hypokalemia unless they are treated with diuretics. In such patients, in the absence of diuretic therapy, the stimulatory effect of aldosterone on distal sodium reabsorption and potassium and proton secretion is counteracted by decreased distal sodium delivery.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Loop or thiazide diuretics",
"    </span>",
"    &nbsp;&mdash;&nbsp;These diuretics increase both distal sodium delivery and the secretion of aldosterone. The ensuing increase in urinary hydrogen secretion results in metabolic alkalosis and hypokalemia, which is amplified by a contraction alkalosis if the diuresis is large [",
"    <a class=\"abstract\" href=\"UTD.htm?8/22/8551/abstract/16-18\">",
"     16-18",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H13\">",
"     'Contraction alkalosis'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H535878776\">",
"    <span class=\"h2\">",
"     Bartter and Gitelman syndromes",
"    </span>",
"    &nbsp;&mdash;&nbsp;Metabolic alkalosis and hypokalemia are present in Bartter and Gitelman syndromes. These disorders are produced by genetic defects in ion transporters in the loop of Henle and distal tubule, respectively, producing a similar inhibitory effect on sodium chloride reabsorption as loop and thiazide diuretics. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/43/23226?source=see_link\">",
"     \"Bartter and Gitelman syndromes\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Posthypercapnic alkalosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Chronic respiratory acidosis causes an appropriate increase in renal hydrogen secretion, and the ensuing rise in the plasma bicarbonate concentration will raise the pH toward normal [",
"    <a class=\"abstract\" href=\"UTD.htm?8/22/8551/abstract/19\">",
"     19",
"    </a>",
"    ]. The elevation in the serum bicarbonate concentration is associated with some chloride loss [",
"    <a class=\"abstract\" href=\"UTD.htm?8/22/8551/abstract/20\">",
"     20",
"    </a>",
"    ]. If the chronically elevated PCO2 is rapidly lowered, usually by mechanical ventilation, the plasma bicarbonate concentration may remain elevated, especially if the patient has a low effective arterial blood volume or a reduced glomerular filtration rate (GFR). This results in metabolic alkalosis. Thus, a posthypercapnic alkalosis may persist until sodium chloride is given to replete the volume and chloride deficit and allow the excess bicarbonate to be excreted [",
"    <a class=\"abstract\" href=\"UTD.htm?8/22/8551/abstract/20\">",
"     20",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The rapid fall in PCO2 that induces a posthypercapnic alkalosis can acutely raise the cerebral intracellular pH, a change which may produce serious neurologic abnormalities and death [",
"    <a class=\"abstract\" href=\"UTD.htm?8/22/8551/abstract/21\">",
"     21",
"    </a>",
"    ]. Thus, the PCO2 should be reduced gradually in patients with chronic hypercapnia.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Hypercalcemia and the milk-alkali syndrome",
"    </span>",
"    &nbsp;&mdash;&nbsp;Significant metabolic alkalosis can occur in patients with the milk-alkali syndrome. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/29/27094?source=see_link\">",
"     \"The milk-alkali syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In such patients, the ingestion of calcium (usually as",
"    <a class=\"drug drug_general\" href=\"UTD.htm?41/32/42504?source=see_link\">",
"     calcium carbonate",
"    </a>",
"    ) and alkali (",
"    <a class=\"drug drug_general\" href=\"UTD.htm?0/52/840?source=see_link\">",
"     sodium bicarbonate",
"    </a>",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    calcium carbonate) causes hypercalcemia and elevates the bicarbonate concentration. Vitamin D ingestion may further exacerbate the hypercalcemia, and vomiting can worsen the alkalosis. The hypercalcemia reduces the GFR and impairs bicarbonate excretion [",
"    <a class=\"abstract\" href=\"UTD.htm?8/22/8551/abstract/22-24\">",
"     22-24",
"    </a>",
"    ]. Hypercalcemia also increases renal hydrogen losses [",
"    <a class=\"abstract\" href=\"UTD.htm?8/22/8551/abstract/22,25\">",
"     22,25",
"    </a>",
"    ], due at least in part to impairment of sodium chloride reabsorption in the loop of Henle, mimicking type V Bartter syndrome. The resulting increase in distal sodium delivery in conjunction with hypovolemia induced aldosterone release enhances renal hydrogen secretion. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/43/23226?source=see_link&amp;anchor=H88846693#H88846693\">",
"     \"Bartter and Gitelman syndromes\", section on 'Type V'",
"    </a>",
"    .) In addition, the elevation in systemic pH enhances renal calcium reabsorption, exacerbating the hypercalcemia [",
"    <a class=\"abstract\" href=\"UTD.htm?8/22/8551/abstract/25\">",
"     25",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h1\">",
"     INTRACELLULAR SHIFT OF HYDROGEN",
"    </span>",
"    &nbsp;&mdash;&nbsp;In addition to hydrogen loss, metabolic alkalosis can be generated by the shift of hydrogen ions into the cells. This most often occurs in patients with hypokalemia. Shift of hydrogen ions into the cells may be mechanistically important in patients with metabolic alkalosis due to vomiting or nasogastric suction [",
"    <a class=\"abstract\" href=\"UTD.htm?8/22/8551/abstract/26\">",
"     26",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/18/25891?source=see_link\">",
"     \"Potassium balance in acid-base disorders\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Hypokalemia",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hypokalemia is a frequent finding in patients with metabolic alkalosis, contributing to both the development and maintenance of the alkalosis. The potassium loss and metabolic alkalosis interact at multiple levels [",
"    <a class=\"abstract\" href=\"UTD.htm?8/22/8551/abstract/1\">",
"     1",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      First, the major causes of metabolic alkalosis (vomiting, diuretics, mineralocorticoid excess) directly induce renal potassium loss. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?5/17/5402?source=see_link\">",
"       \"Causes of hypokalemia\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Second, hypokalemia causes potassium to move from cells into the extracellular fluid, and this transcellular potassium flux is accompanied by movement of hydrogen ions from the extracellular fluid into cells to maintain electroneutrality [",
"      <a class=\"abstract\" href=\"UTD.htm?8/22/8551/abstract/1\">",
"       1",
"      </a>",
"      ]. The movement of hydrogen into the cells increases the plasma bicarbonate concentration and simultaneously lowers the intracellular pH. The ensuing intracellular acidosis in renal tubular cells promotes hydrogen secretion and therefore bicarbonate reabsorption [",
"      <a class=\"abstract\" href=\"UTD.htm?8/22/8551/abstract/27\">",
"       27",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?25/18/25891?source=see_link\">",
"       \"Potassium balance in acid-base disorders\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?10/28/10692?source=see_link\">",
"       \"Pathogenesis of metabolic alkalosis\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h1\">",
"     ALKALI ADMINISTRATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;It is difficult to produce more than a modest increase in plasma bicarbonate with chronic alkali therapy in normal individuals. This was illustrated in a study in which the administration of as much as 15 to 20 meq of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?0/52/840?source=see_link\">",
"     sodium bicarbonate",
"    </a>",
"    per kg body weight per day (1000 to 1400 meq per day in a 70 kg individual) for as long as two to three weeks only raised the serum bicarbonate concentration to a maximum of 36",
"    <span class=\"nowrap\">",
"     meq/L",
"    </span>",
"    because most of the excess bicarbonate was rapidly eliminated in the urine [",
"    <a class=\"abstract\" href=\"UTD.htm?8/22/8551/abstract/28\">",
"     28",
"    </a>",
"    ]. The rapid administration of alkali loads can cause short-term metabolic alkalosis. &nbsp;",
"   </p>",
"   <p>",
"    More pronounced metabolic alkalosis can occur if large quantities of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?0/52/840?source=see_link\">",
"     sodium bicarbonate",
"    </a>",
"    (or any sodium salts of organic anions that are metabolized to bicarbonate such as lactate, citrate, or acetate) are given over a short period of time. Examples include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The administration of",
"      <a class=\"drug drug_general\" href=\"UTD.htm?0/52/840?source=see_link\">",
"       sodium bicarbonate",
"      </a>",
"      to treat lactic acidosis or ketoacidosis may produce a post-correction metabolic alkalosis. In these settings, the administered bicarbonate represents \"excess\" alkali since reversal of the underlying disorder will regenerate bicarbonate from the metabolism of lactate or beta-hydroxybutyrate [",
"      <a class=\"abstract\" href=\"UTD.htm?8/22/8551/abstract/29\">",
"       29",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?10/28/10692?source=see_link\">",
"       \"Pathogenesis of metabolic alkalosis\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?14/48/15114?source=see_link&amp;anchor=H17#H17\">",
"       \"Treatment of diabetic ketoacidosis and hyperosmolar hyperglycemic state in adults\", section on 'Bicarbonate and metabolic acidosis'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?39/44/40646?source=see_link\">",
"       \"Bicarbonate therapy in lactic acidosis\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Administration of large quantities of citrate salts can produce a metabolic alkalosis. This becomes likely when more than eight units of banked blood (anticoagulated with a combination of",
"      <a class=\"external\" href=\"file://en.wikipedia.org/wiki/Citric_acid\">",
"       citric acid",
"      </a>",
"      ,",
"      <a class=\"external\" href=\"file://en.wikipedia.org/wiki/Monosodium_citrate\">",
"       sodium citrate",
"      </a>",
"      , and",
"      <a class=\"external\" href=\"file://en.wikipedia.org/wiki/Dextrose\">",
"       dextrose",
"      </a>",
"      ) are transfused or large amounts of fresh frozen plasma are administered, for example, during plasmapheresis. The use of citrate salts rather than",
"      <a class=\"drug drug_general\" href=\"UTD.htm?39/34/40489?source=see_link\">",
"       heparin",
"      </a>",
"      as an anticoagulant in hemodialysis patients or during continuous renal replacement therapy also represents an alkali load.",
"     </li>",
"     <li>",
"      Freebase and crack cocaine are produced with",
"      <a class=\"drug drug_general\" href=\"UTD.htm?0/52/840?source=see_link\">",
"       sodium bicarbonate",
"      </a>",
"      , and extensive use can generate metabolic alkalosis especially when renal function is very poor [",
"      <a class=\"abstract\" href=\"UTD.htm?8/22/8551/abstract/1,30-34\">",
"       1,30-34",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      The intentional induction of metabolic alkalosis in athletes has been studied as a method to improve exercise performance [",
"      <a class=\"abstract\" href=\"UTD.htm?8/22/8551/abstract/35,36\">",
"       35,36",
"      </a>",
"      ]. The presumptive mechanism of action may be related to enhanced hydrogen ion efflux out of muscle and decreased interstitial potassium accumulation in muscle, resulting in improved ATP resynthesis and anaerobic glycolysis.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h1\">",
"     CONTRACTION ALKALOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;A contraction alkalosis occurs when there is loss of relatively large volumes of bicarbonate-free fluid [",
"    <a class=\"abstract\" href=\"UTD.htm?8/22/8551/abstract/17,18\">",
"     17,18",
"    </a>",
"    ]. The plasma bicarbonate concentration rises in this setting because there is contraction of the extracellular volume around a relatively constant quantity of extracellular bicarbonate. The degree to which this occurs is minimized by intracellular buffering, which results in the release of hydrogen ions from cell buffers to lower the plasma bicarbonate concentration toward the baseline value [",
"    <a class=\"abstract\" href=\"UTD.htm?8/22/8551/abstract/18\">",
"     18",
"    </a>",
"    ]. Administration of intravenous loop diuretics to induce rapid fluid removal in a markedly edematous patient is the most common cause of a contraction alkalosis [",
"    <a class=\"abstract\" href=\"UTD.htm?8/22/8551/abstract/17,37\">",
"     17,37",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Contraction alkalosis may also occur in other disorders in which a high-sodium chloride, low-bicarbonate solution is lost. These include sweat losses in cystic fibrosis, possibly loss of gastric secretions in patients with achlorhydria, and congenital chloride diarrhea [",
"    <a class=\"abstract\" href=\"UTD.htm?8/22/8551/abstract/8,38-40\">",
"     8,38-40",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?5/5/5210?source=see_link&amp;anchor=H3479576#H3479576\">",
"     \"Overview of the causes of chronic diarrhea in children\", section on 'Congenital chloride diarrhea'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Use of the term \"contraction alkalosis\" to characterize the metabolic alkaloses associated with vomiting, nasogastric suction, and diuretic use is confusing. In such settings, the generation of bicarbonate by the stomach or kidneys plays a crucial role in the development of these metabolic alkaloses. Although contraction of the extracellular fluid space does also elevate the bicarbonate concentration, a more important effect of the contraction is enhanced renal bicarbonate reabsorption, which maintains the alkalosis.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3160990\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Metabolic alkalosis, which produces an elevation of the serum bicarbonate, is a relatively frequent clinical problem that is most commonly due to the excess loss of hydrogen ions from the gastrointestinal track or in the urine (",
"      <a class=\"graphic graphic_table graphicRef57489 \" href=\"UTD.htm?26/4/26699\">",
"       table 1",
"      </a>",
"      ). Increased serum bicarbonate may also result from hydrogen movement into the cells, alkali administration, or volume contraction around a relatively constant amount of extracellular bicarbonate (called a contraction alkalosis). Patients with preserved renal function will rapidly excrete excess bicarbonate in the urine. Thus, for metabolic alkalosis to persist, there must be a reduction in the ability to excrete the excess bicarbonate in the urine. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Gastrointestinal hydrogen loss can result from the removal of gastric secretions (vomiting or nasogastric suction) or rectal loss of intestinal secretions (some unusual causes of diarrhea, such as villous adenoma). (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Gastrointestinal hydrogen loss'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      An increase in renal acid loss is usually due to adequate or increased sodium and water delivery to the distal nephron combined with increased mineralocorticoid activity. This combination occurs with primary mineralocorticoid excess, use of loop or thiazide diuretics, Bartter and Gitelman syndromes, and hypercalcemia with the milk-alkali syndrome. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Renal hydrogen loss'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H6\">",
"       'Primary mineralocorticoid excess'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H7\">",
"       'Loop or thiazide diuretics'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H535878776\">",
"       'Bartter and Gitelman syndromes'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H9\">",
"       'Hypercalcemia and the milk-alkali syndrome'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Chronic respiratory acidosis leads to an appropriate increase in renal hydrogen secretion, and the ensuing rise in the plasma bicarbonate concentration will raise the arterial pH toward normal. If the chronically elevated PCO2 is rapidly lowered, usually by mechanical ventilation, the plasma bicarbonate concentration may remain elevated, producing a posthypercapnic alkalosis. (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Posthypercapnic alkalosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      In addition to hydrogen loss from the body, metabolic alkalosis can also be due to the shift of hydrogen ions into the cells. This most often occurs in patients with hypokalemia. (See",
"      <a class=\"local\" href=\"#H10\">",
"       'Intracellular shift of hydrogen'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Alkali loads administered to a patient with an impaired renal capacity to excrete the bicarbonate (due to low effective arterial blood volume, chloride depletion, hypokalemia, or intrinsic renal disease) may produce metabolic alkalosis. The rapid administration of alkali loads can cause short-term metabolic alkalosis. (See",
"      <a class=\"local\" href=\"#H12\">",
"       'Alkali administration'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      A contraction alkalosis occurs when there is loss of relatively large volumes of bicarbonate-free fluid. The plasma bicarbonate concentration rises in this setting because there is contraction of the extracellular volume around a relatively constant quantity of extracellular bicarbonate. (See",
"      <a class=\"local\" href=\"#H13\">",
"       'Contraction alkalosis'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     Rose BD, Post TW. Clinical Physiology of Acid-Base and Electrolyte Disorders, 5th ed, McGraw-Hill, New York 2001. p.559.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/22/8551/abstract/2\">",
"      Palmer BF, Alpern RJ. Metabolic alkalosis. J Am Soc Nephrol 1997; 8:1462.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/22/8551/abstract/3\">",
"      Galla JH. Metabolic alkalosis. J Am Soc Nephrol 2000; 11:369.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/22/8551/abstract/4\">",
"      Khanna A, Kurtzman NA. Metabolic alkalosis. J Nephrol 2006; 19 Suppl 9:S86.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/22/8551/abstract/5\">",
"      Seldin DW, Rector FC Jr. Symposium on acid-base homeostasis. The generation and maintenance of metabolic alkalosis. Kidney Int 1972; 1:306.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/22/8551/abstract/6\">",
"      Luke RG, Galla JH. It is chloride depletion alkalosis, not contraction alkalosis. J Am Soc Nephrol 2012; 23:204.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/22/8551/abstract/7\">",
"      Kassirer JP, Schwartz WB. The response of normal man to selective depletion of hydrochloric acid. Factors in the genesis of persistent gastric alkalosis. Am J Med 1966; 40:10.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/22/8551/abstract/8\">",
"      Perez GO, Oster JR, Rogers A. Acid-base disturbances in gastrointestinal disease. Dig Dis Sci 1987; 32:1033.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/22/8551/abstract/9\">",
"      Giovannini I, Greco F, Chiarla C, et al. Exceptional nonfatal metabolic alkalosis (blood base excess +48 mEq/l). Intensive Care Med 2005; 31:166.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/22/8551/abstract/10\">",
"      Mitchell JE, Seim HC, Colon E, Pomeroy C. Medical complications and medical management of bulimia. Ann Intern Med 1987; 107:71.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/22/8551/abstract/11\">",
"      Stemmer CL, Oster JR, Vaamonde CA, et al. Effect of routine doses of antacid on renal acidification. Lancet 1986; 2:3.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/22/8551/abstract/12\">",
"      Madias NE, Levey AS. Metabolic alkalosis due to absorption of \"nonabsorbable\" antacids. Am J Med 1983; 74:155.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/22/8551/abstract/13\">",
"      Gennari FJ, Weise WJ. Acid-base disturbances in gastrointestinal disease. Clin J Am Soc Nephrol 2008; 3:1861.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/22/8551/abstract/14\">",
"      Khadouri C, Marsy S, Barlet-Bas C, Doucet A. Short-term effect of aldosterone on NEM-sensitive ATPase in rat collecting tubule. Am J Physiol 1989; 257:F177.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/22/8551/abstract/15\">",
"      Harrington JT, Hulter HN, Cohen JJ, Madias NE. Mineralocorticoid-stimulated renal acidification: the critical role of dietary sodium. Kidney Int 1986; 30:43.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/22/8551/abstract/16\">",
"      Hropot M, Fowler N, Karlmark B, Giebisch G. Tubular action of diuretics: distal effects on electrolyte transport and acidification. Kidney Int 1985; 28:477.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/22/8551/abstract/17\">",
"      CANNON PJ, HEINEMANN HO, ALBERT MS, et al. \"CONTRACTION\" ALKALOSIS AFTER DIURESIS OF EDEMATOUS PATIENTS WITH ETHACRYNIC ACID. Ann Intern Med 1965; 62:979.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/22/8551/abstract/18\">",
"      Garella S, Chang BS, Kahn SI. Dilution acidosis and contraction alkalosis: review of a concept. Kidney Int 1975; 8:279.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/22/8551/abstract/19\">",
"      POLAK A, HAYNIE GD, HAYS RM, SCHWARTZ WB. Effects of chronic hypercapnia on electrolyte and acid-base equilibrium. I. Adaptation. J Clin Invest 1961; 40:1223.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/22/8551/abstract/20\">",
"      SCHWARTZ WB, HAYS RM, POLAK A, HAYNIE GD. Effects of chronic hypercapnia on electrolyte and acid-base equilibrium. II. Recovery, with special reference to the influence of chloride intake. J Clin Invest 1961; 40:1238.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/22/8551/abstract/21\">",
"      ROTHERAM EB Jr, SAFAR P, ROBIN E. CNS DISORDER DURING MECHANICAL VENTILATION IN CHRONIC PULMONARY DISEASE. JAMA 1964; 189:993.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/22/8551/abstract/22\">",
"      Hulter HN, Sebastian A, Toto RD, et al. Renal and systemic acid-base effects of the chronic administration of hypercalcemia-producing agents: calcitriol, PTH, and intravenous calcium. Kidney Int 1982; 21:445.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/22/8551/abstract/23\">",
"      Orwoll ES. The milk-alkali syndrome: current concepts. Ann Intern Med 1982; 97:242.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/22/8551/abstract/24\">",
"      Abreo K, Adlakha A, Kilpatrick S, et al. The milk-alkali syndrome. A reversible form of acute renal failure. Arch Intern Med 1993; 153:1005.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/22/8551/abstract/25\">",
"      Patel AM, Goldfarb S. Got calcium? Welcome to the calcium-alkali syndrome. J Am Soc Nephrol 2010; 21:1440.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/22/8551/abstract/26\">",
"      Halperin ML, Scheich A. Should we continue to recommend that a deficit of KCl be treated with NaCl? A fresh look at chloride-depletion metabolic alkalosis. Nephron 1994; 67:263.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/22/8551/abstract/27\">",
"      Capasso G, Jaeger P, Giebisch G, et al. Renal bicarbonate reabsorption in the rat. II. Distal tubule load dependence and effect of hypokalemia. J Clin Invest 1987; 80:409.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/22/8551/abstract/28\">",
"      VAN GOIDSENHOVEN GM, GRAY OV, PRICE AV, SANDERSON PH. The effect of prolonged administration of large doses of sodium bicarbonate in man. Clin Sci (Lond) 1954; 13:383.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/22/8551/abstract/29\">",
"      M&aacute;ttar JA, Weil MH, Shubin H, Stein L. Cardiac arrest in the critically ill. II. Hyperosmolal states following cardiac arrest. Am J Med 1974; 56:162.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/22/8551/abstract/30\">",
"      Levin T. What this patient didn't need: a dose of salts. Hosp Pract (Off Ed) 1983; 18:95.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/22/8551/abstract/31\">",
"      Kelleher SP, Schulman G. Severe metabolic alkalosis complicating regional citrate hemodialysis. Am J Kidney Dis 1987; 9:235.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/22/8551/abstract/32\">",
"      Pearl RG, Rosenthal MH. Metabolic alkalosis due to plasmapheresis. Am J Med 1985; 79:391.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/22/8551/abstract/33\">",
"      Gupta M, Wadhwa NK, Bukovsky R. Regional citrate anticoagulation for continuous venovenous hemodiafiltration using calcium-containing dialysate. Am J Kidney Dis 2004; 43:67.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/22/8551/abstract/34\">",
"      Diskin CJ, Stokes TJ, Dansby LM, et al. Recurrent metabolic alkalosis and elevated troponins after crack cocaine use in a hemodialysis patient. Clin Exp Nephrol 2006; 10:156.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/22/8551/abstract/35\">",
"      Bishop D, Claudius B. Effects of induced metabolic alkalosis on prolonged intermittent-sprint performance. Med Sci Sports Exerc 2005; 37:759.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/22/8551/abstract/36\">",
"      Street D, Nielsen JJ, Bangsbo J, Juel C. Metabolic alkalosis reduces exercise-induced acidosis and potassium accumulation in human skeletal muscle interstitium. J Physiol 2005; 566:481.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/22/8551/abstract/37\">",
"      Miller PD, Berns AS. Acute metabolic alkalosis perpetuating hypercarbia. A role for acetazolamide in chronic obstructive pulmonary disease. JAMA 1977; 238:2400.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/22/8551/abstract/38\">",
"      Kennedy JD, Dinwiddie R, Daman-Willems C, et al. Pseudo-Bartter's syndrome in cystic fibrosis. Arch Dis Child 1990; 65:786.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/22/8551/abstract/39\">",
"      Sweetser LJ, Douglas JA, Riha RL, Bell SC. Clinical presentation of metabolic alkalosis in an adult patient with cystic fibrosis. Respirology 2005; 10:254.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/22/8551/abstract/40\">",
"      Augusto JF, Sayegh J, Malinge MC, et al. Severe episodes of extra cellular dehydration: an atypical adult presentation of cystic fibrosis. Clin Nephrol 2008; 69:302.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 2331 Version 7.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0605-213.134.24.46-82D89F4E57-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f8_22_8551=[""].join("\n");
var outline_f8_22_8551=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H3160990\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      GASTROINTESTINAL HYDROGEN LOSS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Removal of gastric secretions",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Loss of intestinal secretions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      RENAL HYDROGEN LOSS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Primary mineralocorticoid excess",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Loop or thiazide diuretics",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H535878776\">",
"      Bartter and Gitelman syndromes",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Posthypercapnic alkalosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Hypercalcemia and the milk-alkali syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      INTRACELLULAR SHIFT OF HYDROGEN",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Hypokalemia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      ALKALI ADMINISTRATION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      CONTRACTION ALKALOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3160990\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"NEPH/2331\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"NEPH/2331|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?38/43/39613\" title=\"figure 1\">",
"      Distal acid secretion",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?12/31/12797\" title=\"figure 2\">",
"      Collecting tubule transport",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"NEPH/2331|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?26/4/26699\" title=\"table 1\">",
"      Causes of metabolic alkalosis",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?5/13/5338?source=related_link\">",
"      Approach to the patient with hypertension and hypokalemia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/43/23226?source=related_link\">",
"      Bartter and Gitelman syndromes",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?39/44/40646?source=related_link\">",
"      Bicarbonate therapy in lactic acidosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?5/17/5402?source=related_link\">",
"      Causes of hypokalemia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?38/35/39479?source=related_link\">",
"      Clinical manifestations and evaluation of metabolic alkalosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?6/6/6246?source=related_link\">",
"      Factitious diarrhea",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?5/5/5210?source=related_link\">",
"      Overview of the causes of chronic diarrhea in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?10/28/10692?source=related_link\">",
"      Pathogenesis of metabolic alkalosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?25/18/25891?source=related_link\">",
"      Potassium balance in acid-base disorders",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/29/27094?source=related_link\">",
"      The milk-alkali syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?14/48/15114?source=related_link\">",
"      Treatment of diabetic ketoacidosis and hyperosmolar hyperglycemic state in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?14/14/14568?source=related_link\">",
"      Treatment of metabolic alkalosis",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f8_22_8552="Surgical treatment of septic arthritis of the wrist";
var content_f8_22_8552=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=SURG%2F80113&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=SURG%2F80113&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 568px\">",
"   <div class=\"ttl\">",
"    Surgical treatment of septic arthritis of the wrist",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 548px; height: 412px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Septic arthritis is a surgical emergency and early exploration is necessary to avoid joint damage from the disease process. The photographs show the surgical treatment of septic arthritis of the wrist. Panel A illustrates the surgical approach through the third dorsal compartment and panel B illustrates exposure of the joint and infective erosion of the carpal bones.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f8_22_8552=[""].join("\n");
var outline_f8_22_8552=null;
var title_f8_22_8553="Hypersensitivity reactions to fluoroquinolones antimicrobials";
var content_f8_22_8553=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Hypersensitivity reactions to fluoroquinolones antimicrobials",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?8/22/8553/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?8/22/8553/contributors\">",
"     Roland Solensky, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?8/22/8553/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?8/22/8553/contributors\">",
"     N Franklin Adkinson, Jr, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?8/22/8553/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?8/22/8553/contributors\">",
"     Anna M Feldweg, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?8/22/8553/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Dec 21, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H96179886\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;This topic will review hypersensitivity (allergic) reactions to fluoroquinolones. A general discussion of fluoroquinolones, including adverse effects other than hypersensitivity reactions, is found separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/60/28618?source=see_link\">",
"     \"Fluoroquinolones\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10729921\">",
"    <span class=\"h1\">",
"     TYPES OF HYPERSENSITIVITY REACTIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hypersensitivity reactions, or allergic reactions, are immunologic reactions to a drug. There are several types of hypersensitivity reactions, which are broadly divided into immediate and delayed reactions, based upon the time between administration and the appearance of signs or symptoms [",
"    <a class=\"abstract\" href=\"UTD.htm?8/22/8553/abstract/1\">",
"     1",
"    </a>",
"    ]. Immediate reactions begin within one hour of the first administered dose, and delayed reactions begin later than one hour (and sometimes days) after the first dose. The intent of this classification system is to distinguish immediate reactions from other types, since immediate reactions are more likely to progress to potentially life-threatening anaphylaxis if the patient is re-exposed to the causative drug. Unfortunately, patients often do not recall the chronology of drug reactions and thus it is often not possible to classify reactions based on timing alone. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/62/24554?source=see_link\">",
"     \"An approach to the patient with drug allergy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1312189\">",
"    <span class=\"h2\">",
"     Most common",
"    </span>",
"    &nbsp;&mdash;&nbsp;The two most common types of hypersensitivity reactions to fluoroquinolones are:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Delayed-onset maculopapular cutaneous eruptions",
"      <br/>",
"      <br/>",
"      and",
"     </li>",
"     <li>",
"      Immediate reactions, which are characterized by urticaria, pruritus, flushing, angioedema, wheezing, nausea, abdominal cramping or diarrhea,",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      hypotension",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    These two types of fluoroquinolone-induced hypersensitivity reactions are relatively common, and in some studies, the incidence of delayed reactions due to fluoroquinolones is comparable to that due to beta-lactams [",
"    <a class=\"abstract\" href=\"UTD.htm?8/22/8553/abstract/2,3\">",
"     2,3",
"    </a>",
"    ]. The remainder of this topic review will focus on these two forms of hypersensitivity.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1312196\">",
"    <span class=\"h2\">",
"     Other types",
"    </span>",
"    &nbsp;&mdash;&nbsp;A variety of other uncommon hypersensitivity reactions have been attributed to fluoroquinolones, including fixed drug eruptions, drug fever, vasculitis, serum-sickness like syndromes, drug-induced hypersensitivity",
"    <span class=\"nowrap\">",
"     syndromes/drug",
"    </span>",
"    rash with eosinophilia and systemic symptoms",
"    <span class=\"nowrap\">",
"     (DiHS/DRESS),",
"    </span>",
"    symmetrical drug-related intertriginous and flexural exanthema (SDRIFE), Stevens-Johnson syndrome (SJS), and toxic epidermal necrolysis (TEN) [",
"    <a class=\"abstract\" href=\"UTD.htm?8/22/8553/abstract/4-9\">",
"     4-9",
"    </a>",
"    ]. There is no diagnostic testing for these types of reactions and avoidance of the causative drug is uniformly recommended.",
"   </p>",
"   <p>",
"    SJS and TEN are severe and potentially life-threatening, and any future re-exposure, which can result in recurrence, is contraindicated except in extreme circumstances. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/29/17882?source=see_link\">",
"     \"Stevens-Johnson syndrome and toxic epidermal necrolysis: Clinical manifestations; pathogenesis; and diagnosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The classification and pathogenesis of drug hypersensitivity reactions are reviewed in greater detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/11/1210?source=see_link\">",
"     \"Drug allergy: Classification and clinical features\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/35/38456?source=see_link\">",
"     \"Drug allergy: Pathogenesis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10729855\">",
"    <span class=\"h1\">",
"     APPROACH TO THE PATIENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;Evaluation of a patient with a past drug reaction always begins with a careful clinical history and an assessment of the type of hypersensitivity reaction the patient most likely experienced. Important questions for the patient with drug allergy are reviewed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/62/24554?source=see_link&amp;anchor=H18#H18\">",
"     \"An approach to the patient with drug allergy\", section on 'Clinical history'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    A thorough history of the reaction is essential, since many patients labeled as allergic to fluoroquinolones actually experienced nonallergic adverse reactions, such as tendon inflammation or damage, myalgias, neurologic side effects, or gastrointestinal symptoms. In some cases, such patients should continue to avoid the causative drug, but they are not candidates for allergy evaluation. Nonallergic adverse effects of fluoroquinolones are reviewed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/60/28618?source=see_link&amp;anchor=H24#H24\">",
"     \"Fluoroquinolones\", section on 'Adverse reactions'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10730182\">",
"    <span class=\"h2\">",
"     Multiple drug allergy syndrome",
"    </span>",
"    &nbsp;&mdash;&nbsp;The term &ldquo;multiple drug allergy syndrome&rdquo; is applied to patients who report hypersensitivity reactions to two or more classes of medications. A subset of these patients reacts only to antibiotics. Typically, such patients have reacted to commonly-used antibiotics, such as penicillins, sulfonamides, fluoroquinolones, and macrolides, and have limited antibiotic options remaining to treat infections. Evaluation of one or more of these antibiotics to determine whether the same or related drugs are actually tolerated can be very helpful in avoiding the use of expensive, broad spectrum antibiotics, and in reducing anxiety on the part of the patient and providers. In such individuals, the management goal is the identification of two or more classes of antibiotics that the patient can safely receive, focusing on ones that are most clinically useful. Multiple drug allergy syndrome is discussed in more detail elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/62/24554?source=see_link&amp;anchor=H9#H9\">",
"     \"An approach to the patient with drug allergy\", section on 'Multiple drug allergy syndrome'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H365668\">",
"    <span class=\"h2\">",
"     Referral",
"    </span>",
"    &nbsp;&mdash;&nbsp;Referral to an allergy expert with experience in evaluation of drug allergic reactions is appropriate in any of the following situations:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The patient has reactions to numerous antibiotics (eg, multiple drug allergy syndrome) and treatment options are becoming limited.",
"     </li>",
"     <li>",
"      The patient experienced a life-threatening reaction to a fluoroquinolone and requires advice about how best to prevent re-exposure and whether related antibiotics can be safely administered.",
"     </li>",
"     <li>",
"      The patient experienced a serious reaction in the context of receiving multiple drugs (eg, perioperative anaphylaxis) and the cause of the reaction is not clear.",
"     </li>",
"     <li>",
"      The patient has a high likelihood of needing future treatment with a problematic drug due to the nature of",
"      <span class=\"nowrap\">",
"       his/her",
"      </span>",
"      underlying medical problems (eg, fluoroquinolones in chronic urologic problems).",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    A careful clinical history can avoid unnecessary referrals. Many patients labeled as allergic to fluoroquinolones experienced nonallergic adverse reactions, such as tendon inflammation or damage, myalgias, neurologic side effects, or gastrointestinal symptoms. In some cases, such patients with adverse reactions should continue to avoid the causative drug, but they are not candidates for allergy evaluation. Nonallergic adverse effects of fluoroquinolones are reviewed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/60/28618?source=see_link&amp;anchor=H24#H24\">",
"     \"Fluoroquinolones\", section on 'Adverse reactions'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Immediate-type skin testing and challenge procedures are often required in the evaluation of antibiotic hypersensitivity. These procedures should be performed by allergy specialists. Although these procedures are considered safe, they are not without risk and should be performed in a setting prepared to identify and treat possible allergic reactions, including anaphylaxis. In addition, any procedure that involves the deliberate exposure of a patient to a substance to which they may be allergic should be undertaken by someone with specific training in these techniques.",
"   </p>",
"   <p>",
"    Unlike diagnostic tests for penicillin allergy, methods for evaluating fluoroquinolone hypersensitivity are not standardized or validated, and allergy experts may have different approaches to the use of fluoroquinolone skin testing and challenge.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H365986\">",
"    <span class=\"h1\">",
"     DELAYED MACULOPAPULAR EXANTHEMA",
"    </span>",
"    &nbsp;&mdash;&nbsp;The most common type of reaction to fluoroquinolones is a delayed-onset (defined as greater than one hour after the first administered dose) maculopapular eruption or exanthema that is nonpruritic. Such eruptions occur in 2 to 3 percent of patients treated with fluoroquinolones, and are likely mediated by drug-specific T cells [",
"    <a class=\"abstract\" href=\"UTD.htm?8/22/8553/abstract/10-13\">",
"     10-13",
"    </a>",
"    ]. These reactions are self-limited and generally benign and do",
"    <strong>",
"     not",
"    </strong>",
"    feature urticaria, angioedema, fever, systemic symptoms, involvement of the mucous membranes or other organs, or skin desquamation.",
"   </p>",
"   <p>",
"    Delayed exanthema may occur with any of the fluoroquinolones, although certain agents (eg,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?11/60/12231?source=see_link\">",
"     gemifloxacin",
"    </a>",
"    ) have particularly high rates, and the incidence is higher with prolonged durations of therapy and possibly in women [",
"    <a class=\"abstract\" href=\"UTD.htm?8/22/8553/abstract/14\">",
"     14",
"    </a>",
"    ]. As an example, the incidence of maculopapular rash in patients treated with gemifloxacin (who were receiving the drug for an infection) ranged from 1.2 percent for 5-day therapy to 7.4 percent for 14-day therapy [",
"    <a class=\"abstract\" href=\"UTD.htm?8/22/8553/abstract/11\">",
"     11",
"    </a>",
"    ]. Women &lt;40 years old were found to have a higher incidence of exanthema compared to other groups of patients (2.1 and 22.6 percent, for 5- and 14-day therapy, respectively) [",
"    <a class=\"abstract\" href=\"UTD.htm?8/22/8553/abstract/11\">",
"     11",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6129542\">",
"    <span class=\"h2\">",
"     Cross-reactivity",
"    </span>",
"    &nbsp;&mdash;&nbsp;The development of an exanthema with one fluoroquinolone does not necessarily predict recurrence with others. One of the most illustrative studies about delayed cutaneous eruptions to fluoroquinolones was an unpublished double-blind, double dummy, crossover study conducted in healthy female volunteers &lt;40 years old (not in need of antibiotic therapy), treated with 10 days of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?11/60/12231?source=see_link\">",
"     gemifloxacin",
"    </a>",
"    or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?34/45/35536?source=see_link\">",
"     ciprofloxacin",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?8/22/8553/abstract/15\">",
"     15",
"    </a>",
"    ]. This study specifically focused on younger women and was described in a review, but has not yet been published [",
"    <a class=\"abstract\" href=\"UTD.htm?8/22/8553/abstract/11\">",
"     11",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In the first part of the study, rashes developed in a total of",
"      <span class=\"nowrap\">",
"       260/819",
"      </span>",
"      (32 percent) and",
"      <span class=\"nowrap\">",
"       7/164",
"      </span>",
"      (4.3 percent) of women treated with",
"      <a class=\"drug drug_general\" href=\"UTD.htm?11/60/12231?source=see_link\">",
"       gemifloxacin",
"      </a>",
"      and",
"      <a class=\"drug drug_general\" href=\"UTD.htm?34/45/35536?source=see_link\">",
"       ciprofloxacin",
"      </a>",
"      for 10 days, respectively [",
"      <a class=\"abstract\" href=\"UTD.htm?8/22/8553/abstract/11\">",
"       11",
"      </a>",
"      ]. The vast majority of the rashes were maculopapular and the most common finding on biopsy was uncomplicated exanthem (mild superficial perivascular lymphocytic infiltrate). There was no evidence of vasculitis, bulla formation, or necrosis. Blood and urine tests were unremarkable, with no eosinophilia, hepatitis or other abnormalities.",
"     </li>",
"     <li>",
"      In the second part of the same study, the 260 women who developed exanthema to",
"      <a class=\"drug drug_general\" href=\"UTD.htm?11/60/12231?source=see_link\">",
"       gemifloxacin",
"      </a>",
"      were given",
"      <a class=\"drug drug_general\" href=\"UTD.htm?34/45/35536?source=see_link\">",
"       ciprofloxacin",
"      </a>",
"      and only 10.4 percent developed a rash [",
"      <a class=\"abstract\" href=\"UTD.htm?8/22/8553/abstract/11\">",
"       11",
"      </a>",
"      ]. It is unknown whether this low degree of cross-reactivity between gemifloxacin and ciprofloxacin can be generalized to other combinations of fluoroquinolones. Interestingly, some women who initially tolerated ciprofloxacin for 10 days went on to develop a rash when treatment was repeated for another 10 days.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4093130\">",
"    <span class=\"h2\">",
"     Treatment",
"    </span>",
"    &nbsp;&mdash;&nbsp;Discontinuation of the culprit fluoroquinolone is the primary treatment for maculopapular exanthema. The median time to resolution of the rash is five days [",
"    <a class=\"abstract\" href=\"UTD.htm?8/22/8553/abstract/11\">",
"     11",
"    </a>",
"    ], and symptoms may worsen for a few days even after the drug is stopped [",
"    <a class=\"abstract\" href=\"UTD.htm?8/22/8553/abstract/16\">",
"     16",
"    </a>",
"    ]. Oral antihistamines may be administered at age-appropriate doses if there is a pruritic component. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/50/24360?source=see_link&amp;anchor=H14870405#H14870405\">",
"     \"Exanthematous (morbilliform) drug eruption\", section on 'Management'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H365993\">",
"    <span class=\"h2\">",
"     Evaluation",
"    </span>",
"    &nbsp;&mdash;&nbsp;After resolution of an exanthema to a fluoroquinolone, evaluation is appropriate, although there is a lack of consensus about the best approach. In the United States, these reactions are usually diagnosed based upon the clinical history (and physical findings if the reaction is witnessed by a clinician). Photographs or detailed descriptions in the medical record are invaluable for future reference. Further evaluation is not usually performed.",
"   </p>",
"   <p>",
"    Patch testing for the evaluation of delayed maculopapular exanthema from fluoroquinolones is",
"    <strong>",
"     not",
"    </strong>",
"    useful. In a study of 101 patients with fluoroquinolone allergy, 37 had delayed reactions (defined in this study as symptoms appearing greater than six hours after the last dose) [",
"    <a class=\"abstract\" href=\"UTD.htm?8/22/8553/abstract/5\">",
"     5",
"    </a>",
"    ]. Approximately one-half of these reactions began within 24 hours of the first dose. All 37 patients underwent patch testing and all had negative results. Twenty-eight underwent fluoroquinolone graded challenges with the culprit drug and two patients reacted with recurrence exanthema, both after the fourth dose. Thus, patch testing was not helpful for identifying patients at risk for this type of reaction.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H366000\">",
"    <span class=\"h3\">",
"     Graded challenge",
"    </span>",
"    &nbsp;&mdash;&nbsp;Since cross-reactivity among fluoroquinolones for delayed maculopapular reactions appears to be low [",
"    <a class=\"abstract\" href=\"UTD.htm?8/22/8553/abstract/11\">",
"     11",
"    </a>",
"    ], it is reasonable to perform graded challenge in patients with a history of a self-limited maculopapular exanthema, with a fluoroquinolone different from the one that caused the reaction. However, it is important to understand the limitations of challenge procedures for delayed maculopapular exanthema. Many of these reactions only recur after several days of therapy, and there is no practical way to elicit such reactions without administering a full therapeutic course. This should be explained to patients.",
"   </p>",
"   <p>",
"    The author&rsquo;s approach to challenge in this setting is to administer one-tenth of a full dose, wait one hour, and if there is no adverse reaction, then administer the remaining nine-tenths of the dose and observe for an additional hour. The reason for giving the initial dose under observation is the author&rsquo;s experience that, unless the patient knows that the drug can be safely ingested, there may be continued reluctance to use it in the future. A delayed reaction may occur during the 24 hours following the initial dose, and patients should be instructed to inform the clinician if this occurs. In the study mentioned previously, 28 patients with delayed reactions were challenged, and the two who reacted developed symptoms at 15 and 20 hours after the last of the graded doses [",
"    <a class=\"abstract\" href=\"UTD.htm?8/22/8553/abstract/5\">",
"     5",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    After receiving a full dose under observation, patients who do not need the antibiotic at that time can simply take it normally in the future. Patients who need fluoroquinolone therapy at the time can continue the treatment for a full course.",
"   </p>",
"   <p>",
"    If a patient develops a mild exanthema during future courses of therapy, it may be reasonable to attempt to continue the drug and add antihistamine therapy, provided that the reaction lacks any worrisome features. This approach has not been formally studied and is only appropriate when the benefit of continued treatment clearly outweighs the risk of further reaction. Such situations require clinical judgement. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/50/24360?source=see_link&amp;anchor=H14870405#H14870405\">",
"     \"Exanthematous (morbilliform) drug eruption\", section on 'Management'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6129585\">",
"    <span class=\"h1\">",
"     REACTIONS OF UNCERTAIN TYPE",
"    </span>",
"    &nbsp;&mdash;&nbsp;If a previous reaction to a fluoroquinolone was poorly documented, if the clinical history is uncertain, or if the reaction involved a pruritic skin component, then the possibility of an immediate reaction should be considered. (See",
"    <a class=\"local\" href=\"#H2118347\">",
"     'Immediate reactions'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2118347\">",
"    <span class=\"h1\">",
"     IMMEDIATE REACTIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Immediate reactions are characterized by symptoms that begin within an hour of the first administered dose. Immediate reactions result from activation of mast cells and basophils. Common signs and symptoms include urticaria, pruritus, flushing, angioedema of the face, extremities, or laryngeal tissues (leading to throat tightness with stridor, or rarely asphyxiation), wheezing, nausea, abdominal cramping or diarrhea, hypotension,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    anaphylactic shock. Fatal immediate reactions to fluoroquinolones have been reported [",
"    <a class=\"abstract\" href=\"UTD.htm?8/22/8553/abstract/17\">",
"     17",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6129656\">",
"    <span class=\"h2\">",
"     Pathogenesis",
"    </span>",
"    &nbsp;&mdash;&nbsp;There is evidence for both IgE and non-IgE mechanisms for immediate reactions caused by fluoroquinolones. Animal studies have shown that fluoroquinolones at supratherapeutic doses can cause histamine release",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    generalized rash [",
"    <a class=\"abstract\" href=\"UTD.htm?8/22/8553/abstract/18,19\">",
"     18,19",
"    </a>",
"    ]. Unlike IgE-mediated allergic reactions, non-IgE mediated reactions may occur with first exposure, since prior sensitization is not necessary. Apart from this difference, IgE-mediated and non-IgE-mediated reactions may be clinically indistinguishable, and their relative incidence is not known.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6129663\">",
"    <span class=\"h2\">",
"     IgE-mediated reactions",
"    </span>",
"    &nbsp;&mdash;&nbsp;There is very limited evidence of fluoroquinolone-specific IgE in patients with past immediate reactions. In the most convincing study, fluoroquinolone-specific IgE was detected in 30 of 55 patients by radioimmunoassay (RIA), although at very low levels [",
"    <a class=\"abstract\" href=\"UTD.htm?8/22/8553/abstract/20\">",
"     20",
"    </a>",
"    ]. Inhibition studies were performed to demonstrate that the IgE was functional, although only on a few sera.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6129670\">",
"    <span class=\"h3\">",
"     Natural history",
"    </span>",
"    &nbsp;&mdash;&nbsp;There is some evidence that fluoroquinolone-specific IgE declines over time, implying that some patients could lose the allergy if not re-exposed for a period of time. In the study (mentioned above) of 55 patients with convincing histories of immediate-type reactions to fluoroquinolones occurring 1 to 48 months prior to evaluation, 30 of the 55 had detectable drug-specific IgE by RIA [",
"    <a class=\"abstract\" href=\"UTD.htm?8/22/8553/abstract/20\">",
"     20",
"    </a>",
"    ]. In those patients that had detectable drug-specific IgE, an average of 9.7 months had elapsed since the reaction, compared to 15.6 months in those without detectable IgE. Also, among the 30 IgE-positive patients, those with recent reactions (defined as less than eight months prior to evaluation) had significantly higher RIA values than those with more distant reactions. Although none of the patients were challenged with fluoroquinolones to confirm allergic status, these data suggest that fluoroquinolone allergy will eventually resolve in some patients.",
"   </p>",
"   <p>",
"    Based on a small number of studies of patients with immediate reactions to fluoroquinolones who underwent graded challenge with the",
"    <strong>",
"     culprit",
"    </strong>",
"    drug, most patients in fact tolerated the drug upon re-exposure. Unfortunately, the time elapsed between the reaction and challenge was not specified in two of these studies [",
"    <a class=\"abstract\" href=\"UTD.htm?8/22/8553/abstract/5,21,22\">",
"     5,21,22",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In a study of 33 patients who were evaluated only with challenge, 24 tolerated the culprit drug [",
"      <a class=\"abstract\" href=\"UTD.htm?8/22/8553/abstract/21\">",
"       21",
"      </a>",
"      ]. Reactions occurred 3 to 120 months before evaluation (median 12 months).",
"     </li>",
"     <li>",
"      In the study of 101 patients discussed above, 51 were challenged and 88 percent tolerated the drug (most of whom were skin test negative) [",
"      <a class=\"abstract\" href=\"UTD.htm?8/22/8553/abstract/5\">",
"       5",
"      </a>",
"      ]. The median time elapsed between the initial reaction and evaluation was not specified.",
"     </li>",
"     <li>",
"      In the study of 71 patients already discussed, 17 were challenged and 11 tolerated the drug. All the patients were skin tested, some were skin test-positive, others were negative [",
"      <a class=\"abstract\" href=\"UTD.htm?8/22/8553/abstract/22\">",
"       22",
"      </a>",
"      ]. The median time elapsed between reaction and evaluation was not specified.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10730700\">",
"    <span class=\"h2\">",
"     Incidence",
"    </span>",
"    &nbsp;&mdash;&nbsp;Fluoroquinolone-induced anaphylactic reactions have been increasingly recognized in the last decade, although the incidence is not precisely known [",
"    <a class=\"abstract\" href=\"UTD.htm?8/22/8553/abstract/5,20,23-25\">",
"     5,20,23-25",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The incidence of these reactions was estimated to be between one and five per 100,000 prescriptions filled in a large Unites States (US) health insurance claims database, in which anaphylaxis was confirmed by review of medical records [",
"      <a class=\"abstract\" href=\"UTD.htm?8/22/8553/abstract/2\">",
"       2",
"      </a>",
"      ]. The rates for anaphylaxis to penicillins and cephalosporins were comparable",
"      <span class=\"nowrap\">",
"       (2/100,000",
"      </span>",
"      and",
"      <span class=\"nowrap\">",
"       1/100,000,",
"      </span>",
"      respectively). However, the nature of this study did not allow confirmation that the antibiotic was responsible for the anaphylactic events. Also, it is possible some of the reactions to fluoroquinolones were anaphylactoid (non-IgE-mediated) rather than anaphylactic (IgE-mediated).",
"     </li>",
"     <li>",
"      An estimate of the number of anaphylactic reactions to",
"      <a class=\"drug drug_general\" href=\"UTD.htm?34/45/35536?source=see_link\">",
"       ciprofloxacin",
"      </a>",
"      during its first year of use (1987 to 1988) in the US was 12 reactions among 972,000 prescriptions, or",
"      <span class=\"nowrap\">",
"       1.2/100,000",
"      </span>",
"      prescriptions filled [",
"      <a class=\"abstract\" href=\"UTD.htm?8/22/8553/abstract/26\">",
"       26",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Another study of a database of voluntary reports estimated the incidence to be lower, at 0.2 to 3.3 per 1 million doses [",
"    <a class=\"abstract\" href=\"UTD.htm?8/22/8553/abstract/27\">",
"     27",
"    </a>",
"    ]. However, voluntary reporting of adverse drug reactions (ADRs) likely underestimates the true incidence of reactions.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10730535\">",
"    <span class=\"h3\">",
"     Cross-reactivity among drugs",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cross-sensitization and cross-reactivity to other fluoroquinolones in patients with previous immediate reactions has been demonstrated:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In the study discussed previously, there were",
"      <span class=\"nowrap\">",
"       30/55",
"      </span>",
"      patients with immediate reactions and demonstrable drug-specific IgE by radioimmunoassay (RIA), of whom 24 (80 percent) were positive to more than one fluoroquinolone, and nine reported historical allergic reactions to more than one fluoroquinolone [",
"      <a class=\"abstract\" href=\"UTD.htm?8/22/8553/abstract/20\">",
"       20",
"      </a>",
"      ]. Although subjects were not challenged in this study to confirm reactivity, this suggests cross-sensitivity. Another study using similar methods found a comparable rate of fluoroquinolone cross-reactivity based on in vitro IgE testing [",
"      <a class=\"abstract\" href=\"UTD.htm?8/22/8553/abstract/23\">",
"       23",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Several smaller case-series found clinical cross-reactivity among fluoroquinolones [",
"      <a class=\"abstract\" href=\"UTD.htm?8/22/8553/abstract/25,28-30\">",
"       25,28-30",
"      </a>",
"      ], although others did not [",
"      <a class=\"abstract\" href=\"UTD.htm?8/22/8553/abstract/24,31,32\">",
"       24,31,32",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In a few studies, patients with past reactions to one fluoroquinolone were challenged with other fluoroquinolones [",
"      <a class=\"abstract\" href=\"UTD.htm?8/22/8553/abstract/24,25,28,29,31,32\">",
"       24,25,28,29,31,32",
"      </a>",
"      ]. Of 26 reported patients, 14 reacted to at least one other fluoroquinolone, whereas 12 patients tolerated one or more other fluoroquinolones. However, no clear patterns of cross-reactivity among the drugs were detectable.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6129928\">",
"    <span class=\"h2\">",
"     Management",
"    </span>",
"    &nbsp;&mdash;&nbsp;The management of immediate reactions to fluoroquinolones involves discontinuation of the drug, intramuscular epinephrine for symptoms suggestive of anaphylaxis, intravenous fluid resuscitations, and antihistamines for pruritus and urticaria. This is reviewed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/29/35290?source=see_link&amp;anchor=H18#H18\">",
"     \"Anaphylaxis: Rapid recognition and treatment\", section on 'Immediate management'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1361178\">",
"    <span class=\"h2\">",
"     Evaluation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with previous immediate reactions to fluoroquinolones are challenging to evaluate because the pathophysiology of these reactions is not well understood, immediate-type skin testing with these drugs is not validated, and practice parameters are lacking. In addition, there is evidence for both of the following statements:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Patients with past immediate reactions to one fluoroquinolone may react to others, although the rates of cross-reactivity are unknown and clear patterns of cross-reactivity have not been demonstrated.",
"     </li>",
"     <li>",
"      A substantial proportion of patients with prior immediate reactions to a specific fluoroquinolone will tolerate the culprit drug if they are given it again [",
"      <a class=\"abstract\" href=\"UTD.htm?8/22/8553/abstract/5,21,22\">",
"       5,21,22",
"      </a>",
"      ]. Potential explanations for this observation include the possibility that the patient&rsquo;s reaction was not IgE-mediated and was instead dependent upon other variables, or the patient&rsquo;s reaction was IgE-mediated, but drug-specific IgE declined over time [",
"      <a class=\"abstract\" href=\"UTD.htm?8/22/8553/abstract/5,21,22\">",
"       5,21,22",
"      </a>",
"      ]. (See",
"      <a class=\"local\" href=\"#H6129670\">",
"       'Natural history'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In most cases, evaluation consists of immediate-type skin testing and graded challenge, although there is legitimate debate about the utility of skin testing [",
"    <a class=\"abstract\" href=\"UTD.htm?8/22/8553/abstract/5\">",
"     5",
"    </a>",
"    ]. The approach of the author is presented here.",
"   </p>",
"   <p>",
"    Other types of tests remain investigational. Specifically, we are aware of no published studies reporting the accuracy of commercial assays for fluoroquinolone-specific IgE, and basophil activation tests and lymphocyte stimulation tests are either not widely available or have not been adequately validated.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4825889\">",
"    <span class=\"h3\">",
"     Situations in which evaluation is helpful",
"    </span>",
"    &nbsp;&mdash;&nbsp;Evaluation for fluoroquinolone allergy is not indicated in every patient, as it may be adequate to simply avoid this class of antimicrobials altogether in some patients. The author&rsquo;s experience is that evaluation is most helpful in patients who report immediate reactions that were less severe than full anaphylaxis, such as pruritic rashes, urticaria, or angioedema, AND who are likely to require fluoroquinolone therapy in the future. As examples:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Evaluation would be helpful in a 70 year old female with recurrent, frequent urinary tract infections who has been hospitalized for pyelonephritis and reports an itchy rash while on",
"      <a class=\"drug drug_general\" href=\"UTD.htm?32/46/33504?source=see_link\">",
"       levofloxacin",
"      </a>",
"      .",
"     </li>",
"     <li>",
"      Evaluation is not necessary in a 40 year old male with no significant medical problems who developed an urticarial reaction while on",
"      <a class=\"drug drug_general\" href=\"UTD.htm?34/45/35536?source=see_link\">",
"       ciprofloxacin",
"      </a>",
"      for a vasectomy-related infection, but who otherwise rarely requires antibiotic treatment.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    For patients with past",
"    <strong>",
"    </strong>",
"    fluoroquinolone-associated anaphylaxis, one can distinguish, somewhat arbitrarily, between those with recent reactions (eg within the past five years) and those with more remote reactions:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      We do not perform skin testing or challenge for patients with recent anaphylaxis, since skin testing is not sufficiently reliable and a challenge would pose risk to the patient. If such a patient required treatment with a fluoroquinolone antibiotic and there were no acceptable alternatives, it should be administered using rapid desensitization protocol (aka, rapid induction of drug tolerance) [",
"      <a class=\"abstract\" href=\"UTD.htm?8/22/8553/abstract/33,34\">",
"       33,34",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?28/62/29672?source=see_link\">",
"       \"Rapid drug desensitization for immediate hypersensitivity reactions\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      For patients with anaphylaxis more than five years ago, it is reasonable to perform skin testing, based on limited evidence that drug-specific IgE declines with time and thus the patient may no longer be allergic [",
"      <a class=\"abstract\" href=\"UTD.htm?8/22/8553/abstract/20\">",
"       20",
"      </a>",
"      ]. (See",
"      <a class=\"local\" href=\"#H6129670\">",
"       'Natural history'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2121463\">",
"    <span class=\"h3\">",
"     Immediate-type skin testing",
"    </span>",
"    &nbsp;&mdash;&nbsp;Immediate-type skin testing with fluoroquinolones is not validated or standardized, and it may not distinguish between IgE-mediated and non-IgE-mediated immediate reactions, since fluoroquinolones can cause nonspecific mast cell degranulation. Further, the allergenic determinants are not known and some may be reactive metabolites. Because of these limitations, some experts do not advocate skin testing with fluoroquinolones [",
"    <a class=\"abstract\" href=\"UTD.htm?8/22/8553/abstract/5\">",
"     5",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Despite the above, it is the author&rsquo;s opinion that the negative predictive value of skin testing is sufficiently high that it can be clinically useful in some cases, as described in the following sections. (See",
"    <a class=\"local\" href=\"#H2762724\">",
"     'Interpretation of results'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    If skin testing is performed, prick-puncture skin testing should be performed first. Positive histamine and negative saline controls should be also applied. If prick-puncture testing is negative, intradermal skin testing is then performed. Skin test results are read at 15 minutes.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H569740\">",
"    <span class=\"h4\">",
"     Concentrations for skin testing",
"    </span>",
"    &nbsp;&mdash;&nbsp;It is very important to use nonirritating concentrations for intradermal testing to avoid false positive results, since these drugs can cause nonspecific activation of mast cells. It is the author&rsquo;s approach to perform skin testing with commonly used fluoroquinolones for which nonirritating concentrations are available. Thus, we test with both",
"    <a class=\"drug drug_general\" href=\"UTD.htm?32/46/33504?source=see_link\">",
"     levofloxacin",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?32/51/33584?source=see_link\">",
"     moxifloxacin",
"    </a>",
"    in most cases. In other countries, different fluoroquinolones may be more commonly used, and these could be included in skin testing.",
"   </p>",
"   <p>",
"    The author uses the following",
"    <strong>",
"     maximal",
"    </strong>",
"    concentrations for",
"    <strong>",
"     both prick-puncture and intradermal",
"    </strong>",
"    testing:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?32/46/33504?source=see_link\">",
"       Levofloxacin",
"      </a>",
"      : An intravenous preparation of levofloxacin diluted to a concentration of 0.025",
"      <span class=\"nowrap\">",
"       mg/mL",
"      </span>",
"      (a 1:1000-fold dilution of the commercially available 25",
"      <span class=\"nowrap\">",
"       mg/mL",
"      </span>",
"      solution) was nonirritating in 25 subjects with no history of drug allergy [",
"      <a class=\"abstract\" href=\"UTD.htm?8/22/8553/abstract/35\">",
"       35",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?32/51/33584?source=see_link\">",
"       Moxifloxacin",
"      </a>",
"      : There are no published data on the nonirritating concentration of moxifloxacin, although the author has found 0.016",
"      <span class=\"nowrap\">",
"       mg/mL",
"      </span>",
"      (a 1:100-fold dilution of the commercially available 1.6",
"      <span class=\"nowrap\">",
"       mg/mL",
"      </span>",
"      IV solution) to be nonirritating.",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?34/45/35536?source=see_link\">",
"       Ciprofloxacin",
"      </a>",
"      : A nonirritating concentration of ciprofloxacin has not been identified, and the author does not perform skin testing to ciprofloxacin in his practice. In the study of 25 patients mentioned previously, at least one subject had a positive skin test response with even a 10,000,000-fold dilution [",
"      <a class=\"abstract\" href=\"UTD.htm?8/22/8553/abstract/35\">",
"       35",
"      </a>",
"      ]. However, in another study, a concentration of 0.0067",
"      <span class=\"nowrap\">",
"       mg/mL",
"      </span>",
"      was found to be nonirritating, although only 16 patients were tested and the evaluation of more patients may have revealed irritant reactions [",
"      <a class=\"abstract\" href=\"UTD.htm?8/22/8553/abstract/36\">",
"       36",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H365191\">",
"    <span class=\"h4\">",
"     Utility of skin testing",
"    </span>",
"    &nbsp;&mdash;&nbsp;A small number of studies provide information about the utility of immediate-type skin testing in identifying patients at risk for immediate fluoroquinolone reactions [",
"    <a class=\"abstract\" href=\"UTD.htm?8/22/8553/abstract/5,22\">",
"     5,22",
"    </a>",
"    ]. In the largest, fluoroquinolone prick-puncture skin testing had a negative predictive value (NPV) of 93 percent, sensitivity of 50 percent, and specificity of 93 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?8/22/8553/abstract/5\">",
"     5",
"    </a>",
"    ]. This study included 101 patients with past hypersensitivity reactions to fluoroquinolones within a year of evaluation, of whom 64 had immediate reactions [",
"    <a class=\"abstract\" href=\"UTD.htm?8/22/8553/abstract/5\">",
"     5",
"    </a>",
"    ]. These 64 underwent prick-puncture skin testing, using concentrations significantly higher than those proposed above (eg,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?32/46/33504?source=see_link\">",
"     levofloxacin",
"    </a>",
"    at 5",
"    <span class=\"nowrap\">",
"     mg/mL",
"    </span>",
"    and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?32/51/33584?source=see_link\">",
"     moxifloxacin",
"    </a>",
"    at 1.6",
"    <span class=\"nowrap\">",
"     mg/mL).",
"    </span>",
"    Intradermal skin testing was not performed since the investigators were unable to identify nonirritating concentrations in control subjects for several of the drugs. Of 64 patients with immediate reactions, 12 were skin test-positive and 52 were negative. Six of the 12 with positive skin testing underwent fluoroquinolone graded challenges (including to the culprit drug), and three developed reactions (mostly urticarial, none of which required epinephrine). Among the other 52 skin test-negative patients with immediate reactions, 45 were challenged and 3 reacted. Thus, 6 of 64 patients (9 percent) with past immediate reactions were confirmed to be allergic (although 13 were not challenged).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2762724\">",
"    <span class=\"h4\">",
"     Interpretation of results",
"    </span>",
"    &nbsp;&mdash;&nbsp;Based on the studies described above, most patients with immediate reactions who undergo fluoroquinolone skin testing will have negative results, provided nonirritating doses of drug are used. We use the information obtained from skin testing as follows:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A positive skin test indicates drug-specific IgE",
"      <strong>",
"       may",
"      </strong>",
"      be present, and the available studies indicate that the positive predictive value is about 50 percent [",
"      <a class=\"abstract\" href=\"UTD.htm?8/22/8553/abstract/5,22,37\">",
"       5,22,37",
"      </a>",
"      ]. It is our approach to advise patients with positive results to avoid all fluoroquinolones, because of possible cross-reactivity among fluoroquinolones in causing immediate reactions. If the patient requires treatment with that fluoroquinolone and there are no acceptable antibiotic alternatives, it should be administered via a rapid desensitization. (See",
"      <a class=\"local\" href=\"#H10730535\">",
"       'Cross-reactivity among drugs'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H10732060\">",
"       'Desensitization'",
"      </a>",
"      below.)",
"     </li>",
"     <li>",
"      A negative skin test provides some reassurance but does not definitively exclude IgE-mediated allergy because the allergenic determinants have not been defined and some active metabolites may cause reactions [",
"      <a class=\"abstract\" href=\"UTD.htm?8/22/8553/abstract/37\">",
"       37",
"      </a>",
"      ]. History-positive patients with negative fluoroquinolone skin testing should undergo graded challenge as described in the next section. Based on the study reviewed above, approximately 7 percent of patients would be expected to react upon challenge [",
"      <a class=\"abstract\" href=\"UTD.htm?8/22/8553/abstract/5\">",
"       5",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2121470\">",
"    <span class=\"h3\">",
"     Graded challenge",
"    </span>",
"    &nbsp;&mdash;&nbsp;Graded challenge is the cautious administration of a drug to a patient who is",
"    <strong>",
"     unlikely",
"    </strong>",
"    to be allergic to it [",
"    <a class=\"abstract\" href=\"UTD.htm?8/22/8553/abstract/37\">",
"     37",
"    </a>",
"    ]. Negative fluoroquinolone skin testing should be followed by graded challenge, in order to confirm lack of allergy (or, if the challenge is positive, to demonstrate that the skin test was falsely negative). Otherwise, patients or other clinicians may misinterpret the skin test result to mean that fluoroquinolone allergy has been conclusively ruled out, which is not the case.",
"   </p>",
"   <p>",
"    Because of the uncertain utility of skin testing with fluoroquinolones, another option for evaluating patients with immediate reactions is to forego skin testing and perform a graded challenge with a fluoroquinolone other than the one that caused the reaction. Our approach is to challenge with an alternate, equally efficacious fluoroquinolone, since cross-reactivity is about 50 percent, based on a limited number of challenges reported in the literature [",
"    <a class=\"abstract\" href=\"UTD.htm?8/22/8553/abstract/24,25,28,29,31,32\">",
"     24,25,28,29,31,32",
"    </a>",
"    ]. This is a reasonable approach in patients with isolated urticaria",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    angioedema. The author does not do this in patients with anaphylaxis, although others have reported performing challenges in such patients safely [",
"    <a class=\"abstract\" href=\"UTD.htm?8/22/8553/abstract/5,31\">",
"     5,31",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Fluoroquinolone graded challenge typically starts with",
"    <span class=\"nowrap\">",
"     1/100",
"     <sup>",
"      th",
"     </sup>",
"    </span>",
"    of the full dose and includes two to four steps until the full dose is reached. The degree of caution exercised is determined by the severity of the historical reaction and the time elapsed since the reaction. For example, an outpatient graded challenge with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?32/46/33504?source=see_link\">",
"     levofloxacin",
"    </a>",
"    for a patient with immediate urticaria in the past could be carried out under continuous supervision with 5 mg, 50 mg, and then 500 mg of levofloxacin (oral solution), each given one hour apart. The patient is observed for two hours after the final dose.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10732060\">",
"    <span class=\"h3\">",
"     Desensitization",
"    </span>",
"    &nbsp;&mdash;&nbsp;Desensitization is appropriate for patients who require retreatment with a fluoroquinolone and had [",
"    <a class=\"abstract\" href=\"UTD.htm?8/22/8553/abstract/33,34\">",
"     33,34",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Anaphylaxis to a fluoroquinolone within the recent past (ie, five years)",
"      <br/>",
"      <br/>",
"      Or",
"     </li>",
"     <li>",
"      A prior immediate reaction that was less severe than anaphylaxis, but skin testing to the culprit fluoroquinolone was positive",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Desensitization involves the administration of a drug beginning with very small doses (usually",
"    <span class=\"nowrap\">",
"     1/1000",
"     <sup>",
"      th",
"     </sup>",
"    </span>",
"    of a normal dose or less) and gradually increasing in a stepwise manner until a full therapeutic dose is reached. It is often performed in a hospital setting when the patient requires a fluoroquinolone for a serious infection. Desensitization alters a patient's adverse immune response to a drug and results in TEMPORARY tolerance, allowing the patient with a hypersensitivity reaction to receive an uninterrupted course of the medication safely. Once the medication is discontinued, the patient's hypersensitivity to the medication returns. Therefore, desensitization must be repeated each time the patient requires a course of the drug in question. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/62/29672?source=see_link\">",
"     \"Rapid drug desensitization for immediate hypersensitivity reactions\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2118235\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The two most common types of hypersensitivity reactions to fluoroquinolones are delayed-onset maculopapular exanthema, which are generally benign, and immediate reactions (urticaria, pruritus, flushing, angioedema, wheezing, nausea, abdominal symptoms,",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      <span class=\"nowrap\">",
"       hypotension/shock),",
"      </span>",
"      which can be life-threatening. (See",
"      <a class=\"local\" href=\"#H10729921\">",
"       'Types of hypersensitivity reactions'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Evaluation of a patient with a past drug always begins with a careful clinical history and an assessment of the type of hypersensitivity reaction the patient most likely experienced. Referral to an allergy expert is appropriate if the patient has experienced a serious reaction, has an underlying medical condition that will likely require fluoroquinolone therapy in the future, or reports multiple drug allergies and has limited drug options left. (See",
"      <a class=\"local\" href=\"#H10729855\">",
"       'Approach to the patient'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Fluoroquinolones cause a delayed-onset maculopapular, nonpruritic rash in 2 to 3 percent of patients. These reactions are likely mediated by drug-specific T cells. In most cases, no specific testing is useful. Cross-reactivity among the fluoroquinolones for this type of reaction appears to be low. For patients who require fluoroquinolone therapy in the future, we suggest identifying a safe alternative using a graded challenge with a fluoroquinolone other than the one that caused the reaction (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H365986\">",
"       'Delayed maculopapular exanthema'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Fluoroquinolones can cause rare immediate reactions, including anaphylaxis, through both IgE- and non-IgE-mediated mechanisms. There is evidence of cross-reactivity among fluoroquinolones in patients with immediate reactions, but no clear patterns have been distinguished. Diagnostic tests for immediate fluoroquinolone hypersensitivity are not validated or standardized, in contrast to tests for penicillin hypersensitivity. If skin testing is performed, it is critical to use nonirritating concentrations of the drugs in question since fluoroquinolones can cause irritant false-positive reactions. (See",
"      <a class=\"local\" href=\"#H2118347\">",
"       'Immediate reactions'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We suggest that patients with anaphylaxis in the recent past (ie, &lt;5 years) empirically avoid all fluoroquinolones (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). We do not perform skin testing or challenge in such patients. If a fluoroquinolone is absolutely required in the near future, it should be administered using a desensitization protocol. (See",
"      <a class=\"local\" href=\"#H10732060\">",
"       'Desensitization'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Skin testing for immediate reactions is not standardized or well-validated, although we find it helpful in some clinical circumstances. Skin testing and challenge procedures are most useful in patients who experienced relatively mild immediate reactions, such as pruritic rashes, urticaria, or angioedema, or whose reactions occurred in the remote past (&gt;5 years) AND who are likely to require fluoroquinolone therapy in the future. (See",
"      <a class=\"local\" href=\"#H1361178\">",
"       'Evaluation'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      For patients with negative skin test results, we suggest a graded challenge be performed to confirm that the patient tolerates the drug (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H2762724\">",
"       'Interpretation of results'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H2121470\">",
"       'Graded challenge'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For patients with positive skin test results, we suggest avoidance of all fluoroquinolones (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). If a fluoroquinolone is absolutely required in the future near future, it should be administered using a desensitization protocol. (See",
"      <a class=\"local\" href=\"#H2762724\">",
"       'Interpretation of results'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H10732060\">",
"       'Desensitization'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/22/8553/abstract/1\">",
"      Johansson SG, Bieber T, Dahl R, et al. Revised nomenclature for allergy for global use: Report of the Nomenclature Review Committee of the World Allergy Organization, October 2003. J Allergy Clin Immunol 2004; 113:832.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/22/8553/abstract/2\">",
"      Johannes CB, Ziyadeh N, Seeger JD, et al. Incidence of allergic reactions associated with antibacterial use in a large, managed care organisation. Drug Saf 2007; 30:705.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/22/8553/abstract/3\">",
"      Naldi L, Conforti A, Venegoni M, et al. Cutaneous reactions to drugs. An analysis of spontaneous reports in four Italian regions. Br J Clin Pharmacol 1999; 48:839.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/22/8553/abstract/4\">",
"      Scherer K, Bircher AJ. Hypersensitivity reactions to fluoroquinolones. Curr Allergy Asthma Rep 2005; 5:15.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/22/8553/abstract/5\">",
"      Seitz CS, Br&ouml;cker EB, Trautmann A. Diagnostic testing in suspected fluoroquinolone hypersensitivity. Clin Exp Allergy 2009; 39:1738.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/22/8553/abstract/6\">",
"      Slama TG. Serum sickness-like illness associated with ciprofloxacin. Antimicrob Agents Chemother 1990; 34:904.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/22/8553/abstract/7\">",
"      Maunz G, Conzett T, Zimmerli W. Cutaneous vasculitis associated with fluoroquinolones. Infection 2009; 37:466.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/22/8553/abstract/8\">",
"      Rodr&iacute;guez-Morales A, Llamazares AA, Benito RP, C&oacute;cera CM. Fixed drug eruption from quinolones with a positive lesional patch test to ciprofloxacin. Contact Dermatitis 2001; 44:255.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/22/8553/abstract/9\">",
"      Jongen-Lavrencic M, Schneeberger PM, van der Hoeven JG. Ciprofloxacin-induced toxic epidermal necrolysis in a patient with systemic lupus erythematosus. Infection 2003; 31:428.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/22/8553/abstract/10\">",
"      Ball P, Mandell L, Niki Y, Tillotson G. Comparative tolerability of the newer fluoroquinolone antibacterials. Drug Saf 1999; 21:407.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/22/8553/abstract/11\">",
"      Ball P, Mandell L, Patou G, et al. A new respiratory fluoroquinolone, oral gemifloxacin: a safety profile in context. Int J Antimicrob Agents 2004; 23:421.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/22/8553/abstract/12\">",
"      Ball P, Stahlmann R, Kubin R, et al. Safety profile of oral and intravenous moxifloxacin: cumulative data from clinical trials and postmarketing studies. Clin Ther 2004; 26:940.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/22/8553/abstract/13\">",
"      Schmid DA, Depta JP, Pichler WJ. T cell-mediated hypersensitivity to quinolones: mechanisms and cross-reactivity. Clin Exp Allergy 2006; 36:59.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/22/8553/abstract/14\">",
"      Zhang L, Wang R, Matthew FE, et al. Gemifloxacin for the treatment of community-acquired pneumonia and acute exacerbation of chronic bronchitis: a meta-analysis of randomized controlled trials. Chin Med J (Engl) 2012; 125:687.",
"     </a>",
"    </li>",
"    <li>",
"     Results were presented to the US Food and Drug Administration (FDA) in 2003. See slide 6. file://www.fda.gov/ohrms/dockets/ac/03/slides/3931S1_01_FDA-Albrecht.ppt#273 (Accessed on July 10, 2012).",
"    </li>",
"    <li>",
"     Shear NH, Knowles SR, Shapiro L. Cutaneous reactions to drugs. In: Fitzpatrick's dermatology in general medicine, 7th ed, Wolff K, Goldsmith LA, Katz SI, et al (Eds), McGraw Hill, 2008. p.355.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/22/8553/abstract/17\">",
"      Peters B, Pinching AJ. Fatal anaphylaxis associated with ciprofloxacin in a patient with AIDS related complex. BMJ 1989; 298:605.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/22/8553/abstract/18\">",
"      Kurata M, Kasuga Y, Nanba E, et al. Flush induced by fluoroquinolones in canine skin. Inflamm Res 1995; 44:461.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/22/8553/abstract/19\">",
"      Ishiwata Y, Yasuhara M. Gatifloxacin-induced histamine release and hyperglycemia in rats. Eur J Pharmacol 2010; 645:192.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/22/8553/abstract/20\">",
"      Manfredi M, Severino M, Testi S, et al. Detection of specific IgE to quinolones. J Allergy Clin Immunol 2004; 113:155.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/22/8553/abstract/21\">",
"      Messaad D, Sahla H, Benahmed S, et al. Drug provocation tests in patients with a history suggesting an immediate drug hypersensitivity reaction. Ann Intern Med 2004; 140:1001.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/22/8553/abstract/22\">",
"      Venturini D&iacute;az M, Lobera Labairu T, del Pozo Gil MD, et al. In vivo diagnostic tests in adverse reactions to quinolones. J Investig Allergol Clin Immunol 2007; 17:393.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/22/8553/abstract/23\">",
"      Aranda A, Mayorga C, Ariza A, et al. In vitro evaluation of IgE-mediated hypersensitivity reactions to quinolones. Allergy 2011; 66:247.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/22/8553/abstract/24\">",
"      Chang B, Knowles SR, Weber E. Immediate hypersensitivity to moxifloxacin with tolerance to ciprofloxacin: report of three cases and review of the literature. Ann Pharmacother 2010; 44:740.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/22/8553/abstract/25\">",
"      Gonz&aacute;lez I, Lobera T, Blasco A, del Pozo MD. Immediate hypersensitivity to quinolones: moxifloxacin cross-reactivity. J Investig Allergol Clin Immunol 2005; 15:146.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/22/8553/abstract/26\">",
"      Davis H, McGoodwin E, Reed TG. Anaphylactoid reactions reported after treatment with ciprofloxacin. Ann Intern Med 1989; 111:1041.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/22/8553/abstract/27\">",
"      Sachs B, Riegel S, Seebeck J, et al. Fluoroquinolone-associated anaphylaxis in spontaneous adverse drug reaction reports in Germany: differences in reporting rates between individual fluoroquinolones and occurrence after first-ever use. Drug Saf 2006; 29:1087.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/22/8553/abstract/28\">",
"      Anovadiya AP, Barvaliya MJ, Patel TK, Tripathi CB. Cross sensitivity between ciprofloxacin and levofloxacin for an immediate hypersensitivity reaction. J Pharmacol Pharmacother 2011; 2:187.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/22/8553/abstract/29\">",
"      D&aacute;vila I, Diez ML, Quirce S, et al. Cross-reactivity between quinolones. Report of three cases. Allergy 1993; 48:388.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/22/8553/abstract/30\">",
"      R&ouml;nnau AC, Sachs B, von Schmiedeberg S, et al. Cutaneous adverse reaction to ciprofloxacin: demonstration of specific lymphocyte proliferation and cross-reactivity to ofloxacin in vitro. Acta Derm Venereol 1997; 77:285.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/22/8553/abstract/31\">",
"      Lobera T, Aud&iacute;cana MT, Alarc&oacute;n E, et al. Allergy to quinolones: low cross-reactivity to levofloxacin. J Investig Allergol Clin Immunol 2010; 20:607.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/22/8553/abstract/32\">",
"      S&aacute;nchez-Morillas L, Rojas P&eacute;rez-Ezquerra P, Rea&ntilde;o-Martos M, et al. Systemic anaphylaxis caused by moxifloxacin. Allergol Immunopathol (Madr) 2010; 38:226.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/22/8553/abstract/33\">",
"      Gea-Banacloche JC, Metcalfe DD. Ciprofloxacin desensitization. J Allergy Clin Immunol 1996; 97:1426.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/22/8553/abstract/34\">",
"      Lantner RR. Ciprofloxacin desensitization in a patient with cystic fibrosis. J Allergy Clin Immunol 1995; 96:1001.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/22/8553/abstract/35\">",
"      Empedrad R, Darter AL, Earl HS, Gruchalla RS. Nonirritating intradermal skin test concentrations for commonly prescribed antibiotics. J Allergy Clin Immunol 2003; 112:629.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/22/8553/abstract/36\">",
"      Bro�� P, Harr T, Hecking C, et al. Nonirritant intradermal skin test concentrations of ciprofloxacin, clarithromycin, and rifampicin. Allergy 2012; 67:647.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/22/8553/abstract/37\">",
"      Joint Task Force on Practice Parameters, American Academy of Allergy, Asthma and Immunology, American College of Allergy, Asthma and Immunology, Joint Council of Allergy, Asthma and Immunology. Drug allergy: an updated practice parameter. Ann Allergy Asthma Immunol 2010; 105:259.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 83728 Version 1.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1104-61.234.146.186-5DB5CB92DE-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f8_22_8553=[""].join("\n");
var outline_f8_22_8553=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H2118235\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H96179886\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10729921\">",
"      TYPES OF HYPERSENSITIVITY REACTIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1312189\">",
"      Most common",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1312196\">",
"      Other types",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10729855\">",
"      APPROACH TO THE PATIENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10730182\">",
"      Multiple drug allergy syndrome",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H365668\">",
"      Referral",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H365986\">",
"      DELAYED MACULOPAPULAR EXANTHEMA",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6129542\">",
"      Cross-reactivity",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4093130\">",
"      Treatment",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H365993\">",
"      Evaluation",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H366000\">",
"      - Graded challenge",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6129585\">",
"      REACTIONS OF UNCERTAIN TYPE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2118347\">",
"      IMMEDIATE REACTIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6129656\">",
"      Pathogenesis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6129663\">",
"      IgE-mediated reactions",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H6129670\">",
"      - Natural history",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10730700\">",
"      Incidence",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H10730535\">",
"      - Cross-reactivity among drugs",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6129928\">",
"      Management",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1361178\">",
"      Evaluation",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H4825889\">",
"      - Situations in which evaluation is helpful",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H2121463\">",
"      - Immediate-type skin testing",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H569740\">",
"      Concentrations for skin testing",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H365191\">",
"      Utility of skin testing",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H2762724\">",
"      Interpretation of results",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H2121470\">",
"      - Graded challenge",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H10732060\">",
"      - Desensitization",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2118235\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/62/24554?source=related_link\">",
"      An approach to the patient with drug allergy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/29/35290?source=related_link\">",
"      Anaphylaxis: Rapid recognition and treatment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/11/1210?source=related_link\">",
"      Drug allergy: Classification and clinical features",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/35/38456?source=related_link\">",
"      Drug allergy: Pathogenesis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/50/24360?source=related_link\">",
"      Exanthematous (morbilliform) drug eruption",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/60/28618?source=related_link\">",
"      Fluoroquinolones",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/62/29672?source=related_link\">",
"      Rapid drug desensitization for immediate hypersensitivity reactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?17/29/17882?source=related_link\">",
"      Stevens-Johnson syndrome and toxic epidermal necrolysis: Clinical manifestations; pathogenesis; and diagnosis",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f8_22_8554="Guttate psoriasis 2";
var content_f8_22_8554=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F64836%7EDERM%2F82073%7EDERM%2F56410&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F64836%7EDERM%2F82073%7EDERM%2F56410&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Guttate psoriasis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 325px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAFFAbADASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwDtoEZSMnPqac0O/D4RgDU7Q4+ZQQCOakhUBN3IU9q8W3Q9+/UiEaEEr908ECpPLRCOcse4qRYQB95h9P4qe0SL82CMCm0IiiiMp3MTwcc1YWNVJ4YnPWmLHgYTIZjnPUVN5DBtxJIx07U0D0GFAxwchTxipYFO5gB9e+acFI6ckDvR8wG8FgB37VS3J1JViCtuIAx61HK6xEk9W6DPSnxPvXCncR1xTkto2CM6bmXoab1Wg0ktytcopkiVk3A8Zx0+tWt/kJt2klj/AAjpTxGDyQ3XPTipIyFnAOW7gelCjYfNdDHt+r8gnFWY1KhdwySM4prTkyEIucc4qXyhKUd8hhzjNWrLYzd+oIm/AyUIPbk1OyMoJJ2o3AqJGXzCQvI6nsKnOcjHzqeo9KpK6JZAqNHuMxLDsAOlWYlYsDgqMY2/1qRFyTkc44OKQngFSdo4xVWsJu5DMCEY5z6AcVyOq2DJPK3leb5i4yf4T7V2M0gKgnHDcZqukatIuVLBxyM8VlVgp6HRQqunqZfhmN4IERhke54/Gtwb5lYptODnkfnSNFhoiiAY7DgAGraIvBPBXoB/Orpw5VYyq1OeXP3KmdjODhXxkk1zF3cXK3ZmR8pnGGbg468V10hE0rwkHcBwTXMXNjcEvFGgZcnDt1BPpWddO2hthmru5paTei7tkZSEbOCOtaCJIJwhKhQuSMc9aztJgSys1hlwNxxk9a03JEqFXAQdRjOa1he2pjVtzPlI548rIRtDnAU5z+NNRJV2jdk4+bHenwOJgWUgoG4YVL3UtkZ5wOtVbsZtlKNA8jSGMq+cYPGaVym8BmCN02nvUzt5k4QDBHBFV5RHkytkoDn6VNil5iLFgHO0EnPBqNwSudo+U9DRfytDEJYVb0IxSW0plhjlPyOeoqLq9iknbmFWLEu7q3pmh3UhsnjpUxijExkAO9h270wOjqyxneUOGH90/wCTTsLciADrzwfWqN9fx24Afd19K0AGRuo2YyAazNRtml3FRnNRNtL3TSko83vDoJIpY8xDjODx0qZoVXcWPTnPYVDpdo1rDsYct3PpVkgKF6kdKIarUU0k9CisOyd2ViY2HANDqeN+A46YNX3XI3K3AHPFVpSxcZQgHjNJqwk7mTqJZIXMfIGc+tZWj6jJPO0EiY2810jQL82M++fSoreyigcvHHgsefUVk4Sck7nRGpBQcWtSoVYE8ZOc05QxJbGPQetXZIRGzYHzeppqxdW43Y5ArTlOdyKLRAgD7ueSaryRKCGAyR0PrV1iAW3gjbzn1qHKyxhlGVPpUvUdjOmjbGQTnr/9ahYAAWZCGPpzmrLRhNxfIbPApGBJAOQCO5qStyqQNpI4+tVZEKwkLg5xgHtWk0QwRkAHjGetR+QpG3HzAc1NugtDGDF/M8xWBHTNRMDtXYqsSe5xgVNrDS28DlNvA49646XU7y1nheVgyucFcdKyc1HRm8aLmro6gxRbjgjd0pDaK6Epxml8hZ4A0a7iwySKlgttq4kUjjB5q0YSVjumyUC7dx6ZqNgyKyqMkcVPEy7AxyBjvUgjBfdjI7Gt9xLQqsjMgCnOO/vTzE4RdpyRxz3qfYm/AI+Xkk0bdrDBJH1osO7I4zhsBfmxg+lThGwu7jH8qEUZ4UH8elTlBjEmMVUUJldk3ocgkYxjGM1JHGCMDPAwF7CnMhLKckAc465qYRKVypxzTSFcrpEI87c8n0qymVPA+XHekhyoAY7snjtinxogwM43eveml2B+YxVYkYPynvmnLGUVsAkg5GO9Odoo1bPygcmiLa8qyqW6cDPH1pgVZ0lWMzRIfNHbNWLZnMIkm4bGWFPvZ/skRmOW5HA7VnW+vW09wsQwpboT61LlGLs2aRhOcbpbGuhAUEZO49BU0cYVh1wxPGabGMJleAfT1p6qBNndx+XNaowY+MBQxznuc9qjuJAiNgDaB0pDGu87s7eoApzxRxqzsAM9ec0xKxy2rzzS3BS3cjb8x9qZpWoT212ILhgyg/e9vWrt3p0u8zWLZLr6UlhoshlaWVt79AG4rj5Z810elzU+Sz2/E6SFhNHlZNyMAAR2qVFAwpLEqMEkcUkMaxwrGFA6HPSpAwWTaSNpGK7rdzym9dCAF0KuMFieT6Urpu2oynAOfrSX8Uj2jLBgOPQ0y33rDiTcZQACPrR1sV05hkiBrhEZNy8nOeBT0bYuWA3EEAe1TZBK4IAHGKgkh3JnqcnGONtT5oad9GK6YVUiUKCdxWhM+buZmwvAUU/Zlyx6hQoJqTADbQQe5Jp2JuQqBKoZSN+eeOAKcVDcA4I6ccE1BEqozIgZBk5JqXzEBYbseWPm9KVxtEdxD5km1Tx6ZyKa8YZP3ajjjkYBFW1G5AynAPJpGj3ocjCn1oaEpFYLsYYzg56dvaoWiSNJGVAATyR1JqzKpZAsRG7jkjioZY0cqenGGA70mi0yMRExrtw3YjPNQucyeUxGOpGORViUOFCwHBBAPuKcQpZiwBOPvdKloL2INoIwxJINLIBsIBHr0pEuIy3ytkd/anSFAC2DkjoDT0sGpSc7gjJhl3YJBpl9MkK5dsfWrKFF3Ko2gHgjpmsvXraW4UNGCWx+dZTbUW1ua04qU0nsSQzRyKQCQ31p1sNoIYncO5FYej291DOzXBZUAwc/pW902sScN1NTTm5q7RdaHI7J6DJ1OQSQQeCM0eWQRkAY6+pFTTgbAM49x61Csm5duRntV6JmNm0QTpG3zMPw/wAarxxx4Vc4PUAVduBtj5OAeme1Z83lNcANhZB93B5NRLfQtJj8K0hjxk0x4RuIxhsVIBvl5DAr3Pc0mSWcEfMDjNILPoVGj5yfmA6Y7Ux49ozyA3bNXEJYkN25+tKyhx0+UDg9aErhdmPd2azxlGGVPTNYjeGYZLpZ2ycDGDzXVTqxyFGM9c1CqGNQDz6gCocIt6mkKs4R91lK2hWOMxMmzHAPrUEkBLuP4MZyTzWsFy2G4J6fSoZIQSMgH6U2jK+pvhSgbeSVz6VaiRyOe4xTIikzlwcjoB1BqyM/Nx061qkEm9iu0eGzjI9aUqXyPmGTwancggAL8x98UgARQPvDv7U7CuxIYgF4H09qlaM/eLZAHamBh7Y9vSnbd3HVD3zTS0Fq3cb5eXDCpHLLgLz68cU9UUIdpPpinjH8fA7560WE3cqhGacEHA7ilkaRZU2gue/sKsghxnjb9OaekQROB7/NRYrmIXCyHY44PY1IsWw4VDjHTtSuMSgHBP8AD7USbllTrxxg96dhXKup2/2i0baT0PIrn9P0iRbuPcoVEbdv7112Rubn5awNb8TWWl3K28qlpDy3GAM1lVjC6nPQ6KNWdnCCudEirHGqE8HgHvUixRpGc8IOhJ61StryC7gjnU5x90ntmrELo8RVvmWt010OVxfUgvrxIIfMDdeAAOtYC6tcSiSTZlY+WGeo9hWrrcBeyPkgkDpWPBJAq4mVwyLtBxgsT1rnquXNa530IR5LpXZoWGqCRxhD5YxwT3NbsI2kysQM8eormdM09nI8tFEO4hTXWWduRGqSkMV9a1oOT3OfFKEX7o9IuScnnke1JD8jCMv83JyV608yFgQfkJGMClRSzDY2SnBJHWuheRx+o1dhjJUlgW5571G/3ZBnr3p0uwAQsCFl6bRQ6AqyYIwMA56UnsNdytaIIJhGuXB+Zm96sgZDsBjnv0IpVhVIkCHPTBPPFIp3sFDAoQRQlbQG76kZXcNr/dZsnmpJQQRsAIJ5z6U9CGKuDnt9TTQoCBZGGSeKBXIkLyRyK6bBnAIoEYRwpBZSOSelSSnC4AyOmAaST5Y8qwAHWlYdxsZywDfLgcD0pNmYnDEkN1pVAZiwbORxWTrN5PbRFUQqec85zUykoxuy4R55cqNAYCgRtiPrk0ojU528g/ez6+1Q2DGe2jDLlSMsKtZAzkfKOnNC1V0J6OzK6FGUDGSScnHpVDVFleFvKYjPQnsK1GJMQwmPYVBLHIyjZwD1FKcbqxdOVpXOMu4mhaORmdJMZypIz7kV09hmSCJ2GSV+lQnRlmlYSOck5NaMFuINqrkBeM1hRpyi22dFerGcUluROmX+Rec8g0kwZchFOf6VYcRxsWY4H1prqNhYfNnvXRY5LlUhSQp78ZxTXjIjAQAHPTsKm25yQeT0z1pMu0q7SCD+lS13Kv2KbRbVO3JPXr0NU0RY5SPvFjzWpPgKzAZbqQBUZVMAlWBbjpzUSjfYtSsUnicwlUYFwf4hxXKapa3yamjw7t+c5HQCu3JxIARwBkUx1Uu28HcOhrOpSU1a5rRrezu7GdblyMSKMYFPQbyd6gYPGOeKmAjVmUlt3cntmjY+PlZQB3qkrIh6kTRAE7ARkc5pFAUYCjaRip2TaehbimGNAC+eSfXpVEFJwo5wWxxg1AFJJxggcdOlXWUMxyeP0NRbVViFB55zioaK3KkytHt2Luz3znFQsj7mJPOOMVoSpleh46EVVEY3F1znpx0qWgQnhgTx4V95UAjDdq6KOYefsYfNj8KkggRchUKke3WntbLKSQpU4ABHWqhTcFZM0q1Yzk3aw0gltynIBGRUOpEx2hdQAe4q4sahefzJqtqKB7VvMPC89etXLZkQ1kjk0vbj7QGRpNpYjGOK6hZ4/IjErqhcDj/CuVtrqL7WpALKrYDBeM10D6d9tljmJ4UdPSuWi3Z21O3ERjdX0NSVA6YUnJHGKkVTtIfLfh1otYykYGDj1NS7CZAcgDpiuxLqee+wy1RRlVB565NWioA44B4z6VHkDJzg1LuBTA+bHXIqo7EN31AKoYgA8cVVWOdrsksDABx61bjjABzuB6YzTwrIfmOQelDVwUrbFYLgBsZA6n0NeI/EMXN/4lnMJcRKdoT6d694LDyyAAAex4rjdT0G0l1R5pUDMfmI6f8A6658VSc4pI7cDUjGTcl0MjwfczroYju2OWb5CT/DjrW7FJcJ57h9oQBlx0Ye1RGMErHCqoYxkbfSrH2dnh8swHg5zu/SsYp2t2OiXLe/c3tPmW5tgxIORz9KV7CB5VZVU4Oai0q2MFuQMeYea1DiErIw4xiu6K5ormPNnLlk+QrlRErOqEbOgFZaaqzXRDJ1445reKMZRhfkKnJP+FUG02J7hpgu05zyO9KcZO3KFOcNectwfvYlLMxOc5HFWd20hFAKEcnNRW6rHEY0BBUkn3qGWZIgJfN2rt5WttlcxtzOyLMyqUXDYOMA4qHYXURMSXYckcVBY6hFcPtiPCdj3qaRnjjYuc5OR6gUrp6oOWUfdZIzBUcphnRdoHXNGwuIyflPt2pF+VlOOW6k+lKyMwHz4AbP4UxbCKfM3oycK350gwDuKkNk9e9S71Bx0H6moJjuKkIflOM57UMNxs0W/eyOwJ6e1NUPGx80gp1x1zUhXdk5I2dDS7Eyp3fe+Y5pWGmMkZmCeSAFPTtxVe7jWXdwGkU9xwKshTgMy+WAc9c8UxWLtKAgWPoCe9JocXZ6DIoxBgJnnt2zU7QgICeMc8U2MIyjvjpUzbAQvOfQ9qaWgm9SHncFxlGHBP60YHBzkdKCFA+Vt/PHtTAFDtk9QOPSkFhpIdT5ZGRwSPrUmQQOmD7VE5XYxT5SevHWoYxJtLINpBxtPNJsrluSSJg7sjHdfUVj6xqa2UPyruc9FFaxCs7SYG7jOaytWsFun3qzK3sKzq83L7u5tR5eZKZV0vVzcXDRSKUdB0/nWsCJMnaA3tWXpukNFdGaVssy4IFbAUAYIHsSailzcvvFV+Tm9waO2VJ7fSmMCUG3rngCpWzhSWKgHJzTWTGdoAycnJrQxKd1C8uNp2MpzTiGZSOrfqankGMZOWx1FImzd1Lc/gaVtSrtogMJRchBk9u+aijRnjKOQGA5I4q2yCUKQzAKeRTVjbfhsHJ7GlYVyu+QOhfHSoo9rJnBVs9DxVuSMKrADODwMY5qNVD7WVdrAYINLqNbFTI2NwvHao5ACh25HtU8qEHbHjk4PtT2iKgED24NKzY9CmcDg4zUTLjlR171bmUIUznJOOlJtAJB64+lFhPTY3do27jksevPAp2CMgjOe/XFAj2uBycYqTaN2SOT6VtYjciRMnHf171WvLYTxSKCfmBXgVoIuF5BB7Gk2kjJVSD6UnFNWHGVnc46HQpxhNxWInJx3rpoIPJhESg/7xrQWPIJOB7CgjBIIx64qadFQ2NKuIlU0ZXCZO1ske1Pk4ICDnuTUwVQQRz6nPSk2jnpzz7YrRoxuVkUgjzTyeMCpUbLjcuMelOEe0MzEE/y9qwda1KeJAYEIPYkdazlNU1dmkIOq7I3ElRiFDD5eopbqYRRlmVn9hXIaJqN1NqEayHcrHkV2SAJtA5B9e1FKr7RXRVaj7GVmQuSYfOIYH0rl7qWS41CMghQrfLn+L2NdbOx3bfx5rmpbWW2LeUhKsSSfrUVk3bsa4ZpX7lPU5zbzwlYdu7qxODn0+ldBosjTWxaRcHtXM/Z7qbyo7rAVX+Vz1rr9JtBFCF+8BUULynfoa4rljTt1LFrB5cryHliatArh0KhmHOP5U11dVURths9/SpfdcFxwea7UraHmSd9QZZGCMvyY6jNNDs6sQh+Ukc01pBG5JYhcYA7UitIHJLARYBxRcSQy6neG3LqBuOATnp715zq+qv9u8uOXejMcgc45ru9XXz9Pk8kA7gcdq4fS9BnuLx5JVZADxnmuHFc8moxPUwKpxjKczotDiOwXO454Xae3tW+smIozKB5jHGByM1Ts7X7HFFGgLDuT1og+0byzY3FuF7AV0U1yKxy1Ze0bkXnfYwZiBk4H1pRjZsY8kc57iqjnzHKMuVQ569TVshl2gDLHgj0rRamDjYeVVBnA4HAqGaUgKNpLEdh0pXch3LDPy5wTUicklyMnn6CnuTtuAVgEHVj14xmmSOI3IKsSw6j+GgldxJzlzgf/qpzt+7bcvyngH2oH1GblZQMfIBkkmpkYNGpVMA4GfWo/KiACycK3AWpJJAkQ8tTjOOO1P1Fo9EMIyCvAB7jvWLrF3JbGJVKqzHGTxzUtjqIubloNjK2flPtmo9b077YuWc//XrCo3KF4HVSgqdS1QxYLm8SaUTORHGcs3b8Ksyawfs7PEpcj07e9UItNu4w0c0n7s5woP8AOmlkt45EPyN0PuK5FKS30O9whLZXJrDXxNOwnJySMV0tvL5yq2cA15lNI0l+yQLkbvvYwK7/AEtwLZMg5UDPpV4apJtpmeLoRilKKNIfMjIiqG7VFEHMKmToPfrUZvoomJZlwP5UlrI9xJI25GiI+UDtXSpJuyOHkaWpPn5gUXtjk9qRUEjCPlvfpipH4UkfKR0wahw5hw5/eDHSnYnQWWNTFu7jimqNxGR2zzTzllG4AAc9eKRYxkEgBB0xTFe2jCSLOAG5OM1AI9hCgKMdcVPsbPOcE9u1MIVZcqSwJwaTGhANwPU8YPvTAckgcHpkinqhySvA9MdaZKr44XPP5UhIjw4YjOBnvzShVzzyfUdqcCApCgZ6nNKULEYBHqRRYdypgM+cFcn17Uqg7SQMgc8UoGMqMn09RUqjax64PXikhy2IJAcDgHvg1WkVTjPJ7VdPzRkcEAdcVWiRQMMcnpjH60nuJbGwDz8rgqOKmhBVg+QR71TtLZrfcJiSCck9qtKypwAWPX3q4vuEl0RLIGJyhIHcEdTTICWDKwwM4Ge1Ir5wQv1z1qaNcl/lI59e9V1JeiEJZQSDk0i5YbdwBxxx0pSw3yDbgDqe2TTE2luuaOohwHGDwetNWTlQ5564pxGBkHrg9elRNGnnK7feHT0oKVibByMAY6E+lV57RLjDSpnAPy9qsA4Y/NweabGmwMCxPP40NJ6MSbWqIrHTIbYBo0GR/EatRoTgkdDwKeoVkwj8/XqaUZzzkj1pqKirIUpuT1B2Cvlx8x4x6VFOyY5AC+lRXas0qmNj8o5HtVfVEP2WQxcShePWlKTsyoRTa1My71Kx+1JHIQxUk5FdDZussMe0gA52mvKyiiWQncZS2Mc5zXoGgpMLeH5xtUfNXLhqznN3O/F4aNOCszWurgQYd+3FPXb5fmRjO79aQLHJGVkbcOc5qaNShboV/hFdqWtzzHaxEoBCxlflA3ZFMeRgQvAyO9SyN+7LMCCM8CoZAPOQ84PGMUmOL7lD7Vm9a3MTbFGQeetWEieN3bClW6Adqbc3MVvKvmMNx49MVMZg9uSrcEZyKhdmzWV7aLQZczAFWLBQoycelUIdUhmnMAJB9+/vU17GZreRI2OSvWuY03TLw6khmzsRs5rOpOcZJRWhvRpU5Qk5PVHYKGE+4bRHj8/elZ5GXKfMzNgn2rPuo2a9h2MdicFRV2P5kLjlweAeBWid9DCSS1HkK0ufvE4BAP6U/GGySDu7YpjNiT7uFA+b1poc7FGzg8decVV7EWuTAsrHgdcDHQChjuRgrHA6ZH9KaEBwFJG3360/a7ZAIVc/pTFohqOQeASAPvGlkYiNiSoY9uwFIXCqSfuD0FUtVvFtoC2OevNQ2oq7ZUIucrJDoYIIrkm3QCVuWbpVt0Ro0WQkknOa53RtW+1XrLwFBwO3PrXQRyFVbzPvfzqacoyV0aVoShKz3GPGAS2Pn7Y9MVhXelC9bzW69wfWtTULgwwPKu7jj6Cquj3EtwsgbkA9aiajKSgzSm5wi5pmVZ6KUv083BVf1Fa06GKyYQAbRnA6VoNGfMQkBR0J96aR5oljVF29DRGkoppBLESnJORwLzq9xK10Ty3GCQD+FXfCt7KzMjc9cA+nvV3UfDwaTMOOuce9XdO0tLNlYrkY6gVy06VSM7ndWr0pU9DVtyTjfg+9Ol+VSefenRcLuXpjGMUoIYYK5OPwr0Oh5LepGfnCjaMEYNIY8dSwUHkVIrIVBBC7fXioid0bBmyfWkCB13YIOzt14NVwjC5JGCu3oPrTyfLCI7FuRyamRlGGA4Y4BNTa5SdiLflHYK3HJx60jbmXgHnnPXNL5hAPAyeoHepEUDIY8H2p+Qm7alVy6MPkyenXgCnxDtntVnYAeQc4z9aijjEPRgOc80WaYc10RMFXlu3em/fB4DZ6GpJdsy7HA5/CmwxkYXGVXr7VNtQvoRGIjI28dhUEisCTt4OOauyBs8D6c1VlKEgMSpXse1DBGy0ZYMN5ye5pvl4B+Y9cg1NuPJIBA6npTd4fO3Aya10JVxgwqhh8x9qdE29Mggc09VUDPTPahUUAYAJ9+KEhXuMn3DC7dwbk5piI6McfMmOmalkkTfsyN45xUSyrGwGcsf1pPuNX2JNpxyOnWmueT0OD+VPUqQScDI4zUJZmYADCZ5HemwQqgpGZHyT060v3uh+8MZ6UYYuMdP5U98Z2j5mB6jtSC5T06yFnDIpk3OW3ZJ9atI4Jbc5UH1pzHGc42jgmoJ7y3hQGT5snIpaQRfvTfdl8IASQCe/HrTJ1EkeHAB7Y9aitrlZl+ViV9KmEiEli3Qdq0umtDKzT1MttDtxJ5pjBk7GrcSpGTAqkdzjjNWs+hPI6CmrtyMfMx5+lQoJaot1JS+J3HM+1kQqfmGMjt9akZkJC7juWmrhS245OMgA1EWKoW2fNjpnrVp2M7XJ7iVQOCRu4H1qAGUMquNw6k04APsLjkHIFKXw5RuCehobuFrKxzPiGykkZGj2bQSDuOOSetTacy21osUsmdgO5jWteRgoAFLZ7GsTXIXS3eRSQuACo/rXLOHs5OaO6nP2kVTkJeawUEf2aFnDsFIHatlcFYg52HGcetcv4dkUu5Ucg5x7d66eQKyiQAFhnAFOjJyXMTiIKD5EiNsGdd4285Uev1qWEuUyy8qxCgd6jMsi3AXAwe/pVj70flIxyRnP92tUYMYi8OHyy9WPrRbs4wHCA/wAhQh2gxeYSygbjjnFMjDOCxBwD+dPqIsRkMp5xu464pyFQdgJA7ZqHcDIikHPXHb86kfzOiMA2OeOlNMTQ4LkqpI+Xg471keJ4t9i3ljLdB69a1HVWVWJZVU53DvUXko0zMWLg4PPSpnHmVi6UuWSl2OI0Gzmj1EPImxD8rDHJrvlJEZwuTjjPUGoYIdrsX2dflCirEe9gxkwgzx64qKNL2asaYmv7aVyKSIzRnzcAcZ+lMjVIyqRL8o5OKnf50YAZBP4cUqpuBKgBdvXrWttTC+gh4wBzngk9KjZgsoQLjAyRjgipg2Ih19cYqOVm2+Yg+c46+lDEhjRgqwU4bp9KRo13BSQQDg4NO3ErlevcGo7mWO1jZm9s0npqVq3ZEm+MR5O0YNMSWNt3llc98Gse+v8AzbSR4kPqMCsvRrtzcMiE/OOTj7p96wlXtJI3jhm4OT3OtZc7gwBU9qghjkWVlJHlYyOelOhfaqq/zMeoqZ9sfJXJPXH6Vto9TDVaCMAOX6A8cdK5HWtYa3uAFLNF0x05rrJTujYjIJXA7g1594msZklJJBBJ46Vz4mTjG8TswUIylaZa03xJG90I5wwLHapJrr4ZFKK4BbPT3rym2RnlQj5MMMLjp7/WvTtHH+hRcj5h61nhakp3TNcdRjTs0W0lBYBgV3D16fjR8wBLYJ9qm24b5eQO1NlXc+ADnpXZY80rb9/QfUGnow7ZBxUu1cjaAp7HsacVwMcEmhIGzNuJmjZgFOR6981yV29wt7uRpN+77pNdzLEcgEcd++KpT28Ttu+UkjrjmsalNy6nTRqqHQ3wgCcDntUTIqnAHPfFCtuVT1XpSFvfkHpiulnJqImSfmJxnPHanOdoJ6HNI7Atxxxxihm3knv6daEHUjVFEzuF/eMOTTI9rTb2Xay9DUoA4PU/zpGjKuxUfMRg1JQOGDYznPFJHlWbJ4HWgrl9ucdximEERgMwY9flFAyUAMcq2B7dKFbZjagOe9UJI5vtSeWAIyCW96uBeg5HcZpKVxuNrEV2/lQSNIVyOcVyF3eS3DKy48sNsI9/XFdHrSGe1KITuH3j1rjlFwokgWIMxbIbpjFceIk726Ho4KC5ebqdZoUoFuVDcqSrA9jVsarDC5VznuDxgiudSKfTdLy+SWJY5POT71Hbxp+9afDRlQQSe57U1VlFKKQpUISbm3odNZakJyVEm4seARjFaEcvySK4IweDjrXBaHPs1Eqd2VY9+1d5AMoCoz9a3oVXNXZhi6KpSsiccLwOfXvilUbhuVhjHGO9RM7LKqhQSRy3tT1YMuVYbV9K3ucbTDcydgxPJJNM8sSjax5B3c04szOoH3AOe+fwqPbmQsGwMdOxpMEiQHOSSWHYDtWT4gYrYEfdBOSa0fn852BJBGAtRXwWW1YOodfTr+lTUXNFo0pPlmmzzoXXltutjhtuWCjr7V1/h+9+12qSZ+6uCv8AnvVWTw7BNMC6ngdFGMfWtfTbWGzgCRIiqK5aFKcJa7Hdia1OcbR3LcTb1zjGR3FIpG7y42Hy8FvSsrXJ7mGHNqrkn+6MkCrWlGY2kTTr+9K7mroU7y5TjdO0Oe5dYYfruJ68U2OPBQZye4qRT8rhxk4znOKjjOd7E4UDoOpqzO+hKVOzGQSTwR9alYlFJOB2HvUUse4IdwAAztzT0dGVQMgHrmqJYjxjy8ckDnn+VZFubr7YwdeM8dh1rcGWGAcL1z1zTShVmcOvHrSlC9io1OVNCBMKoXoeSakcgFSozzzmkUxhgcksfQ04uwIULjj2qjMqyyM8+1R8gGSfepoGIB3DII4FOKlhhQDxgmooohE0hMpJLcD+79KWqZTs1YLkt5bKhCvjAzUNukqKomId1XqOnSnTNgjduKr1IpqS72OOhGPrUt63K6WQqsWUkglvWueuNTaS9+zzIGQnbnuK6OMIuUQ/d7DmqzWkbTicRLnH05qKkZStZmlKcY35kNjjjVUUqFDHAUDilitUDjCqM5yRU6IoGCpyfxxTlXBO04+vrV2RDkyEIQ+HYsR0NPG5BjOTnv3pQTuxgZ71G7uzBucjpnpQ7IWrJJAFXgAHFUry1W5iKOvynvVlpPMDIQdp4BHehTtB35Pbik0mNNx1RgRaFb28jOoCg9citq1RAF2MGTHHuKnK5wpCn0pFRYlKhflUYGKmNNR2KqVZTXvMeo2McfKT3601n455A9ulJK+FBXGPQ00FiueACOlXcyHKBuBABUd6f8oAw2enPpUS8EnjA9aVjmPKDlu/pTQDZScsCw6cA1RZ23OMKqhsDnO4Y6+1VZ5hbarPNdQzSK6qsUkaFwBjlcDpzzXNanb30IaS2jmit2ctBCeqDjrnoDzxWVVuMbo1ox9pLlvY9HD4AHfHSkcZJOcD6ciq5Xa4O4ntjpTnddwzk89u1aXM7dh5bPOMCkcjgsANx4ApnLZOcKeKr3dv57Id/CHIA6Gk2+hSiupckJBqMyncoUnJOBUmWKsDnI4x61G3ysATlu4oYkSSPlAADnGPwpAVyRg4wMVG8gdsYCg/oKQOA2BnkfhS6jsLc3CWsLtITx0AHNNt7tJ4xtdd3p/9eud8TXbxkDblcE4J61X8PTyKUbBAbque3rWDrNT5Trjhb0uc6pgXkYEAAdR3zUbWiHDKAp9cCrKbRFubk4yaj85ARGGwx6Zrey6nMpPZFW+txeW/lhuAOR61y2oxSi3MMCncuQxXkH613KRqVIYbj3FVorVRLIfLHPG7uayqUec3o4j2focl4U0ycXHmyZ5HLNXdRLlQg4JH0pohEKAw4yODx1qeJfm3lQWHc1pRpKmrGWIxDry5hrMuWQcsOvFRuVI8rjJGTjinyOCGVGCnPOO1IpBcDGTjrWhiiZGGAVbC4xjFR+WTIzt93HQCnrkNnHAFHQtsweM1RNxrMB+8fjPFMcjaoVAVHJzTptnylzll5x2FVUu0mRirZULgEf0qW7blJNq6GyMx3hMAquAvqTQCyorOg4HzEdKb5ixAgAk8Ee/tTywf5WHy9cVCLfoLt83gnCHnA9KUfuxg5JbkY/lSBwp4yewFOjIOMud+OuOlUiWNkYuTwEjUHcCO1NjmDz7EZen3c0l2SsMggDMQvGK5lZ0F4jW7ESFlBBzketYzqcjN6VLnTOxQcAHk8kn2oTbK+UH7te9RDKsincVPLGpySkIwCPQetbrU5noOX7odzzyMU1QCzbh8hPAHHFEe5nJ24XsMUTRjehZiCPm46UwW49eG+VMACjcjNgjkelBZgScZwOxqGLcFOxvnZs5btRcLdR67EuPKTPA3e1ORAJS0YO7ufSlkC7SQMuB0pkbMQC7YI5IoF5inIJDHcD2x+tM8pW/1ajjvT5C+35RzTXbbgjJzwfekNAcKpPQ1VNygCsScFtoyKslgVDEHkevaq5GUJ2DGc4x0pN9iopdSOSU/aQQw55I71OpA3YJBPP0rAu9WSG4GFJUNhj3H0q7YXsd0pkVskdayjVi3a5rOjKMVJo0l3rGS4O4c8HrTDJhjkHnjHpS4clCp+UZyDTJCJHIB4HGOma1bMUkDuPLJCexAHNKdsfIyBjPTpSZJypyMc1BdFypUY+6ealuyuUldkX9oQ+ftB57npVtHYuPKwVB5rz26lnjvWUEhy3DHpXWaPOWhQY2kjnJ+9XPSrOTszrr4bkipI25AG6ngdqaGJVM5KgYA9KEySCGwxoGWJxjA46V1HCDsjMM8gcEZqOQtkCMgLjp1xTirZyduR14qvMGdGSJ9jkHD4zilcaMO7lgGsXMd9fzQBQuxI5CoxjnOO9XdO+yvAxtbhrmPdyzuXOePWmiy1AnL6knOOtupNWLeKS3ib7VOszZyGCBOPoKG9AjuXJ97/c+8f8KiXfGyBmxjg571YWQluFwuOKjCA/MwGfSk11RadtCf5igHXP5mmxsG3ct1wOKaXUDkZNOhfOOvTv2qkT0JCcnAyT6+9RSv5eSR06c9KldgCckkDgY/lVe4XzI2UrwRjPc0m9Bx31OW1LVZZJnNqP3a8U/TNUeaJnkLEKTwOmagv9EuTMy2zqA3UkdKuwWIs7FIEUFxyx9feuBc/M2z1G6XIkjE1K7lubtldwFTkE8g+2KraRqUkN3HGxzlyCCO3rUWpxxM21s+du3AjOQOlS6FpEt1deYWk2dNzdTWCcnLTc7LQjT12PRrQuVJJG0gYyKQjM4LAMo7k4qOIIoWJm5xj8KsyKAqqAPL75r1FqjwXoyb5VJUDjHJHU0D5HG1CUIyTn+lRLG3nblkO3ptzwKsoCDktnHbFWiHZEcp82NlMhUN6DpTsqE4kIx3zTjuGSCGBPQ8VRzN9qdXjO04yccfhQ2kOKuXdgAIyASeD60qBkY7QDHjimb8YZvlwMDApYp4pgVglUuh+bB609CbMlRiq7eeeMjr9aYW25jVsso59aTYS3ykcnOakZ1yy/KSOP8A9dPcnYpXEx+zsTGW3EYAPWqcNmsU8k7sxDDhCOAPStJowxByAKrXG5OjgZ4BIyRWbXVm0ZfZQzO1mYY659gKerqclGAXOKZcQu0LhThm5AqDTLU28C+Ydzk88VKbvaw7LlvcmdUSR5dpLjjPbFMsbhnlIf75OT3wBVoDI2j5U9xTAiqxdBgCnZhzJqzJFUGQ+rdT6U0WsKHzDs3dRnqTU0e8qx4GT6dKayhmLSJ90/Kepq7EXae5YOegAUBf1pwOGCk7mXj60zC4IYkgcnIpoIkbcuVJHp0qrkJE/RdwYZOSKjxIyKwGc8kGmOdygRleOpHemzu20BScE9qTfUEiRQRuDMSQePao0h8vJEm5ic/N2qZFwpIOSeWxSknvwuOvenYL2FMnlgLgb2PcUSKcZd8H2piEEAKrEetOwwZhQKxDJcASCIMu8nNKzHzCGQ4A4NRS2qvOJyo8xelSAMyZbOalX6lvl6DXOCSWznoOlQXAyvBYDrU0qksBt5z1pwUFcDA9QaTVwTscVrsMwlbK/I3IcDpSeG4p2uGkHyRj14zXWTwxyqUMeU9KWKCKJUKptXtXMsP7/Nc7Hi/3fI0Sxvx84xxx70z7p3EgnuRUvykc5GOMVBhTIcDPqK6ji3EkyFJQDdk8E1WtZpZ94mQRtnuOtWWyeiqCTwBShR1zgg96nqXzJKxh69axrZvII1L5z0rJ0y+Md2qnJiPr/DXXXSLIpRsYIxjFYsGhxwXZeNmOTnBFc1WnLnTiddGtHkcZm/EwMakj6ZqVCvzHgkVW2lU27grD2pVG1P7uT1BzXUmcLRYlPyngZ7c1W3DdtDc+1PY/JkkNnjIqMgNng8cnNN3EmkQt5iyMxcbB3NQJLM0j+YkXlZwjK2SR9OlZuqW09xdTQmORkn8tPNDfIkY+8D7/AONT6XCYYp/LiMMLSlooW6qMAfhk5NQ1YpSubIfDlVU8e3FNyXJO7jsfWhWLBivA9ahiOWZN3T0pFLUmV93QcDpmlDEN8gzjqTUTEqm1MZxnce1IjEqgkbc3c9Kd2Fi2G243kAdgKhaVBJsJJY9BilV8tjPGePUVF9nT7QZRnfjGc9KG30CNluTBiAOi89elJIgflhwQaY37whSOM9Ce1TFkRNxbGB+VPfcNtihb6ZCpL43sTn5u1Wliii+RAqtnJIHSgTwyQlkbOOWI4FYOpanI7SNafdjHzsDjmspSjBaG8YTquzZ0caoSCByOM+tSbQJwSoOTj6Vxeja1MbxUkYvk4PrXYoztgKBuz9406VWNRaCrUJUZWZKzKmPm2nPUjNSjb5m9gSxGBTUIDgPgL3z3+lJNu5KvtUc5rbzOa3QeEUyMcnPXGaEYMv3vlzxioY2wpYYZT3Azn1qyrgINoyM9T2pp3BqxFufbhx16cY/WoLO2hgDGFQu4ZY5q0GUdMtuOODkU2Rd+AjBccn3pNDUmtAeQRoCOEHApFIUnaOuBk0gVzkyYCjpg0gfBUvzk4AAzigB1xIEDYyXx1Udq5u7TUf7ViKjcuckk8Ad66OQ7cA5PGSR2phZduSvB68c1M4c/UulU9n0uIrFlBDby3btSO8gBVVG8dPSlkUoSyjanoO9RtJGhOGI3cHJ5zTuTa48ZR1JYBiMAelSsMZJG7JwPWoFbc2Rzz+NV767lgGQpLAEluwpOSSuylBydi8zhWI2560sEhcDBBAOG4rnNI1OW6unhkbJPzZA5966JQo3gnc3BKg9KmnNVFzIdWn7N8rJS/wA+0jAPNRMsjbWQk8jvxSzYLqVYbc4xngUPdJDbNI3Cj8K073ISfQQhweSFUHIxTkYMdqoBzyTWfaXsd5MAp5B4571onKoxbjb/ABUotS1Q5xcdGO3KGbZznv6UMzIFHDD1piZZeFzkdaYG2XCKUyx6H0p3JsSuVGSzfKewp7EFDhm24z70wsWPCD39qXJGQcEDnPanclikdCGxjikkYCL5zk+tIXXI+Ue2DTGIViUwe5zQNIWPagHX5uee9BYcfLzjqaieVl3F1wnUEmsy41aGJwnmAKMHPtUOajuaRpSnsjXGMZTo3XNNdlV0UDqeMVUhn+0RFocbM8A96sO20LgEsecDtT5r7EONnZjpGIyRzu7gUxTgkxnBHenYKclt1Q3EmzO0Zz1FD03Euw5iflCkHucVGWOct9wdxTWKL5fVSfQ05sHO3r+VIq45ZFUjJDc+maY8hHG7Yx7gUpHAYDPseKaUB5A2+1FhXFDZJXktjnmhphHjqT0x6Ghs5OCOeg9KZ0XAA3e1K7QEiuecDIPODSiUL94DH86ifhc9++RVATI84LB1dcgZ9KbnYcY3MrW5FGomW6LLtkiMGSdu3PzfjV/SCzRTOgf7OZiYS+QduB0z2znFVnknm1K5jF81vHGqkJsUk5GSRntUFldXKzxhrwXEbztByoAI253DHp0NG6I2Z0ysEB5zjtVRpH81gqfKOhz1qwVGc55H60hwp3HjPrUPU2WhS1O8NpaM78HsDXOjxDeR/KwHGDyMcH0rV8R2z3VmNh+ZfxrkBb6lqUsds6MkKkLnbz9c1y1pT5rI9HC06coXlbzPR9OuPOhSQkHIzU6hUkZ1OCx6VT063+zW8cakEIO9XJNxAKOoOcn6V1q9tTz5W5nbYnYjAORj3qKa3E8WyUnaR1zQwDjoMrzjsafuDoAwOCOarfRme2qKrxrb2jxjIAONx/nXEahPHFHKqk7y3UDt6mu9nBlVdpC84IIzxWBf+Go55mcMcN1Gelc1aEpL3TuwtWEW/aM5vw7A8moiQNls5Jx1P9K9HjR2TYfugctmszTNNSyjCBgWH8W3mtWPn5VUnHBINVQpcisyMXWVWV1sVpRObqIIcoO2P61fVg6lJUPJ2nvTSMbcEqMYGBRESiNtUk56ZrdR5Tlk72JsKkflxDbt6YFVftEYBMsoCrwRnAqyJGEPz4XPXmuR8S3EuXit0ztPROc1NWfJG5ph6XtZ8p01vNbgBIXBxyMGp2ClTkkE89K850nULj+2Ujkz8nJx6V38UjuQWAx2B7VNGt7RbGmJwzotajjvBPJfPr0FQW0LWyOTK0m5sgnt7VV1C8eFeGGPTNXoGXyw2CFUZq003bsZSi4xv3HqpwQM+2fWgsVkVWPzd8dKC2U3Bjzzzxmog2xS0uMngAVT0M1qOZmZs8kdgOlV4kVDgqS7E8dakOSvHGe1ARt4IOF7ipeupa0JC4HITp0A/rTJwrJswDuPJPP4U52CqORz0BP61FFH5a7ss4LZBzQ9rCXcrWNhbWs8rwDD8E+1aMJdw52ge9A2chVAY8nn+dCE5IUHIH1ojFR0Q5Tc9WOliDlVQgYIY44qjrVrLeW5jjcpgZHHWrryheGDdMk01HVsFshjxinJKScWEJSg1JHPaBp9zBf7pwAi84Ga6Vpg0m0qeeh7Uu/C4PT0oVd+JAcg8YxUQpqCsh1arqvmYnmhSNhJHQimSq7yoV4XqeKGAJHIDA5wD0qSNwo+c5HYitLX3M/Qk2Fm3KykVG8ipC3cZ+op4dRnYVCk547VDdxiW2dE4UjHFD0V0C1dmYUmuMLkqWG3OK2LeVXZWUAoe4PNedXwuYrxoCrZDYLY/lXbeHjss4xISD7+1cdCrKUnGR6OKoQhBSiWtYZvsMgiPzhelecXcriUxuGBJwc9vpXp9yUlXY4HPArAuvDsTSGTknPAzTxNKVRpxJwdeFJNTKHhm5kDmCRtyFsKRXWq3ODjgdTWNo+nLaOwCbVJxhjWuNoK7iVxWlCLjGzMMVKM53iAZwATjce1NLEsdwJY85p07AOvHGeAaADj5csfWtzlMHVNXFrKF2AnPOelXbLUIryMtGWVh1GKqa7ov2t/NSQo6jBGKk0qxNjb7T87E5J9a5o+0U3fY65eydNW3NTJPDdaczg/MW9qjDAnZnBPrSjBTAXnp0/Wt7nLYdkMpORjtk1FlSSARgHIFJnY21snofpUZjKklX2knOMdaGNLuSiTOdxz2GKi8o7myg3HvUF7dx2cReTsePelgvPtMKyxMdrc8io5lexfI0r9DF1hnllmVrW0kigZELyqSct6Y7c1a0pXxItxFbpLbsY1Ea4CrgHA+vWo7/8Af3dykVn5rbFjlZpdmc8jj1HrVjTI2gt2EkXluWJOZPMLcdSat7Gavc1FO1AAM89MUuGJI7ehqOIkd/xJqcEsOoI9TSLIJWGDGoBI6g9BT0WPaAFGcflTW2hcsBjn8qYLiBx8jjfjoDU311Ls7aExIYH5dwBxinNvVhgfLnJB7ipYc/dLZ4qSQ/LlgAevFWlchu2gzllHUAdhTguGBZvpmh2B6dQO9ReYQOuAP1oEkSHlhwM+tIAQcnqOgAqDznaQeWoxzkqamhkdl5Xp3Pc0J3G42FiA5Zg2egzyasoTtIjGPeo9m05aQYxwPU05W3LxkCqSsSxXbDApyT/eFSs+1Rsxn+KqkolbmI4wRy1TRk7NvGfrwaaeomtBCCwOR8p6g1yXiEtZaktwp+Ugj6iuxVOThqz9UsVvlCnAK9GrKrTco6bm+HqqnPXY5HSXkvNSEmFAViV+XBx7120aBYlXPPUnFUdO0uGyUqgLk9asuZ/Owsf7rHX/AAqKMHTj725piKqqy93ZCyxRThXaMSbT8uAOKlYhmKfNtH4VDKrAxhG8uNeo9T6VIzEkDGV7k8Vsc76CjaBkjAHrUcyhpFdgWK9PShiWY7hkdqagb5iAMD1pO7QLTUWNUBZycsPb+VOEmXPPIPIJ6VBPMkcil5dgAOFHGaS1aP52UbmY9M5pKWtirO1yaUOVbcAWbp2ApVbcw+b5l688UwtneFK7u5PQU0t833VA7t60/MW5L5u2fHU4zuxRazq0zBcnb1PTNQoJBvb5Rn7tOHyNI4Hznj2pXYaWsRz6pF5ixqcsO3pUwuFZxtwRjg+9cXqkt1a382E/dyAfMRmrcCz3VoJPP2hidqjoOeOa51WbbVjteGgop3OticM42lWcjk1KuVTBPOPwrltNv7i3uTb3SsMnbuIroo5EIVg2SePrW1OopanLVouDsZus6q1mhSQAOSeR6VU0/Ws3ISUnL/yqh4zjkMnnoNyDAYZ5xWPY3E97fRiOIpsO0ZPOBXJOrJVLHoU6EJUr2PS4ir/MQePU0/ITKjj096q20ZMAEg2sAOc9TUwYmXBBJIyD1rvT0PKa1K9zZW8hBkAMh6H1p9rEsUexRj0NI6b5h5qYCfdbNPz8/DbuOMUlFXuNydrNj3ALA5yV4wRzSpxnI4PemFuhHJzzT2kVF3feb0qlYh3I2QKGLEkdcConQTRAZ2jOfmNTbsxjP3s9+KYu1iFcZHXJpNJjuBI3KmfmHIA6U4HadoGM9M9TTHbBzg8dKSMMyZbAPehAOlO0425XPAHWocqXCHPtUhXbk9V60whN24E7un0pMFoDRncCCRj9RQu5nwDkdKryeaJeoaOpVLDG0DHv3pIb2JCcMQASe2f8aixvOWABx1NSGXHQEcU0pnLtgAHtVWJKl0iNv3xq6nqPWnRqVUCNQqgYx6VOQrLhsBelRShvKYRuFfGASMgfhUW1uXzO1jnrowDV7j7ddTRgKvlGLIBGOc4HWr+ntCbV2tppZlDEFpCSQcdBkdKY8OqbyDfQHH/TD/69WLfzoo2W5kWd89UXbx6U2Jb7F0tuXpnHbPapE+7n/wCtVaNRkv17Y9asfeHPBqUWyK5j8+OSMNgsuA9Zul6TJa3hleXdgYC1sqQeFPTrkU8k8FByec4pOEW1JlxqyinFbMfG4DYzgn170skjbhyNue9RE5ZRnjPYVMVDLkEnHStLtmVktyMjg5Od1RuDsZHAxS8liAQCPWkuYnaFwr4BB4qWWtzlLrV7hJpBaI/kRdSo/XNbmg6kb6No5Mhl9BjNcq9neRSywrFMyyHLY6Gum8P6dLEnn3LkyngLnhR6VyUXNyPQxEacafQ6CKZJASBkLxk9qa+G53kH2pYlJIJyc0EBGQNgsecY5ru1seXpfQcoG4gsQMdPSkXaqjAO3OOadluPlyPT0qVgCF3HI7cVRLIwFQZx1qMspcEtjjAXNSNym0sCw/GkEZLBjt49e3sKTv0GvMYud5CjDdzjrQN5kYqRgCkc/N852gYzikc5yA2F7nFJsaQ58ykZA4GcmqN7fpbZySS3AA7VYUSNIZA2ExwB0qORIJSQ6qwjOcelTK7WhcOVPUfvLRoWOAeaVnABBB3VBLLtC7s4zyMdKeQMluNoHXoaLiaOU8RXJiuSbgkpsJBGcn2FXfC8k0mngzlk3HIHUgVfukhnYCURhh0GM1I0ggVVUZ3DJVR0+tc8YWm5NnXOtemoWLLb2UbB0PRhSOxIBXAbpyKjMm6IdhnOB1xVdZVTCQjOck55xW7ZzJXLodhGuMsc/MfSoY5D5xjBwSN2SafEcggHHYE9DULPELghXDS9Pak2EVuh9zaJIHyd+RjHXmuPnn1TR1eGGJDAxP3hmu0cvsONoOM1RvbcTRZkXd2K1lVhzax0ZvQq8uk9UcjbX04m3uS7BNpzk4Nd1pRMsKMwIIANZdvpMCHK4PONrckVtQq0SAcADjA9velQhKLvIrFVYTVoobe2yXKFHVTkd+cVn2ej29pKZN3ze1a5ZZMqeFx16c0yQMCGVxtxxxxWzgm+axzxqyiuW5KuQgPmEAH7vrSqxGQrhvU9warMJDjYB5Y7jqalt3EoPlkAHsRyKq92Q1oOLfPhsuG6AcUy7lNtFujQkgdKmZQDywD+opJBlRnp70WdhJpNFDT9QS6aTAOVOOaugfvC4HAGMEfrUK28cbnai5bqccVZCZQgnHpSinazHUcW7x2Ar8pDVHIXztwduPvCnBsjDHFRyH5gGOVx2PSqbISH4ySTwelMYkklPujsRSj5zgckUSAhCQceuO9FhdRhYkZXIHQUICVO4c96gVyXKZIxzkjip1J29cA96lO5bVkNXAx0JP8AnNRoJPMbOSPTFPYbcMG68cUITyCTTEJI7GPI4A5psVxuhLN29qkZTgjOfqagKsqkRg8np2pO6GrWAyAqNwwPXvUHmlo3MSqHwQC2cZqU+YVQdezcVDNGzwyIpIJGM1LbKSRiyanOrbXvNNU+hLD9KvafMZ4neSSGXDY3QEkdOlYH9hXMF1dSbI5WfZJGxI/hPK49629KWQRSt5XkRySFo48g7QQM9PfNEdVqgkkpWi9DStWBVThunGKtBS2BgEDk1QtZ9oAb7xqfeSRyMA9Kq+gNakokCsRypPTP86esjM2On41i63qyWZRcKZWPBHXFP0PUDeA4Xkd/eo9oubkNfYy5PaW0Nw4xkHPHHNSAkKMcAcbRVTY7OwZvkNSmQIr5OdtaGNug2W8hhnWI4EsucZGasIocfN90cEioQsU22QqN2PTpU0T8cZx05oXmDt0BQo4JUluQDSqjA5yNvp3odEPzbhux1NNhUKxLuG7Y7U9hXuWY/l5J+X86HyT/AHn9ahe4xMiIuXf24Aqb5iACeepxVJohpoAT8pbI56dKfM6nlc8dKrsVJYlvm4zzSRtJnGeOxHWhuw7X1JFbEQYqdx7d6VW2klh83YGo1djgbSKem5QSWyT364ouDGMx3fMwIpApyxf/AFfYClfClQ+evNNDiRSxbCtwB0xSY7jAxAAjIEeMDFQSBiG8sbmPPPSrJdQihenQcVCc5PRc9qTKTsNUHjcAW6ke9RXErMXQA7hznrk0Sbl3Ek5fge1Q+cgm2k4YDPNS9ikr6mcivDcPPdOSM/Kv8qtw3CTpuXBOecdhVfUYpZ7fbbSEMM1V0exaziCtJvkPLMemaxV4yslobtxlDmb1NOMnYQmQgOeepFSxA/NukBLHHPb2qiZJfM2AgjqzE/yq3Co53DI7etXF6mU0SyvsQA9R0wO9YqWl5/aSyvIoiLZwev0rZX96qsVKjvnk0D9420ICAePelOHMx06jpp26k+/KhehAxn0p5RFyzKS3TioURSxKoQepyKnaT5lzklvatU+5jtsNVVjJwpJ+vWnSltoJzx2z1pTyRg/Ooxx0pjSlVO4HngYpbFbjkdETJDHPGMVKHSNdxX7o7d6ggIZfMQknvu4NBTgmUEk8DHehNpA0mTB1z8hwvXFZN9qqw3YVCDt5O3j8K1fLCoVI4IwDXMazoNzNdCWzkxu5Kt0FZ1pTS902w8ablab0Ons7yK7iWRCSD69qdLKIgowWDH1zVHRLZrO2WN1G8DB960znjZj0/wDrVrBtxTe5hUUVJqOxCZSJ8HATsRTBc7ZgnzDdkgnpT7j92CWUEDpz0rGvtUBkC2ah3J2haiU+Xdl06bqbI2OCwyv+NLvLE7lAPTg1y0WtS2935N4CNx6YwRXTphwpXPIDcd6IVFPYdSk6dr9R8Zw2SxGB2pGbeDtzg80FiV2AHPsKazfLtJAJ71oYjMk/Kq4IPUjg1LtKR7mJyPTtTAzOpRdwC9TThwFGT6Y9aQmJhdvOPcelD87RjA7jHanEBs9CvTI7UwkySFgcEdOetAhxXgYA9qYzZb72SOopjPk4+YfSlAzlsjI9eDQNIr3AbaMEg5pOfu4wDwT3pxBKEk5OeOajMaPCVbJyCDgkH86Vrl30MuWQWmpTSzQzSq6KI3RC+0d1x255pumRmKKYGNoY3kLRxN1QYHbtzziq98oa/kjW3vJGjRctHPtUDHHfrUWm3UKNsMN1H5khUGV93zAcjOeOKT20Ety5YXE0vMqFWBwp9a0CrCUEMc4wc9qjDbQN4yM8Y5pZiSRjgDt3qNkat3d7Gdq+kpqEiMWKyKeDVzSLaO0hxGSxPGT61Kh3DK7uD0qzGvPIAOKFCPNzIp1ZcvI9i3E/IJIB6896VzucjjJqv5i4OecDn0FSRthfvfL19DWl+hj5j0MiEjHy+tWQQRyegqpGXV8KSVzkg/0qyZABwRtxnkU0hNksbFhjjrSBY1LEAgk/nUXmB8DGTjgg1m6jqyWs6LgkqNzc9KJTUVdlQhKbsjZjJIyoGc9CKdIwXAZjuJ5ANUrO/FxBFLGASffkCrQkQnAwzdeneqTT2IlFxeo+YrjATBNVwjMmHfJznKjHFPkVfMRmBLhenam5IOSB9BQwW2hLnIIVs47Z6n0pn/LMPJhcc4zmo2dlBUrgdm96bGQse0OXJPXrk0rhsSiVTjIP+NULO4nkmnEybEDYQdOKspjzNxfpxxSSHaGwMj19aTu9Sk0tAE4fAQjhuWpjyAEkgf41Fjag4C9+aq+Y3msS4K46dAKTkNRuOkWZpfMaYCPOAo7U2RPlJjwfVj3qG8vEt4VJ6cnk8YptrfRXduDFgDOOtZpxvY1tLl5raEvmOBgD8u9DcKAvPYEcZqJmaIMS/wCXWs/U9WaCJJVGDnqeMUnJRWo4wc3ZGkMJKAF5bnpUzSIo3ZOAcHJxXN6HrjXs80WGLLyGI6VvRkSBlOW9OetEJqavEKtN05WkSiXJLAcDpz2qaNmD8c5HAA61BvKrs2bhnGB2p9vJulbHVTg5q0zNrS5bjk2IR0HY0qMMgucDoKiD/vRkcHqTShtr7Nmd3JJ9aq5JbVh0UgkUyQ4fg/XPaoz9zC5BGOc0RuWyWGT0x1zQ2CXUfIink559D0rnbjxOILwwtjCtg5Oa3lbAGVxzXMa14c+23/2iFvLYnLL2PvWNZzt7h04b2d2qp1EdyJI8oVbjJ/HvUyMSoZwA/QlegqnplsLa2RE+fbgc8HFWi20MyqQOpFbRbtqYTSvaOxIMBi6Elcc+lPDqR5g/nTIlGwFQMHkCnSqeMfd9KaIdjP16QizdI3AJU49q5KK4W50mSKGSOLUIjmLdxuPp/wDXqz4muykhjLYGetYGnoLy5IxuHX61wVal6h6+HoKNK7fma813daj5Ed1bL5oALSLnAPeux092FtEMHGMYPBFUNMsjAwZzuGOgHT6VqoWG0KNo9a6aUWtWcNeope7HYmXlhszn2pJ/3alsZHcmnxEKoOCc9CaCdzHOSDXRa6OPqV4LpJFYREEfxZFTnaU47jBINRyhVOFG0j26U5XVVbcw2gdvWktNGKXdDVDIm1myBnnHWooIdoChhtBz9KdIeeOfWmszKowBnuaTGhX+YE9CD2pgYDbvUhT3zSGTJCg4J9O9RyShcj5tvY9qVykhZmUKeBu6epqqTsGFPX9akc8HBwScg9RTJMKFC45H5UmNKxh6o/l3UnkSyebIAZI1h8wcdD2wajt4Y5vJmW5eTZI0jhl2lpMY59MelXLlLuK7lltFidJgC6uxGCBjOfSq9sCn2hpHQytJmQIOFOBx+WKG9AWrNNCcDkYPPPan8ZzgY96pxSp5gG4Z71YEvBDFcfXtUJ3NGrMfLL5ByFLIeuDU8RLxrJgr7E1CGVgCMYHQ0ofltpOM9x1PtTWjEx00rh02KCv8XPNXEcMRg4+tVY8cnaC1KJVVuhOT0WqWmpO+hbZyGz17DFORz3/x4qo2Pv73I/ug1LGyhySxyR09ad9RWJx8q5AIIPA9BWTqGmi8uRJK5AxtO3v7VfMshfaFPJ4JOc1IyYAxz6mlKKmrMqE5U3dFfToVsv3SoAgAwQetaYAIycDuPWqKKqbyuWI65PSnxyEZZm6+tOOmhNRuTuWmdwF8vOO5/wAKY2/zNxK7cZx6GoUeRnDFhjqBU7EEE7gT9aq9ydhNxY/Njbik3Acbdqimsy7fkYH0FQs3GSpZiOx4oYLUlkk24EQXA6nPOKhNwsh+QjA4JPrSt83yBB7nNVyEj6YxnCjFS73KSQ6QD5mc5Ynio1jAZiSCWPIxnFEhKugDZLDk+lN859jM4CheKWlyktLnDeN7qdLp4YgzIw4KVpeEY5E0qJrgFXJJOeDW7NDFMQzxgj1xyaahAfylwCvNc8aVp87Z2TxHNSVNLYlnIWMBV5J71R1G2S6twkyA56c1ZuWOcrjjqx9KapAwGyw6+taSV9Dni3GzMux0+HT438lCGfq2c1tWgXOd+D15qFAHUlVCemR0+tSRh9jKCDilCPLsOcnPVjpJG3EREnB5Aq4ifu1fHPrVVEkOcAYBqxlxhcgcZ6VZD7D4WEiNsbIz9KdCjmUMpyoGMH+dRxyHqU2rnOasIUfAGD3FNK4m7BkIQr5VumPWh0WM70JJBzQijaPm3Behxk0Nlmwg49fSn0JT1J4mDr3J4I4pGBViVGSeKbEcfe4PYVKQPlOcg/rTSuhXsyJPklAUcEc4qwhBOSTjvntUDZEnKbT0DYoCgFS75J69s0IfoTNKI1KnOz+9SpypIyQehzUMm7OFAcZ6H0p4BC4Q8DrmmK2hk69pq3sW35WYc81h6bpDwXR+cqw6HGeK7DAyMA++acIIlGUxyaydGMpcxvHEyhDkERMIB6D71IXJlKqcjvnvUzZ2kEjHpRwmcjkDg9q2sc3NbcaOW2Ddt68dM05QAT1wOlRTb1GQfm9KTzWC/dORyTjpS2E7vUkfDZ3AewqNGDZCjGKVwj4aT5ucg+hqEyMA+w7D6n+dDAeXww4zuHP9KZKkhBIGOcdKcv8Aq8liT7U1XbywGOT9e9BSYx26HAJHBHTFRFiwYkZA79jUTzkzmID7v8R6Uy5UzDG47SfSsy0u5MZhsVtu49CKguZGWEtHGWcDIXOM/jTY9xJXptxgk9aRpBGpLsAuMkt6UXuDWpmyX1+2Nmn4PvMP8KbYCZvtBmjSJpJS+3O7AwB1/Coxe75fNitLp4j0IXAYeuDU0d4j7XhUrglWBGCp9MUrvqFlfQfAowNycnkGpQnz7m69uO1VHztCI2DjIzU0Tlo/n+8OMg1K7F3e5dXGAD8o61JhT8qc9waqrIcjJGPfvUqspC4OR04qkQTmbap8w9OpqS1ZWQSZ4Jz1qs+CCrDP4Ui3CxYj2MTngetNOz1HbTQ0HPzcY5HSkibLDcoDcj1qB2HYHnpn1oV9rkb1J9M8iquTbSxYIEZyD09etMkufM2hdwHqMVC82F3OwKDPJrCbXFWW4OwlYsfvCMLz/WolNI1p0nPZHTq6FQWJLN2HenOQnynJJ71iaPqpvs7hgL39a1tpLjPPeqjJSV0RODpy5WShip3bevv3pzyFME+n0xTVbGQoJP6UhLOuWwuTwPSqIHRvvBGNozziqeragtlEWDZYjCrjp71M0ZUHcQee1YfiPT7i7ZTAMKByTWdSUlHTc2oxi5pSeguk6xJd3Xls7KoBJ/2q1oiQGeQg85Arm9E0eSGd5rqT5jwoHArpYwqAK2No7mppczXvF4nkU/cHbWKbmI4GcH0qCRlcEEZUDJzwKmYgBiWJPt3qteKZ4doYoG6960ehgnd2Yj7WfLEcDIwKr71Xc6hix49SadGqqQoYYAwc9TTygDHnBPalYd7ELOH4C5CrjPekEkYYjkMBgDGKbLIFJGenT0zUQVVm8zIL479alspeZLDI5Lbgd2e3pUN1qsFuQFYn+8R0z6U3U52jtJFi+90HPSuOFyztJuOwRgbhuznnk49OlZzm17sTqoUVNc0tjtbnUWWFZEYf3j/9amWeuCWIPMdjE5Izya5G2uzIZUt3YxIcZIxkZ7VELzDE4VIt2BI7ZycfoKydSVzoWHhy6npySCZFaM4TqSRWbc6u8IfyIy0adZAOP/1VFospk0yIsOCOMelY+qLd6bff6PGJLd/4T+v51tOT5UzlpU1zuL1Z1On3/wBqtBMgwwOCVNXFuGklKSRFcDO71rE8NRlbQONp384Hb2rcQ8ZbGO3fitYNuKbOepyxk0iTaSVYEYHPPpU1uRuIXgHpn1qpFvDMS6lQflxwfxp0jJtOAyev+NWnYza6FqUt03cZwVNMGwN0ypPSmK5CLh9zdyacrK52kDjn3p7iWhLGX2ttI5OQT6U3pKF6nHam7TkHfgHsajlb925QttH6GgFqywAOVGTzyfSmvuV9wYYHYiuftbq/i1Mxyc25zgk8mt4yHYCfu4544qYzUkXUpODWojM+8NkHI6npTzKy/KQDxwRUMYZXJbkHoBU3ynBA+b3qkQx6MAhBPPrUXzZKgjbnOM96kA+T5jzVeXcSVT5cHqaZBNIeRySo6CoWKnPcj24pzMQv8NQRspJXeGcdaTYJEhLMhVQfopxj3qKQMqBuN7cEdcUpfbnafc+lZ19qMcJAfkex5z6VEpJK7NIQlN2RO20MBkADv60km4soQ8D73vWfb6lFOxztDHjaeuatNIQqHjPpUqSa0LcXF6jmUKH7N0z71BMqSQukvPmAqfXFKZScfMNw7f1qOTc6uHXdng4460XEUit9bxjbLA6JgAtGc46c4ohiMaSM7l5ZX3s2MDOMDA/Cqgs7eAOk8vzbjtzMwJHuM1PFBHEuyEsFJzyxbmiT6Cj3Ay8Anqp6VOsqtHkZAPcCqYkAOMZyPyqZcMnOcjpWd7GpObjylGRnHHSrXnAx4z16VQjkUjhskcEYp25mZWXqByDVXaE/M1VkJQY57c04SLnJI3A9/WoUKxoCVyT2x0quURmJOTz2q9jNGgk4L4B5z1qNSvmnBXfjnPpUAKggjgj1pzSqASwAA6mi99x2Keu+a0CiJyhBzlRw1cTK10C0KCVmkY/L2r0CTbKARlCvUD0pRBDuD8HB5461jOm5u6OujifZxs1cz/DFrPZWbG4AL9QBzXSRkcMRy38NU4MLkIcAn6VPFuBwMMfbtW1NcqsctWbnJyZMZedowPw6CnAdhx6k1EUDujtgEUu4iTC42jqSc1XqZ27E4dcbeTjgio5GySTzjsajBw5deD1zTFPOfveme1O4JC/KCztyT2NOyO+MAZqu8oyyKwz1+lIZF8xUY4PYk/rU3Q7EwO7J9+tVp3RhtYbVJwCe9SuNzYyQo6VVkbPMijg4HFNgl3FkzuOAMEdahkY+cDuPAxSoSzu3y7emM9KidlyJBzjgelToytdiO4VJHGMgg7sA0hJUfIo5IH4UwcsxB/ePgn0pfN2ttOM9sd6l6DRneJSEtcI3zc4Gf1rhore4u528qOSSMrtDj5Tn3J6ivQL2FLofvVGQc4PanWltDEm+NACfWsXFylc7aeIVOny21MjRdFa20/8A0gkM2Advamy+Gkluy6lvI/2jmt6SVlQiNQSTjmpYjgFW6N1x6elP2cdiPrFRu9yzZlYYEWMBgByRVk/Mh3LnsM81QRfIt2EBzwduaSyklZFE/wDrTk5I/KtE+hg1e8jTtY/ITahVQORUkjb8EPyOoHeqaTJkh/kI9O49atR7Ixlccgd+1WuxDve5MhAyrYXnINLuY5z07Gq4OHCsTtHIJ/lUoZc5AIYHkU0SyVCQ4AO4jt61l6lqz2V4I1KluuPbNaicnOD9fSqmpabb36YuNu8fdOcVNRScfd3NKUoRl760LdjdrdW6TAnbjnJ6GpEcqrNLgY6/SqtjbC0gWKMEKDz71YnB8vCjIPGDzkVSva73Jly81lsRFVlkWYDjOAR0IqaAzFnR8FB0pIidipwPbHT2qXeQCFAyPaml1JlLoPGAcDr0pC5KsqHBGM0O2FzkZ6jFRgeYwJI3eoNVchdyUNtJBfJ689qjd22EFySO/rQdrZYHp1HrUEpBO3f7/SkwSCGfen7xCGHHFQxxpBI0sQwz8nvSuXLZ7Y7CmPIQ/wA3yjtkVL8ytehNIwMZAHzGuQ1u/NhqS+dCjwSEEs3b3FdMJUfPze+Ky9Ts0vIXDxhh05HSs6qclobYeShL3tjlL7UXGqQyb03scEIf4e36V2FvIJVRwPkx3rlIPDTRzb1cdcgV1FqjQxbDtwByeorKmpXdzfEzptJQJ2LA7hzn2ptwWe3kWI7HK4VvfHWogyhgAxJbpxxTbyZ1t5PKbLKhI+vat7nG0ZLNZhI45LF96j5t0O4k+ue9TaerwxyMsbRxM2Y0Y8qP854qFWligjubSaS5GP3qsc7vXHoR6UlhdmX7S4csgl+X24HHtTZKJBPtbKqelEU29c9MngVGpyoVVyep9Kex+Q7cDvisrGt0SAqgLN3NSC8VWKsw3Nziq07o0QVs4AznPWuNF9df2rKk0bsxYeVxkfWplPk2NqNJVb67Ho8MxkjBx1HepIyGbd06/Q1n2SsIl8xtpPUDsateYVLcg+1aX0MWkmWcOWDOvHbimzeWCAWG0+lRCQgA4Iz05qOCRmLb0XG7jnrQ2NItxuW5yy9zUyOqMGY4B7VTt58s4ZcBTj1xTp0aWHKPgk8HpxRfsFtbMvxO2SWACg8c81OshLYU4H061RTdGoyCzAc5NPWZhjacE+nUVd7ENXLbNkkH7p4C0TccKfqPwqHftbnOM9fesbUdaVLloySwQckdqUpKK1Kp05Tdom+CWGMjaOmKSRiy4QLuHQHpWTot/FdQkK2c5JJPSr7TIpXnA7D1pqSauhTg4S5X0AwDYQThifmIqrf3sVrC7sPuDG73qaViQG6Zqpe2cdxAyFshz83pmpls0ioNXXMM0vVPt0J8pcFeDk9qtsQQQxG4c/Q1mx/ZtLtWESEAnr1JPrWfda8m8RquCeuOtRz8qtLc1dJzbdNaGwoCA7T8rfw+tKOF9PQVDDKWRCSAAM4/WlB3MW/gA5Jq0zBisNoAUkHv3zVWOQebwwJAwO+KrvfRXF55aHBAPy5p+AHypwenSk2nsVyuOjHOzFm8vBOMDPFTWwk8pBKy71+8QOtMTLE4XjH+ealjUxy4DA8Y+lK2tw5rqxYXYI2CkAZ6k96fGI+DkHPc1Wf5pRx8mM4pUG0u2GJOO/H4UxFxGIU9OO1RxS8H5doBxk1Gsq5Y980TAugG7C5z0ouCJjEJVB+oIPep4FWOBUHKjoSelVQ3yqCSVznirAlCjkdsk01bcTb2LQO4EDB9M9qepyAASW4PPasS/wBQNrcw8ZhY4z71opK8gDYAz0z6UKabsNwaSl3NFZBkZbB9Oxo4JJByR2P+NVQdxI6ehI6U/c2A+/cV4wKu5BZLBnBPXGMg01mkeQqwBjxw2e/pUaMQSGAUeuKWORevH0z3oAkU7lZBhSeuacjYABbpwBVeMEAiT5sHOacU3urbSCBxg9aYtyYkANtBJ7AdqjzhiWG3vmmhtrFg/P55pHmjxlgMngHrQBJcOrqD82BzmoTL1JHuKr30spjCxfKpxzimq5/iJBPepb1BKyJRK7HAUjv1qCSUKcyNxnAB9aUuMDJH9aguGUJwA2KGNDvN3N8rBT79cU4gFchj15xWdKWaTcnGAOvepHkI+UHBIpJ9wfkWX4QhXwT+OKi+dlKn8aqvc+WypyxPccU8ybl6nmkmnoOzRLuCbQhyO+e1RSMAzEdB2qMy7MKTxUFzLmGcQ53MpA9elFhEMt8p3mJWdT3RDtB+o60qNlQ67CX5yOhNUQ4MEoVZjn/VlBwBjjBHTHeks5NodnfIL9Qe+Bkj2zmhoOZi287IoPXGPxqy8gYFduAfeiipWxT3QsKAhY2yQQeSadDDGjDCgkd8UUUkVd3Lo4jJHUUE7gjEc4HSiimwHOxDrg1K0ayRjI6c/jRRQAwtsbIHX04qWCViDk5zxRRSRoloXQx8vHr1NIi5Xlj1oorQxRWvi6WcilyeCQemK8x1LWZImliSJczAAuSSR9KKK56256eCSaZ2fg5T/ZySZ+Zzg10JQOylsEjnOKKK1p/CjjxP8RjgdwOemM4qN3beoBwD1oorQwK93GJURH53HFUZ7C3hwyIC+7GTzRRWckjWMmlZEnKrySR0ArO165eGxO3oTj8KKKUtgppe0RxGl30p1e2yeZGwTmu+Y7mHoo6etFFZ0djfGfEiwg3HGT0xVa9vWgc4UMQMZJoorWWxz0knLUu2spljVmAyVqWFmJ+U7c/pRRTRMhC5eYpwByD70+NyYQOmfSiiktw6D921SKlTlc+owRRRVIl7DQquxDqrJ6EdKt7QF2qSBmiinETF5weeBjHtUsLl1APpRRT6iGiZgyIeQafcIqMjKCDu9aKKGNbkysQC55IpiymSIseCvPFFFUQKzfrVaVQisF/iyaKKl7FDCM4yc4qGYYicEkhfWiik9hrcZbv5gJYDIFK43IB0oopLYHuV1i2KzBj61Xkk/wBkZFFFMTFUDnIBI7kdj2oDbUJHXNFFAmVz824kmhVxt5zyaKKRSKkttE8shKYznIBIB+oFQNGpJIGAOgHSiigR/9k=);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Multiple erythematous papules with scale are typically present in guttate psoriasis.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Seborrheic dermatitis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 346px; height: 330px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    This patient has involvement of the retroauricular area.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Goodheart, HP. Goodheart's photoguide of common skin disorders, 2nd ed., Lippincott Williams &amp; Wilkins, Philadelphia 2003. Copyright &copy; 2003 Lippincott Williams &amp; Wilkins.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Seborrheic dermatitis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 350px; height: 247px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Typical involvement of the cheeks and nasolabial folds is present.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Goodheart, HP. Goodheart's photoguide of common skin disorders, 2nd ed., Lippincott Williams &amp; Wilkins, Philadelphia 2003. Copyright &copy; 2003 Lippincott Williams &amp; Wilkins.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f8_22_8554=[""].join("\n");
var outline_f8_22_8554=null;
var title_f8_22_8555="Rx enterococci UTI";
var content_f8_22_8555=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F73620&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F73620&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Oral therapy for susceptible enterococcal urinary tract infections*",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tr>",
"      <td class=\"subtitle1\">",
"       Regimen",
"      </td>",
"      <td class=\"subtitle1\">",
"       Dosage and route",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Nitrofurantoin",
"      </td>",
"      <td>",
"       100 mg twice daily for five days",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Fosfomycin",
"      </td>",
"      <td>",
"       3 g (single dose)",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Amoxicillin (+/- clavulanic acid)&bull;",
"      </td>",
"      <td>",
"       875 mg twice daily for five days",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Penicillin",
"      </td>",
"      <td>",
"       500 mg four times daily for five days",
"      </td>",
"     </tr>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     * Management should include removal of urinary catheter, if possible; this intervention alone has been observed to cure enterococcal urinary catheter-associated infections in some cases.",
"     <br>",
"      &bull; Infections due to beta lactamase producing enterococci requiring oral therapy can be treated with amoxicillin-clavulanic acid.",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f8_22_8555=[""].join("\n");
var outline_f8_22_8555=null;
var title_f8_22_8556="Prev PICC cath infection";
var content_f8_22_8556=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F57970&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=10\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F57970&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=10\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Prevention of infection with peripherally inserted central venous catheters",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Replacement and relocation of catheter",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Do not routinely replace peripherally inserted central venous catheters (PICC).",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Replacement of catheter-site dressing",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"1\">",
"        Replace dressing when the catheter is removed or replaced, or when the dressing becomes damp, loosened, or soiled. Replace dressings more frequently in diaphoretic patients.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"1\">",
"        There is no need to remove a gauze or opaque dressing if the patient has no clinical signs of infection.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Replacement of administration sets",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Replace administration sets, including secondary sets and add-on devices, no more frequently than at 72-hour intervals, unless clinically indicated.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"1\">",
"        Replace tubing used to administer blood, blood products, or lipid emulsions within 24 hours of initiating the infusion.",
"        <strong>",
"         No recommendation*",
"        </strong>",
"        for replacement of tubing used for intermittent infusions.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"1\">",
"        Replace tubing used to administer propofol infusions every 6 or 12 hours, depending on its use.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Hang time for parenteral fluids",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Complete infusion of lipids or lipid-containing parenteral nutrition fluids (eg, 3-in-1 solutions) within 24 hours of hanging the fluid. When lipid emulsions are given alone, complete the infusion within 12 hours of hanging the emulsion.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Complete infusion of blood or blood products within four hours of hanging the blood.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <strong>",
"         No recommendation*",
"        </strong>",
"        for the hang time of intravenous fluids, including nonlipid-containing parenteral nutrition fluids.",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     *&nbsp;No recommendation is made when there is insufficient data in the literature.",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f8_22_8556=[""].join("\n");
var outline_f8_22_8556=null;
var title_f8_22_8557="Parenteral rx VRE";
var content_f8_22_8557=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F60674&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F60674&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Parenteral therapy for infections due to vancomycin resistant enterococci",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tr>",
"      <td class=\"subtitle1\">",
"       Regimen",
"      </td>",
"      <td class=\"subtitle1\">",
"       Dosage* and route",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle2_left\" colspan=\"2\">",
"       Ampicillin-susceptible enterococci",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\" colspan=\"2\">",
"       <strong>",
"        Monotherapy:",
"       </strong>",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent2\">",
"       Ampicillin (+/- sulbactam)&bull;",
"      </td>",
"      <td>",
"       6-12 g per 24 hours in 6 equally divided doses",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\" colspan=\"2\">",
"       <strong>",
"        Combination therapy:",
"       </strong>",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\" colspan=\"2\">",
"       <strong>",
"        Above plus one of the following:",
"       </strong>",
"       (for bactericidal activity)&Delta;",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent2\">",
"       Gentamicin&loz;",
"      </td>",
"      <td>",
"       3 mg/kg per 24 hours in 3 equally divided doses",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent2\">",
"       Streptomycin&sect;",
"      </td>",
"      <td>",
"       15 mg/kg per 24 hours in 2 equally divided doses",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle2_left\" colspan=\"2\">",
"       Ampicillin-resistant E faecium: One of the following",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       High-dose ampicillin&yen;",
"      </td>",
"      <td>",
"       18-30 g per day&Dagger;",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Linezolid",
"      </td>",
"      <td>",
"       1200 mg per 24 hours in 2 equally divided doses",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\" rowspan=\"2\">",
"       Daptomycin&dagger;",
"      </td>",
"      <td>",
"       For E faecalis: 4 mg/kg every 24 hours (approved dose for complicated skin and soft tissue infection)",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Higher dosing (8 to 12 mg/kg every 24 hours) may be more efficacious for life threatening infections due to E. faecalis or E. faecium.",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Tigecycline**",
"      </td>",
"      <td>",
"       100 mg loading dose followed by maintenance dosing 50 mg every 12 hours",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Quinupristin-dalfopristin",
"      </td>",
"      <td>",
"       22.5 mg/kg per 24 hours in 3 equally divided doses",
"      </td>",
"     </tr>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     * Dosages recommended are for patients with normal renal function.",
"     <br>",
"      &bull; Infections due to beta lactamase producing enterococci may be treated with ampicillin-sulbactam.",
"      <br>",
"       &Delta; Synergistic activity of a cell wall-active agent in combination with gentamicin or streptomycin is required for bactericidal activity, which is warranted in the setting of invasive infections such as endocarditis, meningitis and bacteremia in the setting of valvulopathy and/or critical illness.",
"       <br>",
"        &loz; In patients with normal renal function, gentamicin dosing should be adjusted to achieve a 1-hour serum concentration of 3 mcg/mL and a trough concentration of &lt;1 mcg/mL.",
"        <br>",
"         &sect; In patients with normal renal function, streptomycin dosing should be adjusted to achieve a 1-hour serum concentration of 20 to 35 mcg/mL and a trough concentration of &lt;10 mcg/mL.",
"         <br>",
"          &yen; Some E faecium are ampicillin sensitive. If MIC 16-64 mcg/mL, E faecium may be treated with high-dose ampicillin.",
"          <br>",
"           &Dagger; With or without aminoglycoside (gentamicin or streptomycin).",
"           <br>",
"            &dagger; Although daptomycin has approval only for vancomycin-sensitive E. faecalis, many favor using this agent for treatment of infections due to isolates that are resistant to approved agents (including vancomycin-resistant E. faecalis and E. faecium). Appropriate dosing for soft tissue infections due to vancomycin-sensitive E. faecalis is 4 mg/kg intravenously once daily. Approved dosing for bloodstream infections due to S. aureus is 6 mg/kg intravenously once daily; some routinely use doses of 8 mg/kg intravenously once daily. Doses of up to 12 mg/kg appeared to be safe in a small number of volunteers and could be considered for life treatening VRE infections with relatively high MICs.",
"            <br>",
"             ** Although tigecycline has approval only for soft tissue and intraabdominal infections due to vancomycin-sensitive E. faecalis, some favor using this agent for treatment of non-bacteremic infections due to isolates that are resistant to approved agents (including vancomycin-resistant E. faecalis and E. faecium).",
"            </br>",
"           </br>",
"          </br>",
"         </br>",
"        </br>",
"       </br>",
"      </br>",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f8_22_8557=[""].join("\n");
var outline_f8_22_8557=null;
var title_f8_22_8558="Predicting platelet recovery";
var content_f8_22_8558=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=HEME%2F51649&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=HEME%2F51649&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 520px\">",
"   <div class=\"ttl\">",
"    Predicting recovery of the platelet count post chemotherapy",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 500px; height: 283px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    This graph indicates the ability of two different measurements of \"reticulated\" platelets to predict spontaneous recovery of platelet counts following chemotherapy. The two measurements shown are percent reticulated platelets (x-axis) and the mean fluorescence of reticulated platelets (platelet maturation index, y-axis). Patients with at least a 20,000/microL increase in platelet count over the ensuing 48 hours without platelet transfusion are shown as closed red circles, while those not showing spontaneous recovery within this time period are shown as open blue circles. When both parameters were normal or low (ie, data points falling within the box outlined with dashes) spontaneous recovery within the next 48 hours was not seen, with a negative predictive value of 91 percent. When one or both parameters were increased (ie, data points falling outside of the box), recovery within 48 hours was predicted with a postive predictive value of 82 percent.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Data from:&nbsp;Wang C, Smith BR, Ault KA, Rinder HM. Reticulated platelets predict platelet count recovery following chemotherapy. Transfusion 2002; 42:368.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f8_22_8558=[""].join("\n");
var outline_f8_22_8558=null;
var title_f8_22_8559="Ossification centers patella";
var content_f8_22_8559=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F68483&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F68483&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 476px\">",
"   <div class=\"ttl\">",
"    Saupe's classification of accessory ossification centers of the patella",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 456px; height: 168px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Type III accounts for 75 percent of bipartite patella (see text).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f8_22_8559=[""].join("\n");
var outline_f8_22_8559=null;
